[{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/LsBBcXbiBT","expanded_url":"http://www.emcdda.europa.eu/news/2015/fs5/western-balkans-report","display_url":"emcdda.europa.eu/news/2015/fs5/…"},{"start":112,"end":134,"url":"http://t.co/h5hMBHdDUE","expanded_url":"https://twitter.com/nigelhawtin/status/585795865371115520/photo/1","display_url":"pic.twitter.com/h5hMBHdDUE"}],"mentions":[{"start":3,"end":15,"username":"nigelhawtin","id":"269395266"},{"start":21,"end":28,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":73,"end":87,"probability":0.4971,"type":"Place","normalized_text":"Western Balkans"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_585795284652978176"]},"conversation_id":"586081953977339904","possibly_sensitive":false,"created_at":"2015-04-09T08:23:21.000Z","referenced_tweets":[{"type":"retweeted","id":"585795865371115520"}],"id":"586081953977339904","text":"RT @nigelhawtin: via @EMCDDA First overview of the drug situation in the Western Balkans http://t.co/LsBBcXbiBT http://t.co/h5hMBHdDUE"},{"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/APuyNLFeLq","expanded_url":"http://bit.ly/safefoodchat","display_url":"bit.ly/safefoodchat"}],"mentions":[{"start":3,"end":11,"username":"WHOatEU","id":"3042231323"},{"start":63,"end":74,"username":"WHO_Europe","id":"125403342"},{"start":77,"end":85,"username":"ECDC_EU","id":"204752573"},{"start":92,"end":100,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":22,"end":37,"tag":"WorldHealthDay"},{"start":44,"end":57,"tag":"safefoodchat"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"585365996569001984","possibly_sensitive":false,"created_at":"2015-04-07T08:58:23.000Z","referenced_tweets":[{"type":"retweeted","id":"585357806523539456"}],"id":"585365996569001984","text":"RT @WHOatEU: Today is #WorldHealthDay! Join #safefoodchat with @WHO_Europe , @ECDC_EU &amp; @EFSA_EU at 14.00-15.00 CEST http://t.co/APuyNLFeLq"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/LXeI3otsQ3","expanded_url":"http://www.emcdda.europa.eu/best-practice#view-answer18","display_url":"emcdda.europa.eu/best-practice#…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"582899409526112256","possibly_sensitive":false,"created_at":"2015-03-31T13:37:03.000Z","referenced_tweets":{},"id":"582899409526112256","text":"Neptune project launched clinical guidance for managing New Psychoactive Substances, see EMCDDA Best Practice Portal http://t.co/LXeI3otsQ3"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/TagxbuG4Nb","expanded_url":"https://twitter.com/WHO/status/580290466559692800/photo/1","display_url":"pic.twitter.com/TagxbuG4Nb"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":20,"end":33,"tag":"Tuberculosis"},{"start":110,"end":116,"tag":"EndTB"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":769,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_580290464550633472"]},"conversation_id":"580434798935691265","possibly_sensitive":false,"created_at":"2015-03-24T18:23:34.000Z","referenced_tweets":[{"type":"retweeted","id":"580290466559692800"}],"id":"580434798935691265","text":"RT @WHO: It's World #Tuberculosis Day - over 37 million lives have been saved, but much more needs to be done #EndTB http://t.co/TagxbuG4Nb"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/l2RzT7zbpz","expanded_url":"http://bit.ly/1bqjNCS","display_url":"bit.ly/1bqjNCS"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"annotations":[{"start":13,"end":18,"probability":0.9678,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":73,"end":86,"tag":"tuberculosis"},{"start":110,"end":121,"tag":"WorldTBDay"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"580434709475381248","possibly_sensitive":false,"created_at":"2015-03-24T18:23:13.000Z","referenced_tweets":[{"type":"retweeted","id":"580383333554720768"}],"id":"580434709475381248","text":"RT @ECDC_TB: Europe in need of tailored interventions: evidence brief on #tuberculosis http://t.co/l2RzT7zbpz #WorldTBDay http://t.co/ZdoGJ…"},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/6W30SW3ZXF","expanded_url":"http://www.emcdda.europa.eu/publications/2015/western-balkans-report","display_url":"emcdda.europa.eu/publications/2…"},{"start":101,"end":123,"url":"http://t.co/GHpbnQVNOG","expanded_url":"https://twitter.com/EMCDDA/status/580022724954853377/photo/1","display_url":"pic.twitter.com/GHpbnQVNOG"}],"mentions":{},"annotations":[{"start":53,"end":67,"probability":0.2699,"type":"Place","normalized_text":"Western Balkans"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":17,"reply_count":1,"like_count":10,"quote_count":1},"attachments":{"media_keys":["3_580022724032118784"]},"conversation_id":"580022724954853377","possibly_sensitive":false,"created_at":"2015-03-23T15:06:08.000Z","referenced_tweets":{},"id":"580022724954853377","text":"Just published: Drug use and its consequences in the Western Balkans 2006–14: http://t.co/6W30SW3ZXF http://t.co/GHpbnQVNOG"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/cZznC0PEyF","expanded_url":"http://www.lisbonaddictions.eu/start#register","display_url":"lisbonaddictions.eu/start#register"}],"mentions":{},"annotations":{},"hashtags":[{"start":60,"end":75,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"579980452536168448","possibly_sensitive":false,"created_at":"2015-03-23T12:18:10.000Z","referenced_tweets":[{"type":"retweeted","id":"579978070892892160"}],"id":"579980452536168448","text":"RT @Lxaddictions15: REGISTER NOW — limited places available #Lxaddictions15 \nMake sure you don't miss out: http://t.co/cZznC0PEyF"},{"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/ppiUzZSDeb","expanded_url":"http://eepurl.com/bgqp1P","display_url":"eepurl.com/bgqp1P"},{"start":107,"end":129,"url":"http://t.co/eJVN2bvxbo","expanded_url":"http://eepurl.com/5fZaP","display_url":"eepurl.com/5fZaP"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":35,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"579980424425943040","possibly_sensitive":false,"created_at":"2015-03-23T12:18:03.000Z","referenced_tweets":[{"type":"retweeted","id":"579977412517167104"}],"id":"579980424425943040","text":"RT @Lxaddictions15: #Lxaddictions15 newsletter just published http://t.co/ppiUzZSDeb  Subscribe to updates http://t.co/eJVN2bvxbo"},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/uuouyxq8XX","expanded_url":"http://bit.ly/1Evlqsn","display_url":"bit.ly/1Evlqsn"},{"start":101,"end":123,"url":"http://t.co/9z331F6A54","expanded_url":"https://twitter.com/EMA_News/status/578150531484557312/photo/1","display_url":"pic.twitter.com/9z331F6A54"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_578150530570137600"]},"conversation_id":"578955297017966593","possibly_sensitive":false,"created_at":"2015-03-20T16:24:33.000Z","referenced_tweets":[{"type":"retweeted","id":"578150531484557312"}],"id":"578955297017966593","text":"RT @EMA_News: We've published a book today to celebrate our 20th anniversary: http://t.co/uuouyxq8XX http://t.co/9z331F6A54"},{"entities":{"urls":{},"mentions":{},"annotations":[{"start":36,"end":54,"probability":0.6769,"type":"Organization","normalized_text":"Programme Committee"}],"hashtags":[{"start":20,"end":35,"tag":"LxAddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"578876278427766784","possibly_sensitive":false,"created_at":"2015-03-20T11:10:34.000Z","referenced_tweets":[{"type":"retweeted","id":"578874175735115776"}],"id":"578876278427766784","text":"RT @Lxaddictions15: #LxAddictions15 Programme Committee decided today to double conference sessions due to enormous interest in event! http…"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/fRBlSp0RqX","expanded_url":"http://goo.gl/GLYuhp","display_url":"goo.gl/GLYuhp"}],"mentions":[{"start":3,"end":17,"username":"EUEnvironment","id":"22362552"}],"annotations":{},"hashtags":[{"start":97,"end":110,"tag":"biodiversity"},{"start":111,"end":116,"tag":"SOER"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"578131896221233152","possibly_sensitive":false,"created_at":"2015-03-18T09:52:39.000Z","referenced_tweets":[{"type":"retweeted","id":"578131294242103297"}],"id":"578131896221233152","text":"RT @EUEnvironment: European environment - state &amp;outlook 2015: Today taking a closer look at #biodiversity #SOER http://t.co/fRBlSp0RqX htt…"},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/TlRSDJSL8a","expanded_url":"https://twitter.com/CE_PTrep/status/576376113208918016/photo/1","display_url":"pic.twitter.com/TlRSDJSL8a"}],"mentions":[{"start":3,"end":12,"username":"CE_PTrep","id":"1114731362"},{"start":15,"end":22,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":70,"end":73,"tag":"UE"},{"start":75,"end":83,"tag":"UEjovem"}]},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_576376087766298625"]},"conversation_id":"576376203688460288","possibly_sensitive":false,"created_at":"2015-03-13T13:36:10.000Z","referenced_tweets":[{"type":"retweeted","id":"576376113208918016"}],"id":"576376203688460288","text":"RT @CE_PTrep: .@EMCDDA informa os jovens sobre o consumo de drogas na #UE. #UEjovem http://t.co/TlRSDJSL8a"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/wW7Pko4HKO","expanded_url":"http://prevention-standards.eu/cnd-2015-side-event-developing-and-promoting-quality-standards-in-drug-demand-reduction/","display_url":"prevention-standards.eu/cnd-2015-side-…"},{"start":108,"end":130,"url":"http://t.co/F9DAFBVmcy","expanded_url":"https://twitter.com/pbm_ab/status/575997846849253378/photo/1","display_url":"pic.twitter.com/F9DAFBVmcy"}],"mentions":[{"start":3,"end":10,"username":"pbm_ab","id":"382602234"}],"annotations":{},"hashtags":[{"start":30,"end":38,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_575997845565616128"]},"conversation_id":"576003331916734464","possibly_sensitive":false,"created_at":"2015-03-12T12:54:30.000Z","referenced_tweets":[{"type":"retweeted","id":"575997846849253378"}],"id":"576003331916734464","text":"RT @pbm_ab: If you missed our #CND2015 side event, you can read it up about it here: http://t.co/wW7Pko4HKO http://t.co/F9DAFBVmcy"},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/qttQDyiQjO","expanded_url":"https://twitter.com/daniloballotta/status/575997725658988544/photo/1","display_url":"pic.twitter.com/qttQDyiQjO"}],"mentions":[{"start":0,"end":15,"username":"daniloballotta","id":"1260106290"},{"start":17,"end":24,"username":"EMCDDA","id":"50638521"},{"start":71,"end":79,"username":"cnd2015","id":"2229496241"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_575997717253619713"]},"conversation_id":"575997725658988544","possibly_sensitive":false,"created_at":"2015-03-12T12:53:00.000Z","referenced_tweets":[{"type":"replied_to","id":"575997725658988544"}],"id":"576002954748145664","text":"@daniloballotta: @EMCDDA taking part at a talk on drugs and driving at @cnd2015 http://t.co/qttQDyiQjO","in_reply_to_user_id":"1260106290"},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/2kZutNnBMg","expanded_url":"http://www.seea.net/","display_url":"seea.net"}],"mentions":{},"annotations":[{"start":17,"end":29,"probability":0.3188,"type":"Place","normalized_text":"S.E. European"},{"start":35,"end":42,"probability":0.638,"type":"Place","normalized_text":"Adriatic"},{"start":82,"end":98,"probability":0.4009,"type":"Organization","normalized_text":"Slovene Symposium"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575989105684774912","possibly_sensitive":false,"created_at":"2015-03-12T11:57:58.000Z","referenced_tweets":{},"id":"575989105684774912","text":"Participating at S.E. European and Adriatic drug addiction treatment conference &amp; Slovene Symposium on hepatis C: http://t.co/2kZutNnBMg"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/pinSAFPBeK","expanded_url":"http://futuralia.fil.pt/","display_url":"futuralia.fil.pt"},{"start":110,"end":132,"url":"http://t.co/DHcGbLKEZ3","expanded_url":"https://twitter.com/EMCDDA/status/575962711286218752/photo/1","display_url":"pic.twitter.com/DHcGbLKEZ3"}],"mentions":{},"annotations":[{"start":35,"end":40,"probability":0.6036,"type":"Organization","normalized_text":"EMCDDA"}],"hashtags":[{"start":21,"end":31,"tag":"Futuralia"},{"start":78,"end":86,"tag":"UEjovem"}]},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575962711286218752","possibly_sensitive":false,"created_at":"2015-03-12T10:16:26.000Z","referenced_tweets":[{"type":"replied_to","id":"575962711286218752"}],"id":"575963552286146560","text":"Venha visitar-nos na #Futuralia. O EMCDDA está no stand c11 da União Europeia #UEjovem http://t.co/pinSAFPBeK http://t.co/DHcGbLKEZ3","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/g0gSVNKRpm","expanded_url":"http://on.fb.me/1NJJVqW","display_url":"on.fb.me/1NJJVqW"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":36,"end":45,"username":"Facebook","id":"217804739"},{"start":56,"end":69,"username":"EP_President","id":"818837224003289088"}],"annotations":[{"start":70,"end":75,"probability":0.9113,"type":"Person","normalized_text":"Martin"}],"hashtags":[{"start":77,"end":84,"tag":"Schulz"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575960421619859456","possibly_sensitive":false,"created_at":"2015-03-12T10:03:59.000Z","referenced_tweets":[{"type":"retweeted","id":"575662484582973440"}],"id":"575960421619859456","text":"RT @Europarl_EN: Don't miss today's @Facebook chat with @EP_President Martin #Schulz! Kicks off here in 10'  http://t.co/g0gSVNKRpm http://…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"nzdrug","id":"36256235"},{"start":93,"end":99,"username":"ONDCP","id":"1355187199457841153"},{"start":100,"end":111,"username":"CCSACanada","id":"242412733"},{"start":112,"end":119,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":84,"end":92,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575944439505547265","possibly_sensitive":false,"created_at":"2015-03-12T09:00:29.000Z","referenced_tweets":[{"type":"retweeted","id":"575921848577310721"}],"id":"575944439505547265","text":"RT @nzdrug: Presenting today on a framework for action on drug driving - 1.10pm, M7 #CND2015 @ONDCP @CCSACanada @EMCDDA http://t.co/aaz5nI2…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":40,"end":47,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":27,"end":38,"probability":0.7495,"type":"Person","normalized_text":"Marica Ferri"}],"hashtags":[{"start":18,"end":26,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575654949624889344","possibly_sensitive":false,"created_at":"2015-03-11T13:50:09.000Z","referenced_tweets":[{"type":"retweeted","id":"575654009828196352"}],"id":"575654949624889344","text":"RT @Hep_Alliance: #CND2015 Marica Ferri @EMCDDA \"Evidence does not make decisions - people do\""},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/XxVQ1EfSRv","expanded_url":"https://twitter.com/EMCDDA/status/575653025877991424/photo/1","display_url":"pic.twitter.com/XxVQ1EfSRv"},{"start":94,"end":116,"url":"http://t.co/XxVQ1EfSRv","expanded_url":"https://twitter.com/EMCDDA/status/575653025877991424/photo/1","display_url":"pic.twitter.com/XxVQ1EfSRv"}],"mentions":{},"annotations":[{"start":75,"end":91,"probability":0.7582,"type":"Organization","normalized_text":"Trimbos Institute"}],"hashtags":[{"start":18,"end":26,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_575653016436633602","3_575653016440815616"]},"conversation_id":"575653025877991424","possibly_sensitive":false,"created_at":"2015-03-11T13:42:31.000Z","referenced_tweets":{},"id":"575653025877991424","text":"Side event now at #CND2015: The public health approach — Best practices by Trimbos Institute. http://t.co/XxVQ1EfSRv"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/9zCEMJWk3P","expanded_url":"http://www.emcdda.europa.eu/publications/manuals/prevention-standards","display_url":"emcdda.europa.eu/publications/m…"}],"mentions":{},"annotations":{},"hashtags":[{"start":105,"end":113,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575644019935559680","possibly_sensitive":false,"created_at":"2015-03-11T13:06:43.000Z","referenced_tweets":{},"id":"575644019935559680","text":"For more on the topic of quality standards, see our manual  'European drug prevention quality standards' #CND2015 http://t.co/9zCEMJWk3P"},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/Txo2573hB2","expanded_url":"https://twitter.com/EMCDDA/status/575637163800412162/photo/1","display_url":"pic.twitter.com/Txo2573hB2"},{"start":66,"end":88,"url":"http://t.co/Txo2573hB2","expanded_url":"https://twitter.com/EMCDDA/status/575637163800412162/photo/1","display_url":"pic.twitter.com/Txo2573hB2"},{"start":66,"end":88,"url":"http://t.co/Txo2573hB2","expanded_url":"https://twitter.com/EMCDDA/status/575637163800412162/photo/1","display_url":"pic.twitter.com/Txo2573hB2"}],"mentions":{},"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_575637147593502720","3_575637147606110208","3_575637147597697024"]},"conversation_id":"575637163800412162","possibly_sensitive":false,"created_at":"2015-03-11T12:39:29.000Z","referenced_tweets":{},"id":"575637163800412162","text":"Right now at #CND2015: quality standards in drug demand reduction http://t.co/Txo2573hB2"},{"entities":{"urls":{},"mentions":{},"annotations":[{"start":60,"end":76,"probability":0.5096,"type":"Organization","normalized_text":"Trimbos Institute"}],"hashtags":[{"start":19,"end":27,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575590188438667265","possibly_sensitive":false,"created_at":"2015-03-11T09:32:49.000Z","referenced_tweets":{},"id":"575590188438667265","text":"We will co-chair a #CND2015 side event on Best practices by Trimbos Institute. Today, 14.20-15.10, M6"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":8,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575579573728985090","possibly_sensitive":false,"created_at":"2015-03-11T08:50:38.000Z","referenced_tweets":{},"id":"575579573728985090","text":"#CND2015 side event today: Developing and promoting quality standards in drug demand reduction (13.10-14.00,M3) with EMCDDA involvement"},{"entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/m2SgOImDzo","expanded_url":"http://www.emcdda.europa.eu/news/2015/cnd","display_url":"emcdda.europa.eu/news/2015/cnd"}],"mentions":{},"annotations":{},"hashtags":[{"start":14,"end":22,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575331374447640576","possibly_sensitive":false,"created_at":"2015-03-10T16:24:23.000Z","referenced_tweets":{},"id":"575331374447640576","text":"The EMCDDA at #CND2015. Find out more on our events page http://t.co/m2SgOImDzo"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/GQD5t2DJ2T","expanded_url":"http://eepurl.com/bgwaab","display_url":"eepurl.com/bgwaab"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"575329076359077890","possibly_sensitive":false,"created_at":"2015-03-10T16:15:15.000Z","referenced_tweets":{},"id":"575329076359077890","text":"Deadline for scholarships and early-bird fee for this year's European drugs summer school: apply until 15 March! http://t.co/GQD5t2DJ2T"},{"entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/X40uVo71V6","expanded_url":"https://twitter.com/EMCDDA/status/575230113224200192/photo/1","display_url":"pic.twitter.com/X40uVo71V6"}],"mentions":{},"annotations":{},"hashtags":[{"start":9,"end":17,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":5,"quote_count":0},"attachments":{"media_keys":["3_575230106530115584"]},"conversation_id":"575230113224200192","possibly_sensitive":false,"created_at":"2015-03-10T09:42:00.000Z","referenced_tweets":{},"id":"575230113224200192","text":"Day 2 at #CND2015 - session on \"Drugs and crime\" http://t.co/X40uVo71V6"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/aMHLU9sliI","expanded_url":"http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances","display_url":"emcdda.europa.eu/publications/2…"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":40,"end":47,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":87,"end":92,"probability":0.9933,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"574999336137977856","possibly_sensitive":false,"created_at":"2015-03-09T18:24:59.000Z","referenced_tweets":[{"type":"retweeted","id":"574999260413976576"}],"id":"574999336137977856","text":"RT @andcunningham: &gt; 100 new drugs! “@EMCDDA: report on new psychoactive substances in Europe here: http://t.co/aMHLU9sliI http://t.co/wMVE…"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/9xql3FZZtD","expanded_url":"https://twitter.com/EMCDDA/status/574959315531993088/photo/1","display_url":"pic.twitter.com/9xql3FZZtD"}],"mentions":{},"annotations":{},"hashtags":[{"start":96,"end":104,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"attachments":{"media_keys":["3_574959308112334848"]},"conversation_id":"574959315531993088","possibly_sensitive":false,"created_at":"2015-03-09T15:45:57.000Z","referenced_tweets":{},"id":"574959315531993088","text":"Printed copies of today's report and poster on new psychoactive substances are available at our #CND2015 stand http://t.co/9xql3FZZtD"},{"entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/MLqKEM1uR5","expanded_url":"http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances/poster","display_url":"emcdda.europa.eu/publications/2…"}],"mentions":[{"start":3,"end":11,"username":"profhrs","id":"189969652"},{"start":40,"end":47,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":19,"end":21,"probability":0.4617,"type":"Organization","normalized_text":"NPS"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"574955573671804928","possibly_sensitive":false,"created_at":"2015-03-09T15:31:05.000Z","referenced_tweets":[{"type":"retweeted","id":"574955424014843904"}],"id":"574955573671804928","text":"RT @profhrs: Great NPS infographic from @EMCDDA http://t.co/MLqKEM1uR5"},{"entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/sSqKJAhruT","expanded_url":"http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances","display_url":"emcdda.europa.eu/publications/2…"},{"start":95,"end":117,"url":"http://t.co/SpsDdebBob","expanded_url":"https://twitter.com/EMCDDA/status/574955185484742656/photo/1","display_url":"pic.twitter.com/SpsDdebBob"}],"mentions":{},"annotations":[{"start":54,"end":59,"probability":0.9533,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":27,"reply_count":1,"like_count":10,"quote_count":0},"attachments":{"media_keys":["3_574955184675233793"]},"conversation_id":"574955185484742656","possibly_sensitive":false,"created_at":"2015-03-09T15:29:33.000Z","referenced_tweets":{},"id":"574955185484742656","text":"Download our report on new psychoactive substances in Europe 2013 here: http://t.co/sSqKJAhruT http://t.co/SpsDdebBob"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/DcfHYjwPui","expanded_url":"http://buff.ly/1E16501","display_url":"buff.ly/1E16501"}],"mentions":[{"start":3,"end":15,"username":"DroguesInfo","id":"90431580"},{"start":100,"end":107,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":17,"end":21,"tag":"NPS"},{"start":22,"end":29,"tag":"Europe"}]},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"574953046985326592","possibly_sensitive":false,"created_at":"2015-03-09T15:21:03.000Z","referenced_tweets":[{"type":"retweeted","id":"574952030302781441"}],"id":"574953046985326592","text":"RT @DroguesInfo: #NPS #Europe : évolutions récentes du marché des nouvelles drogues (anglais) - via @EMCDDA http://t.co/DcfHYjwPui"},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/FWkSiJjTW6","expanded_url":"http://www.emcdda.europa.eu/news/2015/1/cnd-new-drugs","display_url":"emcdda.europa.eu/news/2015/1/cn…"}],"mentions":{},"annotations":[{"start":40,"end":41,"probability":0.7313,"type":"Place","normalized_text":"EU"}],"hashtags":[{"start":106,"end":114,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"574952960389726208","possibly_sensitive":false,"created_at":"2015-03-09T15:20:42.000Z","referenced_tweets":{},"id":"574952960389726208","text":"New psychoactive substances detected in EU last year at rate of around 2 per week: http://t.co/FWkSiJjTW6 #CND2015"},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/NBj9ZHS5vi","expanded_url":"https://twitter.com/EMCDDA/status/574940325032124416/photo/1","display_url":"pic.twitter.com/NBj9ZHS5vi"}],"mentions":{},"annotations":{},"hashtags":[{"start":45,"end":53,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_574940318417682432"]},"conversation_id":"574940325032124416","possibly_sensitive":false,"created_at":"2015-03-09T14:30:30.000Z","referenced_tweets":{},"id":"574940325032124416","text":"Pick up a copy of our latest publications at #CND2015 http://t.co/NBj9ZHS5vi"},{"entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"UNODC","id":"17969699"}],"annotations":{},"hashtags":[{"start":51,"end":59,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"574897056730513408","possibly_sensitive":false,"created_at":"2015-03-09T11:38:34.000Z","referenced_tweets":[{"type":"retweeted","id":"574857000078688256"}],"id":"574897056730513408","text":"RT @UNODC: The 2015 Commission on Narcotic Drugs - #CND2015 - is about to begin. Catch today’s opening session live at http://t.co/3evCXlJq…"},{"entities":{"urls":{},"mentions":{},"annotations":[{"start":12,"end":17,"probability":0.9301,"type":"Place","normalized_text":"Vienna"},{"start":84,"end":93,"probability":0.537,"type":"Place","normalized_text":"M-building"}],"hashtags":[{"start":0,"end":8,"tag":"CND2015"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPad","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"574886644911898625","possibly_sensitive":false,"created_at":"2015-03-09T10:57:11.000Z","referenced_tweets":{},"id":"574886644911898625","text":"#CND2015 in Vienna: our exhibition stand with recent publications is located in the M-building. Come and visit us!"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"profhrs","id":"189969652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"573834722750627841","possibly_sensitive":false,"created_at":"2015-03-06T13:17:13.000Z","referenced_tweets":[{"type":"retweeted","id":"573807399406080000"}],"id":"573834722750627841","text":"RT @profhrs: LJMU have annouced new PhD scholarships. If you have an idea for a drug project then please feel free to contact me http://t.c…"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/BS3EL2OBGD","expanded_url":"http://eepurl.com/7PuOX","display_url":"eepurl.com/7PuOX"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"573834151092174848","possibly_sensitive":false,"created_at":"2015-03-06T13:14:57.000Z","referenced_tweets":{},"id":"573834151092174848","text":"The latest issue of our best practice email newsletter on pregnancy and drug use just published: http://t.co/BS3EL2OBGD"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/chDbmoVzF8","expanded_url":"http://www.lisbonaddictions.eu","display_url":"lisbonaddictions.eu"}],"mentions":{},"annotations":{},"hashtags":[{"start":87,"end":102,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"573782415811940352","possibly_sensitive":false,"created_at":"2015-03-06T09:49:22.000Z","referenced_tweets":[{"type":"retweeted","id":"573760096603340800"}],"id":"573782415811940352","text":"RT @Lxaddictions15: Last day to submit your proposals for papers, posters and symposia #Lxaddictions15! Visit http://t.co/chDbmoVzF8 for de…"},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/ZtuCAP37qs","expanded_url":"http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_id=14UK01&tab=overview","display_url":"emcdda.europa.eu/html.cfm/index…"}],"mentions":[{"start":4,"end":10,"username":"idhdp","id":"388761105"},{"start":71,"end":78,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":12,"end":19,"probability":0.8876,"type":"Place","normalized_text":"Scotland"}],"hashtags":[{"start":32,"end":41,"tag":"Naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"572699093744660480","possibly_sensitive":false,"created_at":"2015-03-03T16:37:23.000Z","referenced_tweets":[{"type":"replied_to","id":"572699093744660480"}],"id":"572797931469856769","text":"MT: @idhdp: Scotland's National #Naloxone Programme highlighted in the @EMCDDA best practice portal http://t.co/ZtuCAP37qs","in_reply_to_user_id":"388761105"},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/QhH0JHkulM","expanded_url":"http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_id=14UK02&tab=overview","display_url":"emcdda.europa.eu/html.cfm/index…"}],"mentions":[{"start":4,"end":19,"username":"andrewbrown365","id":"105148303"},{"start":28,"end":35,"username":"EMCDDA","id":"50638521"},{"start":50,"end":64,"username":"MEAMcoalition","id":"78675298"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"572421678501912577","possibly_sensitive":false,"created_at":"2015-03-03T16:35:26.000Z","referenced_tweets":[{"type":"replied_to","id":"572421678501912577"}],"id":"572797441721954304","text":"MT: @andrewbrown365: Thanks @EMCDDA for including @MEAMcoalition in EDDRA http://t.co/QhH0JHkulM","in_reply_to_user_id":"105148303"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":74,"end":89,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"571358572212305920","possibly_sensitive":false,"created_at":"2015-02-27T17:17:53.000Z","referenced_tweets":[{"type":"retweeted","id":"571340682411036673"}],"id":"571358572212305920","text":"RT @Lxaddictions15: Extension of deadline for submission of abstracts for #Lxaddictions15 until 6 March! Find out more at http://t.co/dvGWB…"},{"entities":{"urls":{},"mentions":[{"start":20,"end":31,"username":"LindaBauld","id":"2595027218"}],"annotations":{},"hashtags":[{"start":93,"end":108,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"571316053902565376","possibly_sensitive":false,"created_at":"2015-02-27T14:28:56.000Z","referenced_tweets":[{"type":"retweeted","id":"570872256030773248"}],"id":"571316053902565376","text":"RT @Lxaddictions15: @LindaBauld, Professor of Health Policy, confirmed as keynote speaker at #Lxaddictions15. Find out more: http://t.co/wl…"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/HZ736qHwGC","expanded_url":"http://www.emcdda.europa.eu/news/2015/euro-den","display_url":"emcdda.europa.eu/news/2015/euro…"}],"mentions":{},"annotations":[{"start":8,"end":15,"probability":0.4206,"type":"Organization","normalized_text":"Euro-DEN"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"571280969531068416","possibly_sensitive":false,"created_at":"2015-02-27T12:09:31.000Z","referenced_tweets":{},"id":"571280969531068416","text":"Hosting Euro-DEN meeting today: 'When to call the emergency services for unwell recreational drug users': http://t.co/HZ736qHwGC"},{"entities":{"urls":{},"mentions":[{"start":4,"end":15,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"570980017204817921","possibly_sensitive":false,"created_at":"2015-02-26T17:00:53.000Z","referenced_tweets":[{"type":"replied_to","id":"570980017204817921"}],"id":"570991905779159040","text":"RT: @EDSSLisbon 2 weeks to go:deadline for the 1st phase of registrations is the 15 March","in_reply_to_user_id":"2213957400"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/4zYyAvoiuc","expanded_url":"http://www.thl.fi/en/web/thlfi-en/about-us/organisation/departments-and-units/health/alcohol-and-drugs/staff/pia-makela","display_url":"thl.fi/en/web/thlfi-e…"}],"mentions":{},"annotations":{},"hashtags":[{"start":68,"end":83,"tag":"Lxaddictions15"}]},"lang":"sv","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"569900850149257216","possibly_sensitive":false,"created_at":"2015-02-23T16:45:25.000Z","referenced_tweets":[{"type":"retweeted","id":"569792801141067776"}],"id":"569900850149257216","text":"RT @Lxaddictions15: Pia Mäkelä just confirmed as keynote speaker at #Lxaddictions15 on alcohol research and policy! http://t.co/4zYyAvoiuc"},{"entities":{"urls":[{"start":45,"end":67,"url":"http://t.co/6OOgRQieo8","expanded_url":"http://goo.gl/M5tHLJ","display_url":"goo.gl/M5tHLJ"}],"mentions":[{"start":68,"end":75,"username":"IDPCes","id":"1359827492"},{"start":76,"end":84,"username":"IDPCnet","id":"423396432"},{"start":85,"end":92,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"569873869714157568","possibly_sensitive":false,"created_at":"2015-02-23T14:58:12.000Z","referenced_tweets":[{"type":"retweeted","id":"569801165384364032"}],"id":"569873869714157568","text":"RT @drugpoliciesm: COPOLAD: Countries' views http://t.co/6OOgRQieo8 @IDPCes @IDPCnet @EMCDDA @CONSEP_Ecuador"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/cZznC0PEyF","expanded_url":"http://www.lisbonaddictions.eu/start#register","display_url":"lisbonaddictions.eu/start#register"}],"mentions":{},"annotations":{},"hashtags":[{"start":89,"end":104,"tag":"LXAddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"568386691435769856","possibly_sensitive":false,"created_at":"2015-02-19T12:28:42.000Z","referenced_tweets":[{"type":"retweeted","id":"568332164070301696"}],"id":"568386691435769856","text":"RT @Lxaddictions15: Only 10 days left to benefit from our early-bird fee to register for #LXAddictions15. Visit: http://t.co/cZznC0PEyF"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/cTH2prqPRG","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:C:2015:022A:FULL&from=EN","display_url":"eur-lex.europa.eu/legal-content/…"}],"mentions":{},"annotations":[{"start":106,"end":111,"probability":0.327,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"567359642310049792","possibly_sensitive":false,"created_at":"2015-02-19T12:27:53.000Z","referenced_tweets":[{"type":"replied_to","id":"567359642310049792"}],"id":"568386486581764096","text":"MT @EUlondonrep: Work for the EU: Director of the European Monitoring Centre for Drugs and Drug Addiction Lisbon http://t.co/cTH2prqPRG","in_reply_to_user_id":"111554274"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/VwOz6VnzDQ","expanded_url":"https://twitter.com/ungass2016/status/568019560588296192/photo/1","display_url":"pic.twitter.com/VwOz6VnzDQ"}],"mentions":[{"start":3,"end":14,"username":"ungass2016","id":"2558991061"}],"annotations":[{"start":34,"end":38,"probability":0.716,"type":"Organization","normalized_text":"UNODC"},{"start":50,"end":60,"probability":0.7802,"type":"Place","normalized_text":"Afghanistan"},{"start":66,"end":70,"probability":0.7228,"type":"Place","normalized_text":"Paris"}],"hashtags":[{"start":16,"end":27,"tag":"UNGASS2016"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_568019560478302208"]},"conversation_id":"568021612353552384","possibly_sensitive":false,"created_at":"2015-02-18T12:18:00.000Z","referenced_tweets":[{"type":"retweeted","id":"568019560588296192"}],"id":"568021612353552384","text":"RT @ungass2016: #UNGASS2016 prep: UNODC update on Afghanistan and Paris Pact, discussion on interregional approach http://t.co/VwOz6VnzDQ"},{"entities":{"urls":{},"mentions":{},"annotations":[{"start":20,"end":34,"probability":0.9934,"type":"Person","normalized_text":"Keith Humphreys"},{"start":37,"end":84,"probability":0.5922,"type":"Organization","normalized_text":"Professor of Psychiatry and Behavioural Sciences"}],"hashtags":[{"start":119,"end":134,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"567683914630963201","possibly_sensitive":false,"created_at":"2015-02-17T13:56:06.000Z","referenced_tweets":[{"type":"retweeted","id":"567681017205751808"}],"id":"567683914630963201","text":"RT @Lxaddictions15: Keith Humphreys, Professor of Psychiatry and Behavioural Sciences, confirmed as keynote speaker at #Lxaddictions15. htt…"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/AiEgLoOmm0","expanded_url":"http://www.emcdda.europa.eu/news/2015/ni6/wound-botulism","display_url":"emcdda.europa.eu/news/2015/ni6/…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"567364252378628096","possibly_sensitive":false,"created_at":"2015-02-16T16:45:53.000Z","referenced_tweets":{},"id":"567364252378628096","text":"ECDC and EMCDDA release a joint rapid risk assessment on wound botulism among people who inject heroin http://t.co/AiEgLoOmm0"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/cu5LeOOg4v","expanded_url":"http://www.emcdda.europa.eu//alias.cfm//publications/joint-publications/wound-botulism-norway-uk-2015","display_url":"emcdda.europa.eu//alias.cfm//pu…"}],"mentions":{},"annotations":[{"start":93,"end":94,"probability":0.9468,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"567363916305805312","possibly_sensitive":false,"created_at":"2015-02-16T16:44:33.000Z","referenced_tweets":{},"id":"567363916305805312","text":"Just published joint risk assessment on wound botulism in people who inject heroin in NO and UK http://t.co/cu5LeOOg4v?"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"EC_Budapest","id":"1904294538"},{"start":117,"end":124,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"hu","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565916683324620800","possibly_sensitive":false,"created_at":"2015-02-12T16:53:46.000Z","referenced_tweets":[{"type":"retweeted","id":"565862892432793600"}],"id":"565916683324620800","text":"RT @EC_Budapest: Pályázati felhívás -  Kábítószer és Kábítószerfüggőség Európai Megfigyelőközpontja igazgatót keres: @EMCDDA: http://t.co/A…"},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/mbanyLnXvT","expanded_url":"http://ec.europa.eu/portugal/comissao/premios_concursos_pt.htm","display_url":"ec.europa.eu/portugal/comis…"},{"start":102,"end":124,"url":"http://t.co/4xR9MEZytQ","expanded_url":"https://twitter.com/CE_PTrep/status/565557593998118912/photo/1","display_url":"pic.twitter.com/4xR9MEZytQ"}],"mentions":[{"start":3,"end":18,"username":"Luis_Huacuja_A","id":"157167481"},{"start":21,"end":30,"username":"CE_PTrep","id":"1114731362"},{"start":71,"end":78,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_565557588205375488"]},"conversation_id":"565916660549566464","possibly_sensitive":false,"created_at":"2015-02-12T16:53:40.000Z","referenced_tweets":[{"type":"retweeted","id":"565800698323824641"}],"id":"565916660549566464","text":"RT @Luis_Huacuja_A: “@CE_PTrep: Concurso de recrutamento -  Diretor do @EMCDDA http://t.co/mbanyLnXvT http://t.co/4xR9MEZytQ”"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/fpZwLIcayJ","expanded_url":"http://buff.ly/1DlrTXb","display_url":"buff.ly/1DlrTXb"}],"mentions":[{"start":3,"end":15,"username":"DroguesInfo","id":"90431580"},{"start":111,"end":118,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565916158722080768","possibly_sensitive":false,"created_at":"2015-02-12T16:51:41.000Z","referenced_tweets":[{"type":"retweeted","id":"565916015293644802"}],"id":"565916158722080768","text":"RT @DroguesInfo: L'Observatoire européen des Drogues (EMCDDA) recrute son directeur: http://t.co/fpZwLIcayJ cc @EMCDDA (anglais)"},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/cTH2pshDfS","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:C:2015:022A:FULL&from=EN","display_url":"eur-lex.europa.eu/legal-content/…"}],"mentions":{},"annotations":[{"start":70,"end":85,"probability":0.7364,"type":"Place","normalized_text":"Lisbon, Portugal"}],"hashtags":[{"start":88,"end":92,"tag":"job"},{"start":93,"end":99,"tag":"drugs"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"558566911269941248","possibly_sensitive":false,"created_at":"2015-02-12T16:45:10.000Z","referenced_tweets":[{"type":"replied_to","id":"560050254998167552"}],"id":"565914520083005440","text":"Little over a week (20 Feb) to apply for position of EMCDDA Director, Lisbon, Portugal, #job #drugs: http://t.co/cTH2pshDfS","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":41,"end":63,"url":"http://t.co/WXRSwR6CsE","expanded_url":"http://www.emcdda.europa.eu/publications/work-programmes/2015","display_url":"emcdda.europa.eu/publications/w…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565912545224310784","possibly_sensitive":false,"created_at":"2015-02-12T16:37:19.000Z","referenced_tweets":{},"id":"565912545224310784","text":"Just published: our 2015 work programme: http://t.co/WXRSwR6CsE"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/lKGWLHywgH","expanded_url":"http://www.emcdda.europa.eu/news/2015/hepatitis-c-medications","display_url":"emcdda.europa.eu/news/2015/hepa…"}],"mentions":{},"annotations":[{"start":0,"end":5,"probability":0.4442,"type":"Organization","normalized_text":"EMCDDA"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565912272825249793","possibly_sensitive":false,"created_at":"2015-02-12T16:36:14.000Z","referenced_tweets":{},"id":"565912272825249793","text":"EMCDDA welcomes new moves to make hepatitis C medications more accessible to patients: http://t.co/lKGWLHywgH"},{"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/paHkzyrugb","expanded_url":"http://eepurl.com/bdO2eT","display_url":"eepurl.com/bdO2eT"},{"start":116,"end":138,"url":"http://t.co/eJVN2bvxbo","expanded_url":"http://eepurl.com/5fZaP","display_url":"eepurl.com/5fZaP"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":35,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565799555074383872","possibly_sensitive":false,"created_at":"2015-02-12T09:08:20.000Z","referenced_tweets":[{"type":"retweeted","id":"565789136305807360"}],"id":"565799555074383872","text":"RT @Lxaddictions15: #Lxaddictions15 newsletter just published http://t.co/paHkzyrugb Subscribe to future updates at http://t.co/eJVN2bvxbo"},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/wUiPz5i8g6","expanded_url":"http://www.lisbonaddictions.eu/start#schedule","display_url":"lisbonaddictions.eu/start#schedule"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565799433305354241","possibly_sensitive":false,"created_at":"2015-02-12T09:07:51.000Z","referenced_tweets":[{"type":"retweeted","id":"565542171206750208"}],"id":"565799433305354241","text":"RT @Lxaddictions15: We just published the first draft of the conference programme http://t.co/wUiPz5i8g6 Regular updates will follow!"},{"entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/oAKzYYV7xM","expanded_url":"http://ec.europa.eu/portugal/comissao/premios_concursos_pt.htm","display_url":"ec.europa.eu/portugal/comis…"},{"start":84,"end":106,"url":"http://t.co/kkRJapru0q","expanded_url":"https://twitter.com/CE_PTrep/status/565557593998118912/photo/1","display_url":"pic.twitter.com/kkRJapru0q"}],"mentions":[{"start":3,"end":12,"username":"CE_PTrep","id":"1114731362"},{"start":53,"end":60,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_565557588205375488"]},"conversation_id":"565799318029078528","possibly_sensitive":false,"created_at":"2015-02-12T09:07:24.000Z","referenced_tweets":[{"type":"retweeted","id":"565557593998118912"}],"id":"565799318029078528","text":"RT @CE_PTrep: Concurso de recrutamento -  Diretor do @EMCDDA http://t.co/oAKzYYV7xM http://t.co/kkRJapru0q"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/4EgF221733","expanded_url":"https://twitter.com/daniloballotta/status/565488317169692673/photo/1","display_url":"pic.twitter.com/4EgF221733"}],"mentions":[{"start":3,"end":18,"username":"daniloballotta","id":"1260106290"}],"annotations":[{"start":20,"end":43,"probability":0.6055,"type":"Person","normalized_text":"Vice Ministro Luis Porto"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_565488279232188416"]},"conversation_id":"565539979146043392","possibly_sensitive":false,"created_at":"2015-02-11T15:56:52.000Z","referenced_tweets":[{"type":"retweeted","id":"565488317169692673"}],"id":"565539979146043392","text":"RT @daniloballotta: Vice Ministro Luis Porto opens the EU-CELAC meeting. UNGASS 16 on the agenda http://t.co/4EgF221733"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/z0DKWKjAQr","expanded_url":"https://twitter.com/daniloballotta/status/565236577405001731/photo/1","display_url":"pic.twitter.com/z0DKWKjAQr"}],"mentions":[{"start":3,"end":18,"username":"daniloballotta","id":"1260106290"}],"annotations":[{"start":20,"end":30,"probability":0.9669,"type":"Person","normalized_text":"Ann Fordham"},{"start":36,"end":50,"probability":0.9921,"type":"Person","normalized_text":"Teresa Salvador"},{"start":60,"end":66,"probability":0.3199,"type":"Organization","normalized_text":"Copolad"},{"start":79,"end":88,"probability":0.9877,"type":"Place","normalized_text":"Montevideo"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_565236550431412224"]},"conversation_id":"565434880604270592","possibly_sensitive":false,"created_at":"2015-02-11T08:59:15.000Z","referenced_tweets":[{"type":"retweeted","id":"565236577405001731"}],"id":"565434880604270592","text":"RT @daniloballotta: Ann Fordham and Teresa Salvador closing Copolad meeting in Montevideo today http://t.co/z0DKWKjAQr"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":36,"end":43,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":130,"end":136,"probability":0.9621,"type":"Place","normalized_text":"Finland"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"565434804083363840","possibly_sensitive":false,"created_at":"2015-02-11T08:58:57.000Z","referenced_tweets":[{"type":"retweeted","id":"565428793280823296"}],"id":"565434804083363840","text":"RT @andrewbrown365: Newsletter from @EMCDDA: internet &amp; drug markets, naloxone, harm reduction in prison, 'blanket ban' of NPS in Finland\nh…"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/AYpBayas8f","expanded_url":"http://bit.ly/1z0VVdU","display_url":"bit.ly/1z0VVdU"}],"mentions":[{"start":3,"end":17,"username":"EUHomeAffairs","id":"420461348"},{"start":132,"end":139,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"564830748696674304","possibly_sensitive":false,"created_at":"2015-02-09T16:58:39.000Z","referenced_tweets":[{"type":"retweeted","id":"564822279860015104"}],"id":"564830748696674304","text":"RT @EUHomeAffairs: The European Monitoring Centre for Drugs and Drug Addiction is looking for a new Director http://t.co/AYpBayas8f @EMCDDA"},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/BwnStgv0BC","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/89","display_url":"emcdda.europa.eu/publications/d…"},{"start":91,"end":113,"url":"http://t.co/rdEAYAmeRP","expanded_url":"https://twitter.com/EMCDDA/status/564829843788140545/photo/1","display_url":"pic.twitter.com/rdEAYAmeRP"}],"mentions":{},"annotations":[{"start":60,"end":65,"probability":0.3331,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_564829842852814848"]},"conversation_id":"564829843788140545","possibly_sensitive":false,"created_at":"2015-02-09T16:55:03.000Z","referenced_tweets":{},"id":"564829843788140545","text":"Just published: the latest issue of our Newsletter, Drugnet Europe: http://t.co/BwnStgv0BC http://t.co/rdEAYAmeRP"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/OP9NDrMfdA","expanded_url":"http://www.emcdda.europa.eu/news/2015/clen-meeting","display_url":"emcdda.europa.eu/news/2015/clen…"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":68,"end":75,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":19,"end":51,"probability":0.3779,"type":"Organization","normalized_text":"EU Customs Lab Scientists Network"},{"start":79,"end":84,"probability":0.9854,"type":"Place","normalized_text":"Lisbon"}],"hashtags":[{"start":97,"end":101,"tag":"nps"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"563692271212974080","possibly_sensitive":false,"created_at":"2015-02-06T13:34:45.000Z","referenced_tweets":[{"type":"retweeted","id":"563690442038849538"}],"id":"563692271212974080","text":"RT @andcunningham: EU Customs Lab Scientists Network (CLEN) meeting @emcdda in Lisbon to discuss #nps issues http://t.co/OP9NDrMfdA"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/XCIGx9yxct","expanded_url":"http://cort.as/Oqd-","display_url":"cort.as/Oqd-"}],"mentions":[{"start":97,"end":104,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":43,"end":95,"probability":0.2242,"type":"Other","normalized_text":"Observatorio Europeo de las Drogas y las Toxicomanías"}],"hashtags":{}},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"563266400048140290","possibly_sensitive":false,"created_at":"2015-02-05T09:22:29.000Z","referenced_tweets":[{"type":"retweeted","id":"563252405148876800"}],"id":"563266400048140290","text":"RT @EuropeDirectMur: Vacante: Director del Observatorio Europeo de las Drogas y las Toxicomanías @EMCDDA En: http://t.co/XCIGx9yxct http://…"},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/VUQpxrRssd","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/mortality-among-drug-users-in-europe","display_url":"emcdda.europa.eu/publications/e…"},{"start":107,"end":129,"url":"http://t.co/1S9qLByxHc","expanded_url":"https://twitter.com/EMCDDA/status/562655614401527808/photo/1","display_url":"pic.twitter.com/1S9qLByxHc"}],"mentions":{},"annotations":[{"start":46,"end":51,"probability":0.9978,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":5,"quote_count":0},"attachments":{"media_keys":["3_562655613486784512"]},"conversation_id":"562655614401527808","possibly_sensitive":false,"created_at":"2015-02-03T16:55:26.000Z","referenced_tweets":{},"id":"562655614401527808","text":"Just published: Mortality among drug users in Europe: challenges for public health: http://t.co/VUQpxrRssd http://t.co/1S9qLByxHc"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/QWiaIwL73x","expanded_url":"https://twitter.com/EMCDDA/status/562621507365789696/photo/1","display_url":"pic.twitter.com/QWiaIwL73x"}],"mentions":[{"start":75,"end":84,"username":"CE_PTrep","id":"1114731362"},{"start":85,"end":101,"username":"EUROPEDIRECTMAD","id":"1246527673"}],"annotations":[{"start":9,"end":26,"probability":0.5639,"type":"Organization","normalized_text":"Empreendededorismo"},{"start":35,"end":44,"probability":0.4043,"type":"Organization","normalized_text":"Park Hotel"}],"hashtags":{}},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_562621506501373952"]},"conversation_id":"562549903726243840","possibly_sensitive":false,"created_at":"2015-02-03T14:39:55.000Z","referenced_tweets":[{"type":"replied_to","id":"562580015188312064"}],"id":"562621507365789696","text":"Bolsa do Empreendededorismo Lagoas Park Hotel, Oeiras, 6 Fev, 9-19:00 2015 @ce_ptrep @europedirectmad http://t.co/QWiaIwL73x","in_reply_to_user_id":"1114731362"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":87,"end":102,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"562608287921995777","possibly_sensitive":false,"created_at":"2015-02-03T13:47:23.000Z","referenced_tweets":[{"type":"retweeted","id":"562282904626421761"}],"id":"562608287921995777","text":"RT @Lxaddictions15: Book your hotel until 28 February and get a special hotel rate for #Lxaddictions15 attendees! Visit http://t.co/OfAEl33…"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":86,"end":101,"tag":"Lxaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"561188319829442562","possibly_sensitive":false,"created_at":"2015-01-30T15:44:56.000Z","referenced_tweets":[{"type":"retweeted","id":"561119512108732416"}],"id":"561188319829442562","text":"RT @Lxaddictions15: Submit proposals for symposia, panel discussions and workshops at #Lxaddictions15 by 1 March. Details at http://t.co/Of…"},{"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/SAesgh2cQ1","expanded_url":"http://www.emcdda.europa.eu/publications/technical-reports/internet-drug-markets","display_url":"emcdda.europa.eu/publications/t…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"561177927178813441","possibly_sensitive":false,"created_at":"2015-01-30T15:03:38.000Z","referenced_tweets":{},"id":"561177927178813441","text":"Some weekend reading just published: The Internet and drug markets:  http://t.co/SAesgh2cQ1"},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/ODeR1Wqfo3","expanded_url":"http://www.emcdda.europa.eu/news/2015/fs3/internet-drug-markets","display_url":"emcdda.europa.eu/news/2015/fs3/…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"561177433098186752","possibly_sensitive":false,"created_at":"2015-01-30T15:01:40.000Z","referenced_tweets":{},"id":"561177433098186752","text":"New EMCDDA trendspotter study explores online supply of drugs: http://t.co/ODeR1Wqfo3"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":128,"end":135,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":77,"end":86,"tag":"naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"560748862101794816","possibly_sensitive":false,"created_at":"2015-01-29T10:38:41.000Z","referenced_tweets":[{"type":"retweeted","id":"560130967218962433"}],"id":"560748862101794816","text":"RT @andrewbrown365: ed &amp; training interventions + provision of take-home #naloxone decrease overdose related mortality says @EMCDDA http://…"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/IZBIv4K6Qq","expanded_url":"http://www.emcdda.europa.eu/attachements.cfm/att_234597_EN_2015_01_LIBE-Global%20Commission_UNGASS_web.pdf","display_url":"emcdda.europa.eu/attachements.c…"}],"mentions":{},"annotations":[{"start":25,"end":38,"probability":0.8405,"type":"Organization","normalized_text":"LIBE Committee"}],"hashtags":[{"start":85,"end":96,"tag":"UNGASS2016"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"560105968248561665","possibly_sensitive":false,"created_at":"2015-01-27T16:04:03.000Z","referenced_tweets":{},"id":"560105968248561665","text":"Director's speech to the LIBE Committee today on drug policies in the perspective of #UNGASS2016 — http://t.co/IZBIv4K6Qq"},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/cTH2pshDfS","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:C:2015:022A:FULL&from=EN","display_url":"eur-lex.europa.eu/legal-content/…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"558566911269941248","possibly_sensitive":false,"created_at":"2015-01-27T12:22:40.000Z","referenced_tweets":[{"type":"replied_to","id":"558566911269941248"}],"id":"560050254998167552","text":"Vacancy: Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): http://t.co/cTH2pshDfS Please RT :-)","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":57,"end":71,"tag":"effectiveness"},{"start":76,"end":97,"tag":"pharmacoepidemiology"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"560044326299119616","possibly_sensitive":false,"created_at":"2015-01-27T11:59:07.000Z","referenced_tweets":[{"type":"retweeted","id":"560043620141907968"}],"id":"560044326299119616","text":"RT @EMA_News: Two weeks left to apply for our tender for #effectiveness and #pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurem…"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/HPK9fYssXe","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.CA.2015.022.01.0001.01.ENG","display_url":"eur-lex.europa.eu/legal-content/…"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":34,"end":41,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":46,"end":51,"probability":0.9796,"type":"Place","normalized_text":"Lisbon"}],"hashtags":[{"start":12,"end":20,"tag":"vacancy"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"558599634806145024","possibly_sensitive":false,"created_at":"2015-01-23T12:18:25.000Z","referenced_tweets":[{"type":"retweeted","id":"558587864020418560"}],"id":"558599634806145024","text":"RT @EURLex: #vacancy: Director of @EMCDDA, in Lisbon (Temporary Agent - Grade AD14)\n Info and requirements: http://t.co/HPK9fYssXe"},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/cTH2pshDfS","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:C:2015:022A:FULL&from=EN","display_url":"eur-lex.europa.eu/legal-content/…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":22,"reply_count":3,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"558566911269941248","possibly_sensitive":false,"created_at":"2015-01-23T10:08:23.000Z","referenced_tweets":{},"id":"558566911269941248","text":"Vacancy: Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): http://t.co/cTH2pshDfS Please RT :-)"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/yJcsBh64MV","expanded_url":"http://www.emcdda.europa.eu/attachements.cfm/att_234521_EN_Speech21January_LIBE_Wolfgang_Goetz_Final_NPS.pdf","display_url":"emcdda.europa.eu/attachements.c…"}],"mentions":{},"annotations":[{"start":25,"end":43,"probability":0.3035,"type":"Organization","normalized_text":"European Parliament"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557950027193384960","possibly_sensitive":false,"created_at":"2015-01-21T17:17:07.000Z","referenced_tweets":{},"id":"557950027193384960","text":"Director's speech to the European Parliament today, on new psychoactive substances (PDF): http://t.co/yJcsBh64MV"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/4e4Gx7s0Kk","expanded_url":"http://www.emcdda.europa.eu/attachements.cfm/att_234522_EN_Speech21January_LIBE_Wolfgang_Goetz_Final_WP15.pdf","display_url":"emcdda.europa.eu/attachements.c…"}],"mentions":{},"annotations":[{"start":25,"end":43,"probability":0.3806,"type":"Organization","normalized_text":"European Parliament"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557949755150852096","possibly_sensitive":false,"created_at":"2015-01-21T17:16:02.000Z","referenced_tweets":{},"id":"557949755150852096","text":"Director's speech to the European Parliament today, presenting the agency's 2015 work programme (PDF) http://t.co/4e4Gx7s0Kk"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/u4eT6RgogP","expanded_url":"http://www.lisbonaddictions.eu/start#register","display_url":"lisbonaddictions.eu/start#register"}],"mentions":{},"annotations":[{"start":67,"end":72,"probability":0.9851,"type":"Place","normalized_text":"Lisbon"}],"hashtags":[{"start":37,"end":52,"tag":"LXAddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557938805479858176","possibly_sensitive":false,"created_at":"2015-01-21T16:43:09.000Z","referenced_tweets":[{"type":"replied_to","id":"557938805479858176"}],"id":"557941480623702017","text":"RT @Lxaddictions15: Registration for #LXAddictions15 conference in Lisbon is open! Early bird fees available: http://t.co/u4eT6RgogP","in_reply_to_user_id":"2961808739"},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/Q9VUgeioRw","expanded_url":"http://www.europarl.europa.eu/news/en/news-room/content/20150116IPR09925/html/Committee-on-Civil-Liberties-Justice-Home-Affairs-meeting-21-01-2015-1400","display_url":"europarl.europa.eu/news/en/news-r…"}],"mentions":{},"annotations":[{"start":24,"end":38,"probability":0.3182,"type":"Person","normalized_text":"EMCDDA Director"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557925045419642880","possibly_sensitive":false,"created_at":"2015-01-21T15:37:51.000Z","referenced_tweets":{},"id":"557925045419642880","text":"Watch a video stream of EMCDDA Director at the European Parliament: http://t.co/Q9VUgeioRw"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557478661759463424","possibly_sensitive":false,"created_at":"2015-01-20T10:04:05.000Z","referenced_tweets":[{"type":"retweeted","id":"557239162060148736"}],"id":"557478661759463424","text":"RT @toxicovigilance: Review: The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects http://t.co/OLGgd…"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/zQN0QGdjrU","expanded_url":"http://sco.lt/8TFoq9","display_url":"sco.lt/8TFoq9"}],"mentions":[{"start":3,"end":13,"username":"feditobxl","id":"2175780427"},{"start":90,"end":97,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":34,"end":43,"tag":"naloxone"},{"start":67,"end":76,"tag":"overdose"}]},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557478462529998848","possibly_sensitive":false,"created_at":"2015-01-20T10:03:17.000Z","referenced_tweets":[{"type":"retweeted","id":"557462025241362432"}],"id":"557478462529998848","text":"RT @feditobxl: Vidéo :  Take-home #naloxone programmes in Europe — #overdose prevention | @EMCDDA  http://t.co/zQN0QGdjrU"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/ET63MrHJCx","expanded_url":"http://goo.gl/zO7EjM","display_url":"goo.gl/zO7EjM"}],"mentions":[{"start":3,"end":10,"username":"CQDTox","id":"266003759"},{"start":34,"end":41,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":79,"end":88,"tag":"surdoses"}]},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557478246850494464","possibly_sensitive":false,"created_at":"2015-01-20T10:02:26.000Z","referenced_tweets":[{"type":"retweeted","id":"557478169293651968"}],"id":"557478246850494464","text":"RT @CQDTox: Nouveau document de l'@EMCDDA sur la prévention des décès liés aux #surdoses grâce au Naloxone | http://t.co/ET63MrHJCx"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/M64td6cHQs","expanded_url":"http://www.emcdda.europa.eu/news/2015/naloxone","display_url":"emcdda.europa.eu/news/2015/nalo…"}],"mentions":{},"annotations":[{"start":91,"end":96,"probability":0.9942,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"557177290342539264","possibly_sensitive":false,"created_at":"2015-01-19T14:06:32.000Z","referenced_tweets":{},"id":"557177290342539264","text":"Can naloxone provided in the community help reduce the thousands of drug-induced deaths in Europe every year? http://t.co/M64td6cHQs"},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/DetIJqgnxn","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/naloxone-effectiveness","display_url":"emcdda.europa.eu/publications/e…"},{"start":104,"end":126,"url":"http://t.co/vjLxlNbF6u","expanded_url":"https://twitter.com/EMCDDA/status/557159129828319232/photo/1","display_url":"pic.twitter.com/vjLxlNbF6u"}],"mentions":{},"annotations":{},"hashtags":[{"start":70,"end":79,"tag":"naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":36,"reply_count":6,"like_count":8,"quote_count":0},"attachments":{"media_keys":["3_557159129027190785"]},"conversation_id":"557159129828319232","possibly_sensitive":false,"created_at":"2015-01-19T12:54:22.000Z","referenced_tweets":{},"id":"557159129828319232","text":"Just published: a systematic review of the effectiveness of take-home #naloxone: http://t.co/DetIJqgnxn http://t.co/vjLxlNbF6u"},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/0L6YWX1IrF","expanded_url":"http://www.emcdda.europa.eu/news/2015/EDSS-registration","display_url":"emcdda.europa.eu/news/2015/EDSS…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"555763388941631489","possibly_sensitive":false,"created_at":"2015-01-15T16:28:12.000Z","referenced_tweets":{},"id":"555763388941631489","text":"Registration opens today for the fourth European drugs summer school: http://t.co/0L6YWX1IrF"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"555326811291541504","possibly_sensitive":false,"created_at":"2015-01-14T11:33:23.000Z","referenced_tweets":[{"type":"retweeted","id":"555288521054109696"}],"id":"555326811291541504","text":"RT @Lxaddictions15: Keep up-to-date with all relevant information and news about @Lxaddictions15. Subscribe to our Newsletter at http://t.c…"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/zf7QoK5BxG","expanded_url":"http://www.clubhealthlisbon2015.org","display_url":"clubhealthlisbon2015.org"}],"mentions":[{"start":3,"end":18,"username":"GregorBurkhart","id":"1119061916"}],"annotations":[{"start":20,"end":37,"probability":0.2472,"type":"Organization","normalized_text":"Club Health Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"554657113516294144","possibly_sensitive":false,"created_at":"2015-01-12T15:12:15.000Z","referenced_tweets":[{"type":"retweeted","id":"554609105588195329"}],"id":"554657113516294144","text":"RT @GregorBurkhart: Club Health Lisbon 2015: submit an abstract now! Closing date: Friday 30 January 2015\nhttp://t.co/zf7QoK5BxG&lt;http://t.c…"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/55hIQRISV5","expanded_url":"http://www.promedmail.org/direct.php?id=20150111.3084384","display_url":"promedmail.org/direct.php?id=…"}],"mentions":[{"start":0,"end":10,"username":"mathi__eu","id":"912152453050662912"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"554224577271054336","possibly_sensitive":false,"created_at":"2015-01-12T10:55:27.000Z","referenced_tweets":[{"type":"replied_to","id":"554575517840850945"}],"id":"554592486463909889","text":"@mathi__eu Yes wound botulism among people who inject drugs is seen as an on-going issue in some countries: http://t.co/55hIQRISV5","in_reply_to_user_id":"50638521"},{"entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"mathi__eu","id":"912152453050662912"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"554224577271054336","possibly_sensitive":false,"created_at":"2015-01-12T09:48:01.000Z","referenced_tweets":[{"type":"replied_to","id":"554224577271054336"}],"id":"554575517840850945","text":"@mathi__eu checking with the relevant in-house experts. Will get back to you as soon as I have something. Thanks!","in_reply_to_user_id":"2194607492"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"554574651243134977","possibly_sensitive":false,"created_at":"2015-01-12T09:44:35.000Z","referenced_tweets":[{"type":"retweeted","id":"554560132726943744"}],"id":"554574651243134977","text":"RT @Lxaddictions15: Don't miss the deadline: call for abstracts open until 1 March 2015! Find out more and download submission forms at htt…"},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/TiIUjltUrk","expanded_url":"http://fra.europa.eu/en/news/2015/eu-agencies-express-full-solidarity-victims-attack-french-magazine","display_url":"fra.europa.eu/en/news/2015/e…"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.6412,"type":"Organization","normalized_text":"EU Agencies"}],"hashtags":[{"start":102,"end":116,"tag":"JeSuisCharlie"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"553481645144440832","possibly_sensitive":false,"created_at":"2015-01-09T09:21:22.000Z","referenced_tweets":{},"id":"553481645144440832","text":"EU Agencies express full solidarity with victims of attack on French magazine: http://t.co/TiIUjltUrk #JeSuisCharlie"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/rqqxTLkL5z","expanded_url":"https://twitter.com/eu2015lv/status/553146061137920000/photo/1","display_url":"pic.twitter.com/rqqxTLkL5z"}],"mentions":[{"start":3,"end":12,"username":"eu2015lv","id":"3217949032"}],"annotations":[{"start":101,"end":108,"probability":0.6491,"type":"Place","normalized_text":"Brussels"}],"hashtags":[{"start":31,"end":40,"tag":"eu2015lv"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_553146050865680385"]},"conversation_id":"553203687792078848","possibly_sensitive":false,"created_at":"2015-01-08T14:56:51.000Z","referenced_tweets":[{"type":"retweeted","id":"553146061137920000"}],"id":"553203687792078848","text":"RT @eu2015lv: Opening event of #eu2015lv will be broadcast online. Starting at 18.00 Riga time/17.00 Brussels time. http://t.co/rqqxTLkL5z"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/PO8xOWKlMZ","expanded_url":"https://twitter.com/EMCDDA/status/553188586183745536/photo/1","display_url":"pic.twitter.com/PO8xOWKlMZ"}],"mentions":[{"start":57,"end":69,"username":"EMSA_LISBON","id":"23603194"}],"annotations":{},"hashtags":[{"start":83,"end":97,"tag":"JeSuisCharlie"},{"start":98,"end":111,"tag":"CharlieHebdo"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":["3_553188585286139904"]},"conversation_id":"553188586183745536","possibly_sensitive":false,"created_at":"2015-01-08T13:56:51.000Z","referenced_tweets":{},"id":"553188586183745536","text":"A minute's silence this morning with our colleagues from @EMSA_LISBON this morning #JeSuisCharlie #CharlieHebdo http://t.co/PO8xOWKlMZ"},{"entities":{"urls":[{"start":34,"end":56,"url":"http://t.co/FemSQlkg46","expanded_url":"https://twitter.com/EU_Commission/status/553113401292255232/photo/1","display_url":"pic.twitter.com/FemSQlkg46"},{"start":34,"end":56,"url":"http://t.co/FemSQlkg46","expanded_url":"https://twitter.com/EU_Commission/status/553113401292255232/photo/1","display_url":"pic.twitter.com/FemSQlkg46"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":19,"end":33,"tag":"JeSuisCharlie"}]},"lang":"und","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":775,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_553113399899729920","3_553113400344317952"]},"conversation_id":"553147198016598016","possibly_sensitive":false,"created_at":"2015-01-08T11:12:23.000Z","referenced_tweets":[{"type":"retweeted","id":"553113401292255232"}],"id":"553147198016598016","text":"RT @EU_Commission: #JeSuisCharlie http://t.co/FemSQlkg46"},{"entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/AIZIgt7sNF","expanded_url":"http://www.who.int/features/2014/year_review/en/","display_url":"who.int/features/2014/…"},{"start":81,"end":103,"url":"http://t.co/OvXozzUshw","expanded_url":"https://twitter.com/nigelhawtin/status/552774383899779072/photo/1","display_url":"pic.twitter.com/OvXozzUshw"}],"mentions":[{"start":3,"end":15,"username":"nigelhawtin","id":"269395266"},{"start":19,"end":23,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_552774382108422144"]},"conversation_id":"553135349120385024","possibly_sensitive":false,"created_at":"2015-01-08T10:25:18.000Z","referenced_tweets":[{"type":"retweeted","id":"552774383899779072"}],"id":"553135349120385024","text":"RT @nigelhawtin: . @WHO 2014 in review: key health issues http://t.co/AIZIgt7sNF http://t.co/OvXozzUshw"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/OfAEl33UWf","expanded_url":"http://www.lisbonaddictions.eu","display_url":"lisbonaddictions.eu"}],"mentions":{},"annotations":[{"start":51,"end":67,"probability":0.2952,"type":"Organization","normalized_text":"Lisbon Addictions"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"553133674011824128","possibly_sensitive":false,"created_at":"2015-01-08T10:18:39.000Z","referenced_tweets":[{"type":"retweeted","id":"553133316464214016"}],"id":"553133674011824128","text":"RT @Lxaddictions15: Opening soon: registration for Lisbon Addictions conference, 23-25 September. Keep updated: http://t.co/OfAEl33UWf &amp; fo…"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/bGXDWURSyR","expanded_url":"http://www.emcdda.europa.eu/data/2014","display_url":"emcdda.europa.eu/data/2014"}],"mentions":[{"start":3,"end":11,"username":"profhrs","id":"189969652"},{"start":13,"end":28,"username":"TransformDrugs","id":"59458901"},{"start":33,"end":40,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"553131202270756864","possibly_sensitive":false,"created_at":"2015-01-08T10:08:49.000Z","referenced_tweets":[{"type":"retweeted","id":"553116920980205569"}],"id":"553131202270756864","text":"RT @profhrs: @TransformDrugs the @EMCDDA data archive is useful for an overview of key mortality trends http://t.co/bGXDWURSyR ."},{"entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"JunckerEU","id":"169426475"}],"annotations":{},"hashtags":[{"start":61,"end":74,"tag":"CharlieHebdo"}]},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":731,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"552813813142409216","possibly_sensitive":false,"created_at":"2015-01-07T13:07:38.000Z","referenced_tweets":[{"type":"retweeted","id":"552809053546889216"}],"id":"552813813142409216","text":"RT @JunckerEU: Je suis profondément choqué par l'attaque sur #CharlieHebdo. J'exprime notre plus grande solidarité avec la France http://t.…"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/6RXD9KW47j","expanded_url":"http://isamdundee2015.com/abstracts/","display_url":"isamdundee2015.com/abstracts/"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"552520592382242816","possibly_sensitive":false,"created_at":"2015-01-06T17:42:29.000Z","referenced_tweets":[{"type":"retweeted","id":"552079590332850177"}],"id":"552520592382242816","text":"RT @mvapmoreira: International Society of Addiction Medicine | Congress 2015 - open call for abstracts http://t.co/6RXD9KW47j @ISAMDundee20…"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/ERfDuwzI8j","expanded_url":"http://ow.ly/G9JYI","display_url":"ow.ly/G9JYI"}],"mentions":[{"start":3,"end":17,"username":"Release_drugs","id":"63485178"},{"start":40,"end":47,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":62,"end":71,"tag":"naloxone"},{"start":92,"end":106,"tag":"HarmReduction"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"545902827500236800","possibly_sensitive":false,"created_at":"2014-12-19T11:25:51.000Z","referenced_tweets":[{"type":"retweeted","id":"545902628082040832"}],"id":"545902827500236800","text":"RT @Release_drugs: Informative video by @EMCDDA on the use of #naloxone in opioid overdose. #HarmReduction\nhttp://t.co/ERfDuwzI8j"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/vlInQeMeLX","expanded_url":"http://goo.gl/45skSa","display_url":"goo.gl/45skSa"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":[{"start":46,"end":67,"probability":0.347,"type":"Other","normalized_text":"2015 Lisbon Addictions"}],"hashtags":[{"start":80,"end":95,"tag":"LXaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"545630551949197312","possibly_sensitive":false,"created_at":"2014-12-18T17:23:55.000Z","referenced_tweets":[{"type":"retweeted","id":"545616688776249344"}],"id":"545630551949197312","text":"RT @mvapmoreira: A set replies to FAQs on the 2015 Lisbon Addictions conference #LXaddictions15 is now available on http://t.co/vlInQeMeLX"},{"entities":{"urls":[{"start":50,"end":73,"url":"https://t.co/J49MP8qVvb","expanded_url":"https://www.youtube.com/watch?v=zJKVKEu-6w4&feature=youtu.be","display_url":"youtube.com/watch?v=zJKVKE…"}],"mentions":{},"annotations":[{"start":21,"end":47,"probability":0.6143,"type":"Other","normalized_text":"2014 Scientific Paper Award"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"544909839722618882","possibly_sensitive":false,"created_at":"2014-12-16T17:40:04.000Z","referenced_tweets":{},"id":"544909839722618882","text":"See our video of the 2014 Scientific Paper Award: https://t.co/J49MP8qVvb"},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/CrMX1fFdlL","expanded_url":"http://www.emcdda.europa.eu/topics-a-z","display_url":"emcdda.europa.eu/topics-a-z"},{"start":109,"end":131,"url":"http://t.co/rSWPJOsQNm","expanded_url":"https://twitter.com/EMCDDA/status/543437020002287617/photo/1","display_url":"pic.twitter.com/rSWPJOsQNm"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_543437019087917056"]},"conversation_id":"543437020002287617","possibly_sensitive":false,"created_at":"2014-12-12T16:07:36.000Z","referenced_tweets":{},"id":"543437020002287617","text":"Our new Topics (A-Z) page to makes it easier than ever to find things on our website: http://t.co/CrMX1fFdlL http://t.co/rSWPJOsQNm"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"TimGluckman","id":"302152701"},{"start":83,"end":90,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":19,"end":25,"tag":"risky"},{"start":26,"end":30,"tag":"NPS"},{"start":31,"end":34,"tag":"MT"},{"start":39,"end":46,"tag":"opioid"},{"start":64,"end":69,"tag":"DMAR"},{"start":127,"end":134,"tag":"deaths"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"542614417356357632","possibly_sensitive":false,"created_at":"2014-12-10T09:38:53.000Z","referenced_tweets":[{"type":"retweeted","id":"542613784058396672"}],"id":"542614417356357632","text":"RT @TimGluckman: 2 #risky #NPS #MT-45 (#opioid like) &amp; 4-4'-#DMAR (stimulant): @EMCDDA have reports . Both involved in 30+ #deaths http://t…"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/uUQ1KKjm8q","expanded_url":"http://us7.campaign-archive2.com/?u=7661463396b2fc9d763392225&id=b646b9b426","display_url":"us7.campaign-archive2.com/?u=7661463396b…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"542602253488893952","possibly_sensitive":false,"created_at":"2014-12-10T08:50:32.000Z","referenced_tweets":{},"id":"542602253488893952","text":"Subscribe to our ur email newsletter — 'Just published' to keep up with our recent publications. Subscribe here: http://t.co/uUQ1KKjm8q"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/fiEEr67l5F","expanded_url":"http://prevention-standards.eu/emcdda-drugnet-europe-88-from-guidelines-to-quality-standards/?utm_source=feedly&utm_reader=feedly&utm_medium=rss&utm_campaign=emcdda-drugnet-europe-88-from-guidelines-to-quality-standards","display_url":"prevention-standards.eu/emcdda-drugnet…"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":21,"end":28,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":37,"end":42,"probability":0.6276,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"542373647315656704","possibly_sensitive":false,"created_at":"2014-12-09T17:42:08.000Z","referenced_tweets":[{"type":"retweeted","id":"542324670008397826"}],"id":"542373647315656704","text":"RT @andrewbrown365: .@EMCDDA Drugnet Europe 88: “From guidelines to quality standards” http://t.co/fiEEr67l5F"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/070HOVl92T","expanded_url":"http://bit.ly/1zFFJjC","display_url":"bit.ly/1zFFJjC"}],"mentions":[{"start":3,"end":8,"username":"OFDT","id":"121702523"},{"start":120,"end":127,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"542373595876704256","possibly_sensitive":false,"created_at":"2014-12-09T17:41:56.000Z","referenced_tweets":[{"type":"retweeted","id":"542257254339473408"}],"id":"542373595876704256","text":"RT @OFDT: Financement de la politique des drogues en Europe dans un contexte de crise économique http://t.co/070HOVl92T @EMCDDA"},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/7sqh5Lu6Uo","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/recession-and-drug-related-public-expenditure","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":42,"end":47,"probability":0.9975,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"541978469832617984","possibly_sensitive":false,"created_at":"2014-12-08T15:31:51.000Z","referenced_tweets":{},"id":"541978469832617984","text":"Just published: 'Financing drug policy in Europe in the wake of the economic recession' http://t.co/7sqh5Lu6Uo"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/ODkNe1jKVH","expanded_url":"http://www.emcdda.europa.eu/about/jobs","display_url":"emcdda.europa.eu/about/jobs"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":51,"end":58,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"541003956382863361","possibly_sensitive":false,"created_at":"2014-12-05T22:59:29.000Z","referenced_tweets":[{"type":"retweeted","id":"540966465680470016"}],"id":"541003956382863361","text":"RT @mvapmoreira: 5 vacancies for graduate trainees @EMCDDA. Deadline is 15 January 2015! More info on our website: http://t.co/ODkNe1jKVH"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"infodrogas","id":"110941593"},{"start":20,"end":27,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":59,"end":72,"tag":"farmacología"}]},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"540864119998783488","possibly_sensitive":false,"created_at":"2014-12-05T13:43:49.000Z","referenced_tweets":[{"type":"retweeted","id":"540862290187526144"}],"id":"540864119998783488","text":"RT @infodrogas: Via @EMCDDA Breve perfil de la química, la #farmacología y la síntesis de cada sustancia (no en español) http://t.co/UgA13m…"},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/3v5CnU6G3m","expanded_url":"https://e-recruitment.emcdda.europa.eu/e-recruitment/jobvacancies","display_url":"e-recruitment.emcdda.europa.eu/e-recruitment/…"}],"mentions":{},"annotations":[{"start":54,"end":59,"probability":0.9887,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"540848358076977152","possibly_sensitive":false,"created_at":"2014-12-05T12:41:11.000Z","referenced_tweets":{},"id":"540848358076977152","text":"New traineeship positions available at our offices in Lisbon. Deadline 15 January 2015: https://t.co/3v5CnU6G3m"},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/RyY0SPsxLN","expanded_url":"http://www.emcdda.europa.eu/drug-profiles","display_url":"emcdda.europa.eu/drug-profiles"},{"start":98,"end":120,"url":"http://t.co/pqwK7OWh2z","expanded_url":"https://twitter.com/EMCDDA/status/540538805833723905/photo/1","display_url":"pic.twitter.com/pqwK7OWh2z"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":6,"quote_count":0},"attachments":{"media_keys":["3_540538804281434112"]},"conversation_id":"540538805833723905","possibly_sensitive":false,"created_at":"2014-12-04T16:11:08.000Z","referenced_tweets":{},"id":"540538805833723905","text":"Do you know our Drug profiles? Scientifically sound descriptions of drugs: http://t.co/RyY0SPsxLN http://t.co/pqwK7OWh2z"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":{},"hashtags":[{"start":17,"end":23,"tag":"H2020"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"539703658729201664","possibly_sensitive":false,"created_at":"2014-12-02T08:52:34.000Z","referenced_tweets":[{"type":"retweeted","id":"539478918038708224"}],"id":"539703658729201664","text":"RT @mvapmoreira: #H2020 call still open: vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS http://t.co/2T…"},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/VpoL6EsWcu","expanded_url":"http://www.emcdda.europa.eu/news/2014/hiv-infections","display_url":"emcdda.europa.eu/news/2014/hiv-…"},{"start":97,"end":119,"url":"http://t.co/XNWVTGcisT","expanded_url":"https://twitter.com/EMCDDA/status/539443583447998464/photo/1","display_url":"pic.twitter.com/XNWVTGcisT"}],"mentions":{},"annotations":[{"start":31,"end":36,"probability":0.9656,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":8,"end":12,"tag":"HIV"},{"start":59,"end":72,"tag":"WorldAIDSDay"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_539443582604550146"]},"conversation_id":"539443583447998464","possibly_sensitive":false,"created_at":"2014-12-01T15:39:07.000Z","referenced_tweets":{},"id":"539443583447998464","text":"Gaps in #HIV prevention expose Europe to risk of outbreaks #WorldAIDSDay: http://t.co/VpoL6EsWcu http://t.co/XNWVTGcisT"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/GhN8IFu4On","expanded_url":"http://www.emcdda.europa.eu/publications/risk-assessments","display_url":"emcdda.europa.eu/publications/r…"}],"mentions":[{"start":3,"end":17,"username":"anagallegos77","id":"2450862334"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"539346497687793665","possibly_sensitive":false,"created_at":"2014-12-01T09:13:20.000Z","referenced_tweets":[{"type":"retweeted","id":"539100474855948288"}],"id":"539346497687793665","text":"RT @anagallegos77: Risk Assessment reports on 4,4'-DMAR and on MT-45 now available @ http://t.co/GhN8IFu4On"},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/EEghclc8R7","expanded_url":"http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids","display_url":"emcdda.europa.eu/topics/pods/sy…"},{"start":102,"end":124,"url":"http://t.co/oCmQI6eiFm","expanded_url":"https://twitter.com/EMCDDA/status/537942263742332928/photo/1","display_url":"pic.twitter.com/oCmQI6eiFm"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":38,"end":45,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_537942262936633344"]},"conversation_id":"537904363013152768","possibly_sensitive":false,"created_at":"2014-11-27T12:13:24.000Z","referenced_tweets":[{"type":"replied_to","id":"537904363013152768"}],"id":"537942263742332928","text":"RT @andcunningham: ACMD report quotes @EMCDDA interactive tool on cannabinoids http://t.co/EEghclc8R7 http://t.co/oCmQI6eiFm","in_reply_to_user_id":"430083320"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"}],"annotations":[{"start":20,"end":21,"probability":0.5291,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"537608317833859072","possibly_sensitive":false,"created_at":"2014-11-26T14:06:25.000Z","referenced_tweets":[{"type":"retweeted","id":"537607142036230144"}],"id":"537608317833859072","text":"RT @andrewbrown365: EU asking govts to adopt &amp; start implementing min qual standards for drugs (prev -&gt; recovery) by 2016\nhttp://t.co/xgUBT…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"BeauKilmer","id":"730651705"},{"start":35,"end":42,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":69,"end":78,"tag":"cannabis"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"537538910260568064","possibly_sensitive":false,"created_at":"2014-11-26T09:30:37.000Z","referenced_tweets":[{"type":"retweeted","id":"537324492083978240"}],"id":"537538910260568064","text":"RT @BeauKilmer: Many thanks to the @EMCDDA for hosting so many great #cannabis panels during Reitox week. Was an honor to participate in th…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"brycepardo","id":"25888310"},{"start":110,"end":117,"username":"EMCDDA","id":"50638521"},{"start":121,"end":132,"username":"BeauKilmer","id":"730651705"}],"annotations":[{"start":73,"end":80,"probability":0.8475,"type":"Place","normalized_text":"Americas"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"537538629422555137","possibly_sensitive":false,"created_at":"2014-11-26T09:29:30.000Z","referenced_tweets":[{"type":"retweeted","id":"537172566969159680"}],"id":"537538629422555137","text":"RT @brycepardo: Honored to give a presentation on cannabis policy in the Americas at the Third Reitox week of @EMCDDA w/ @BeauKilmer http:/…"},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/PVepeImGIv","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/88","display_url":"emcdda.europa.eu/publications/d…"},{"start":76,"end":98,"url":"http://t.co/9FeaPxeLZg","expanded_url":"https://twitter.com/EMCDDA/status/537538592625946626/photo/1","display_url":"pic.twitter.com/9FeaPxeLZg"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":["3_537538591770292224"]},"conversation_id":"537538592625946626","possibly_sensitive":false,"created_at":"2014-11-26T09:29:22.000Z","referenced_tweets":{},"id":"537538592625946626","text":"Just published — the latest issue of our newsletter: http://t.co/PVepeImGIv http://t.co/9FeaPxeLZg"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/jhhAHaUvbj","expanded_url":"http://www.emcdda.europa.eu/news/2014/9","display_url":"emcdda.europa.eu/news/2014/9"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":68,"end":75,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"537538291546198016","possibly_sensitive":false,"created_at":"2014-11-26T09:28:10.000Z","referenced_tweets":[{"type":"retweeted","id":"537351802942136321"}],"id":"537538291546198016","text":"RT @mvapmoreira: This evening we honoured the 4 winners of the 2014 @EMCDDA scientific paper award. Congratulations! http://t.co/jhhAHaUvbj"},{"entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/ACTP15D2sL","expanded_url":"http://prevention-standards.eu/manual-available-in-new-language-bulgarian/","display_url":"prevention-standards.eu/manual-availab…"}],"mentions":[{"start":3,"end":10,"username":"pbm_ab","id":"382602234"},{"start":96,"end":104,"username":"profhrs","id":"189969652"},{"start":105,"end":112,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":62,"end":70,"probability":0.5945,"type":"Place","normalized_text":"Bulgarian"}],"hashtags":[{"start":17,"end":23,"tag":"EDPQS"},{"start":24,"end":44,"tag":"preventionstandards"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"536926930675965952","possibly_sensitive":false,"created_at":"2014-11-24T16:58:50.000Z","referenced_tweets":[{"type":"retweeted","id":"536893284640366593"}],"id":"536926930675965952","text":"RT @pbm_ab: Full #EDPQS #preventionstandards now available in Bulgarian! http://t.co/ACTP15D2sL @profhrs @EMCDDA"},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/DjPdWnmGfE","expanded_url":"http://www.emcdda.europa.eu//html.cfm//index232939EN.html","display_url":"emcdda.europa.eu//html.cfm//ind…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"536875697407791104","possibly_sensitive":false,"created_at":"2014-11-24T13:35:15.000Z","referenced_tweets":{},"id":"536875697407791104","text":"Scientific paper award 2014: winning and shortlisted articles: http://t.co/DjPdWnmGfE"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":51,"end":63,"username":"PoliceCEPOL","id":"235351599"},{"start":72,"end":79,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":30,"end":49,"probability":0.4065,"type":"Organization","normalized_text":"Dutch Police Academy"}],"hashtags":[{"start":120,"end":124,"tag":"nps"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"536875072007704576","possibly_sensitive":false,"created_at":"2014-11-24T13:32:46.000Z","referenced_tweets":[{"type":"retweeted","id":"536862979359539201"}],"id":"536875072007704576","text":"RT @andcunningham: Off to the Dutch Police Academy @PoliceCEPOL to give @EMCDDA talk tomorrow about synthetic drugs and #nps."},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/Ruhl1JO4kX","expanded_url":"http://www.emcdda.europa.eu/news/2014/9","display_url":"emcdda.europa.eu/news/2014/9"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"536842440716845056","possibly_sensitive":false,"created_at":"2014-11-24T11:23:06.000Z","referenced_tweets":{},"id":"536842440716845056","text":"Announcing the winners of this year's award for excellence in scientific writing on illicit drugs: http://t.co/Ruhl1JO4kX"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/3PY2qvIXso","expanded_url":"http://www.cph.org.uk/new-funded-phds/","display_url":"cph.org.uk/new-funded-phd…"}],"mentions":[{"start":3,"end":11,"username":"profhrs","id":"189969652"}],"annotations":[{"start":81,"end":83,"probability":0.47,"type":"Place","normalized_text":"CPH"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"536809851473891328","possibly_sensitive":false,"created_at":"2014-11-24T09:13:36.000Z","referenced_tweets":[{"type":"retweeted","id":"535839754013917184"}],"id":"536809851473891328","text":"RT @profhrs: Final reminder! Study NPS/legal highs in a fully funded PhD here at CPH. Deadline Monday 24th Nov http://t.co/3PY2qvIXso"},{"entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"SedefovR","id":"955287361"},{"start":73,"end":89,"username":"toxicovigilance","id":"2291691778"},{"start":121,"end":128,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"536809706241945600","possibly_sensitive":false,"created_at":"2014-11-24T09:13:02.000Z","referenced_tweets":[{"type":"retweeted","id":"535871897184272386"}],"id":"536809706241945600","text":"RT @SedefovR: Looking forward to expert meeting on how we can strengthen @toxicovigilance of new psychoactive substances @EMCDDA 2–3 Decemb…"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/eMsbzUfdAM","expanded_url":"http://www.hivtestingweek.eu/home","display_url":"hivtestingweek.eu/home"},{"start":110,"end":132,"url":"http://t.co/9HAGoihQXI","expanded_url":"https://twitter.com/EMCDDA/status/535756257828012032/photo/1","display_url":"pic.twitter.com/9HAGoihQXI"}],"mentions":{},"annotations":{},"hashtags":[{"start":52,"end":68,"tag":"EuroHIVtestweek"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_535756256892317696"]},"conversation_id":"535756257828012032","possibly_sensitive":false,"created_at":"2014-11-21T11:27:00.000Z","referenced_tweets":{},"id":"535756257828012032","text":"European HIV testing week from 21-28 November 2014: #EuroHIVtestweek @EuroHIVtestweek  http://t.co/eMsbzUfdAM http://t.co/9HAGoihQXI"},{"entities":{"urls":{},"mentions":{},"annotations":[{"start":93,"end":98,"probability":0.9782,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":25,"end":41,"tag":"EuroHIVtestweek"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"535754064274141185","possibly_sensitive":false,"created_at":"2014-11-21T11:18:17.000Z","referenced_tweets":[{"type":"retweeted","id":"535699868392906752"}],"id":"535754064274141185","text":"RT @EuroHIVtestweek: The #EuroHIVtestweek has begun!  694 organisations participating across Europe - Good luck everybody!"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/gvaW0dqJC4","expanded_url":"http://www.cepol.europa.eu","display_url":"cepol.europa.eu"}],"mentions":[{"start":3,"end":17,"username":"CEPOL_BELGIUM","id":"555768976"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"535473226991034368","possibly_sensitive":false,"created_at":"2014-11-20T16:42:20.000Z","referenced_tweets":[{"type":"retweeted","id":"535345252018565120"}],"id":"535473226991034368","text":"RT @CEPOL_BELGIUM: CEPOL Webinar \"Synthetic Drugs\" to take place on 03 December at 11.00! Info &amp; registration: http://t.co/gvaW0dqJC4"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"LocalPassEurope","id":"1857628910"},{"start":63,"end":76,"username":"HeisenbergXL","id":"479428296"},{"start":77,"end":84,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":85,"end":93,"probability":0.8867,"type":"Person","normalized_text":"Pavel Bem"},{"start":96,"end":107,"probability":0.8766,"type":"Person","normalized_text":"C. Schneider"}],"hashtags":[{"start":109,"end":115,"tag":"breda"},{"start":116,"end":120,"tag":"NPS"},{"start":121,"end":136,"tag":"drugprevention"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"535472382547623936","possibly_sensitive":false,"created_at":"2014-11-20T16:38:59.000Z","referenced_tweets":[{"type":"retweeted","id":"535468769007927296"}],"id":"535472382547623936","text":"RT @LocalPassEurope: Invitation to our conference! Speaches by @HeisenbergXL @EMCDDA Pavel Bem, C. Schneider #breda #NPS #drugprevention ht…"},{"entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"Nordicpaivi","id":"112221953"},{"start":17,"end":31,"username":"PompidouGroup","id":"1169002783"},{"start":78,"end":85,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"de","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"535079049610420224","possibly_sensitive":false,"created_at":"2014-11-19T14:41:22.000Z","referenced_tweets":[{"type":"replied_to","id":"535079049610420224"}],"id":"535080397521289216","text":"@Nordicpaivi: MT @PompidouGroup is source of information and inspiration says @EMCDDA s Wolfgang Götz, we complement each other","in_reply_to_user_id":"112221953"},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/VhN36j4aOw","expanded_url":"http://webtv.coe.int/index.php?EventID=43","display_url":"webtv.coe.int/index.php?Even…"}],"mentions":[{"start":3,"end":15,"username":"Nordicpaivi","id":"112221953"},{"start":30,"end":37,"username":"EMCDDA","id":"50638521"},{"start":111,"end":126,"username":"CoEAudioVisual","id":"1133488128"},{"start":127,"end":131,"username":"coe","id":"24150634"}],"annotations":{},"hashtags":{}},"lang":"de","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"535078776825475072","possibly_sensitive":false,"created_at":"2014-11-19T14:34:56.000Z","referenced_tweets":[{"type":"retweeted","id":"535077249809408000"}],"id":"535078776825475072","text":"RT @Nordicpaivi: Now speaking @EMCDDA Wolfgang Götz: 96 new substances so far this year http://t.co/VhN36j4aOw @CoEAudioVisual @coe @Pompid…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"jasmin_hamzic","id":"32126588"},{"start":19,"end":26,"username":"EMCDDA","id":"50638521"},{"start":46,"end":60,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":61,"end":67,"tag":"taiex"},{"start":91,"end":98,"tag":"Zagreb"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"534710978043465728","possibly_sensitive":false,"created_at":"2014-11-18T14:13:26.000Z","referenced_tweets":[{"type":"retweeted","id":"534707414231441409"}],"id":"534710978043465728","text":"RT @jasmin_hamzic: @EMCDDA worshop powered by @EU_Commission #taiex program closing now in #Zagreb. A lot we learned, still more to achieve…"},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/EXyfizUIeK","expanded_url":"https://www.jstage.jst.go.jp/article/internalmedicine/53/21/53_53.2344/_article","display_url":"jstage.jst.go.jp/article/intern…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":[{"start":90,"end":92,"probability":0.4977,"type":"Organization","normalized_text":"NPS"},{"start":97,"end":101,"probability":0.9781,"type":"Place","normalized_text":"Japan"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"534634251195801601","possibly_sensitive":false,"created_at":"2014-11-18T09:08:33.000Z","referenced_tweets":[{"type":"retweeted","id":"534308525389119488"}],"id":"534634251195801601","text":"RT @toxicovigilance: A multicenter retrospective survey of poisoning after consumption of NPS in Japan https://t.co/EXyfizUIeK"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"jasmin_hamzic","id":"32126588"},{"start":67,"end":74,"username":"EMCDDA","id":"50638521"},{"start":90,"end":106,"username":"toxicovigilance","id":"2291691778"}],"annotations":[{"start":33,"end":38,"probability":0.4038,"type":"Place","normalized_text":"Zagreb"},{"start":53,"end":60,"probability":0.8828,"type":"Person","normalized_text":"Christie"}],"hashtags":[{"start":19,"end":23,"tag":"nps"},{"start":107,"end":113,"tag":"taiex"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"534633393397723137","possibly_sensitive":false,"created_at":"2014-11-18T09:05:08.000Z","referenced_tweets":[{"type":"retweeted","id":"534620450777993216"}],"id":"534633393397723137","text":"RT @jasmin_hamzic: #nps workshop Zagreb, day 2. Miss Christie from @EMCDDA to speak about @toxicovigilance #taiex"},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/1daGTOSwc0","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/pregnacy-opioid-use","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"534352843856429056","possibly_sensitive":false,"created_at":"2014-11-17T14:30:20.000Z","referenced_tweets":{},"id":"534352843856429056","text":"Just published: Pregnancy and opioid use: strategies for treatment: http://t.co/1daGTOSwc0"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"533279782164004864","possibly_sensitive":false,"created_at":"2014-11-14T15:26:22.000Z","referenced_tweets":[{"type":"retweeted","id":"533263033314078721"}],"id":"533279782164004864","text":"RT @andrewbrown365: The ACMD recommends that MT-45 be controlled under the Misuse of Drugs Act 1971 as a Class A substance\nhttps://t.co/duz…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":8,"username":"OFDT","id":"121702523"},{"start":116,"end":123,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":47,"end":52,"probability":0.8888,"type":"Place","normalized_text":"France"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"533226800152064000","possibly_sensitive":false,"created_at":"2014-11-14T11:55:50.000Z","referenced_tweets":[{"type":"retweeted","id":"532853573743575040"}],"id":"533226800152064000","text":"RT @OFDT: 2014 national report on drug issues (France) : new developments, trends and in-depth information (156 p.) @EMCDDA http://t.co/PIX…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"nzdrug","id":"36256235"},{"start":98,"end":105,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":106,"end":120,"tag":"drugdrivingnz"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"532454381963464704","possibly_sensitive":false,"created_at":"2014-11-12T08:46:31.000Z","referenced_tweets":[{"type":"retweeted","id":"532298387761008640"}],"id":"532454381963464704","text":"RT @nzdrug: Many new psychoactive substances - 400 in last year, more coming - are hard to detect @EMCDDA #drugdrivingnz"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/rcqOOoB0js","expanded_url":"http://www.emcdda.europa.eu/publications/thematic-papers/druid","display_url":"emcdda.europa.eu/publications/t…"}],"mentions":[{"start":3,"end":10,"username":"nzdrug","id":"36256235"},{"start":103,"end":110,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":89,"end":101,"probability":0.9684,"type":"Person","normalized_text":"Paul Griffith"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"532454365156872192","possibly_sensitive":false,"created_at":"2014-11-12T08:46:27.000Z","referenced_tweets":[{"type":"retweeted","id":"532296958669361152"}],"id":"532454365156872192","text":"RT @nzdrug: Wow! 50 reports on drug use patterns via DRUID but no simple conclusions via Paul Griffith @EMCDDA http://t.co/rcqOOoB0js … #dr…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"CCLTCanada","id":"851447014944632834"},{"start":43,"end":50,"username":"nzdrug","id":"36256235"},{"start":51,"end":57,"username":"ONDCP","id":"1355187199457841153"},{"start":58,"end":65,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"532172182814986240","possibly_sensitive":false,"created_at":"2014-11-11T14:05:10.000Z","referenced_tweets":[{"type":"retweeted","id":"532163613478617088"}],"id":"532172182814986240","text":"RT @CCLTcanada: Heureux de collaborer avec @nzdrug @ONDCP @EMCDDA pr présenter le 2e Colloque international sur la drogue au volant. Suivez…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"CCSACanada","id":"242412733"},{"start":40,"end":47,"username":"nzdrug","id":"36256235"},{"start":48,"end":54,"username":"ONDCP","id":"1355187199457841153"},{"start":55,"end":62,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":71,"end":113,"probability":0.4772,"type":"Other","normalized_text":"2nd International Drugs & Driving Symposium"}],"hashtags":[{"start":127,"end":141,"tag":"drugdrivingnz"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"532172152804757504","possibly_sensitive":false,"created_at":"2014-11-11T14:05:03.000Z","referenced_tweets":[{"type":"retweeted","id":"532163555567894529"}],"id":"532172152804757504","text":"RT @CCSAcanada: Pleased to partner with @nzdrug @ONDCP @EMCDDA to host 2nd International Drugs &amp; Driving Symposium. Follow #drugdrivingnz"},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/UUowoBfZ7K","expanded_url":"http://data.consilium.europa.eu/doc/document/ST-14029-2014-INIT/en/pdf","display_url":"data.consilium.europa.eu/doc/document/S…"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":106,"end":113,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":42,"end":46,"tag":"NPS"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"530282053854830592","possibly_sensitive":false,"created_at":"2014-11-06T08:54:28.000Z","referenced_tweets":[{"type":"retweeted","id":"530031518929145856"}],"id":"530282053854830592","text":"RT @andcunningham: Synthetic opioid MT-45 #NPS risk assessment also just published http://t.co/UUowoBfZ7K @EMCDDA"},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/OqYh0j8STG","expanded_url":"http://eepurl.com/7vijr","display_url":"eepurl.com/7vijr"}],"mentions":[{"start":3,"end":17,"username":"AddictionJrnl","id":"56739214"}],"annotations":[{"start":19,"end":35,"probability":0.2857,"type":"Organization","normalized_text":"Lisbon Addictions"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"530030210583105537","possibly_sensitive":false,"created_at":"2014-11-05T16:13:44.000Z","referenced_tweets":[{"type":"retweeted","id":"530005717756182530"}],"id":"530030210583105537","text":"RT @AddictionJrnl: Lisbon Addictions conference 2015 http://t.co/OqYh0j8STG book early as it will be heavily oversubscribed"},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/jrQPXPWVC6","expanded_url":"http://eepurl.com/7vijr","display_url":"eepurl.com/7vijr"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":[{"start":17,"end":38,"probability":0.3657,"type":"Other","normalized_text":"Lisbon Addictions 2015"}],"hashtags":[{"start":51,"end":66,"tag":"LXaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"530030147827945472","possibly_sensitive":false,"created_at":"2014-11-05T16:13:29.000Z","referenced_tweets":[{"type":"retweeted","id":"530019349873295360"}],"id":"530030147827945472","text":"RT @mvapmoreira: Lisbon Addictions 2015 conference #LXaddictions15 Newsletter#1 http://t.co/jrQPXPWVC6"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/g05MBA6dTC","expanded_url":"http://data.consilium.europa.eu/doc/document/ST-13500-2014-INIT/en/pdf","display_url":"data.consilium.europa.eu/doc/document/S…"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":47,"end":54,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":94,"end":98,"tag":"NPS"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"530030032518135808","possibly_sensitive":false,"created_at":"2014-11-05T16:13:01.000Z","referenced_tweets":[{"type":"retweeted","id":"530029952910254080"}],"id":"530030032518135808","text":"RT @andcunningham: Council of the EU publishes @EMCDDA risk assessment of synthetic stimulant #NPS 4,4'-DMAR http://t.co/g05MBA6dTC"},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/k6ZHRwHu2W","expanded_url":"http://www.emcdda.europa.eu/best-practice#view-answer2","display_url":"emcdda.europa.eu/best-practice#…"},{"start":109,"end":131,"url":"http://t.co/vkaorwwaZo","expanded_url":"https://twitter.com/EMCDDA/status/529922473748611072/photo/1","display_url":"pic.twitter.com/vkaorwwaZo"}],"mentions":{},"annotations":{},"hashtags":[{"start":45,"end":58,"tag":"bestPractice"},{"start":59,"end":65,"tag":"drugs"},{"start":66,"end":74,"tag":"alcohol"},{"start":75,"end":83,"tag":"tobacco"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_529922472770957312"]},"conversation_id":"529922473748611072","possibly_sensitive":false,"created_at":"2014-11-05T09:05:37.000Z","referenced_tweets":{},"id":"529922473748611072","text":"Prevention for school students — what works? #bestPractice #drugs #alcohol #tobacco : http://t.co/k6ZHRwHu2W http://t.co/vkaorwwaZo"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":[{"start":17,"end":38,"probability":0.3508,"type":"Other","normalized_text":"Lisbon Addictions 2015"}],"hashtags":[{"start":51,"end":66,"tag":"LXaddictions15"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"528454994190946304","possibly_sensitive":false,"created_at":"2014-11-01T07:54:23.000Z","referenced_tweets":[{"type":"retweeted","id":"528213589057097729"}],"id":"528454994190946304","text":"RT @mvapmoreira: Lisbon Addictions 2015 conference #LXaddictions15 call for abstracts just launched! Mark the dates in your calendar - http…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"profhrs","id":"189969652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"528118077225832448","possibly_sensitive":false,"created_at":"2014-10-31T09:35:36.000Z","referenced_tweets":[{"type":"retweeted","id":"527901012594810880"}],"id":"528118077225832448","text":"RT @profhrs: Fully funded PhD studentship with me, @pbhaatki and @FionaMeasham  on the topic of Novel Psychoactives. Please RT http://t.co/…"},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/tlNIZxlhI3","expanded_url":"http://www.emcdda.europa.eu/best-practice/guidelines","display_url":"emcdda.europa.eu/best-practice/…"},{"start":103,"end":125,"url":"http://t.co/7msYKmzaJV","expanded_url":"https://twitter.com/EMCDDA/status/527385893980876800/photo/1","display_url":"pic.twitter.com/7msYKmzaJV"}],"mentions":{},"annotations":{},"hashtags":[{"start":65,"end":78,"tag":"bestPractice"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_527385892944896000"]},"conversation_id":"527385893980876800","possibly_sensitive":false,"created_at":"2014-10-29T09:06:10.000Z","referenced_tweets":{},"id":"527385893980876800","text":"Our searchable database of international drug-related guidelines #bestPractice: http://t.co/tlNIZxlhI3 http://t.co/7msYKmzaJV"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/ugblnIRZCS","expanded_url":"http://drugdriving.org.nz/","display_url":"drugdriving.org.nz"}],"mentions":[{"start":3,"end":10,"username":"nzdrug","id":"36256235"},{"start":120,"end":126,"username":"ONDCP","id":"1355187199457841153"},{"start":127,"end":134,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":82,"end":96,"tag":"drugdrivingnz"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"527384925822279680","possibly_sensitive":false,"created_at":"2014-10-29T09:02:19.000Z","referenced_tweets":[{"type":"retweeted","id":"527252081762004992"}],"id":"527384925822279680","text":"RT @nzdrug: Patting self on back - what a great line-up of speakers - check them: #drugdrivingnz http://t.co/ugblnIRZCS @ONDCP @EMCDDA @CCS…"},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/3pc4UmlpWj","expanded_url":"http://ht.ly/DqVJZ","display_url":"ht.ly/DqVJZ"}],"mentions":[{"start":3,"end":17,"username":"Prison_Health","id":"85601740"},{"start":89,"end":96,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"527093987526840321","possibly_sensitive":false,"created_at":"2014-10-28T13:46:14.000Z","referenced_tweets":[{"type":"retweeted","id":"527093768974249985"}],"id":"527093987526840321","text":"RT @Prison_Health: Best Practice in Amphetamine User Treatment http://t.co/3pc4UmlpWj RT @EMCDDA"},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/VzUbNselDe","expanded_url":"http://www.emcdda.europa.eu/best-practice#faq","display_url":"emcdda.europa.eu/best-practice#…"},{"start":100,"end":122,"url":"http://t.co/YF3ag6aePF","expanded_url":"https://twitter.com/EMCDDA/status/527024175173873664/photo/1","display_url":"pic.twitter.com/YF3ag6aePF"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_527024174121103361"]},"conversation_id":"527024175173873664","possibly_sensitive":false,"created_at":"2014-10-28T09:08:49.000Z","referenced_tweets":{},"id":"527024175173873664","text":"See our best practice in drug interventions FAQ or submit your own question. http://t.co/VzUbNselDe http://t.co/YF3ag6aePF"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/klQ95fTOyB","expanded_url":"http://buff.ly/1wviyb1","display_url":"buff.ly/1wviyb1"}],"mentions":[{"start":3,"end":15,"username":"DroguesInfo","id":"90431580"},{"start":101,"end":108,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"527022896066351104","possibly_sensitive":false,"created_at":"2014-10-28T09:03:44.000Z","referenced_tweets":[{"type":"retweeted","id":"526828264145571840"}],"id":"527022896066351104","text":"RT @DroguesInfo: \"Qu'est-ce qui marche pour... ?\" Nouvelle version du portail de bonnes pratiques de @EMCDDA http://t.co/klQ95fTOyB (anglai…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"IDPCnet","id":"423396432"},{"start":91,"end":98,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":27,"end":38,"tag":"prevention"},{"start":40,"end":54,"tag":"harmreduction"},{"start":56,"end":66,"tag":"treatment"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"526768156833243136","possibly_sensitive":false,"created_at":"2014-10-27T16:11:30.000Z","referenced_tweets":[{"type":"retweeted","id":"526765180320235520"}],"id":"526768156833243136","text":"RT @IDPCnet: Interested in #prevention, #harmreduction, #treatment and more? Check out the @EMCDDA best practice portal! http://t.co/kfksCa…"},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/pg1S3FKrWa","expanded_url":"http://www.emcdda.europa.eu/best-practice#view-answer1","display_url":"emcdda.europa.eu/best-practice#…"},{"start":105,"end":127,"url":"http://t.co/6QWyKogFYD","expanded_url":"https://twitter.com/EMCDDA/status/526664003825967104/photo/1","display_url":"pic.twitter.com/6QWyKogFYD"}],"mentions":{},"annotations":{},"hashtags":[{"start":67,"end":80,"tag":"bestPractice"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_526664002789990400"]},"conversation_id":"526664003825967104","possibly_sensitive":false,"created_at":"2014-10-27T09:17:38.000Z","referenced_tweets":{},"id":"526664003825967104","text":"What works when delivering drug prevention programmes to families? #bestPractice: http://t.co/pg1S3FKrWa http://t.co/6QWyKogFYD"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/Hf2IptgjaE","expanded_url":"http://www.emcdda.europa.eu/best-practice","display_url":"emcdda.europa.eu/best-practice"}],"mentions":{},"annotations":{},"hashtags":[{"start":49,"end":62,"tag":"bestPractice"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"526663224603983872","possibly_sensitive":false,"created_at":"2014-10-27T09:14:32.000Z","referenced_tweets":{},"id":"526663224603983872","text":"Thanks to everyone who retweeted our post on the #bestPractice on Friday — much appreciated! http://t.co/Hf2IptgjaE"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"},{"start":91,"end":107,"username":"toxicovigilance","id":"2291691778"},{"start":117,"end":124,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"526659079138443264","possibly_sensitive":false,"created_at":"2014-10-27T08:58:03.000Z","referenced_tweets":[{"type":"retweeted","id":"526648724320444416"}],"id":"526659079138443264","text":"RT @mevansbrown: If you work with legal highs, research chemicals, new drugs, etc., follow @toxicovigilance from the @emcdda for latest inf…"},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/Hf2IptgjaE","expanded_url":"http://www.emcdda.europa.eu/best-practice","display_url":"emcdda.europa.eu/best-practice"},{"start":100,"end":122,"url":"http://t.co/zKAzwaAkcd","expanded_url":"https://twitter.com/EMCDDA/status/525579210132570112/photo/1","display_url":"pic.twitter.com/zKAzwaAkcd"}],"mentions":{},"annotations":{},"hashtags":[{"start":50,"end":63,"tag":"bestPractice"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":25,"reply_count":1,"like_count":4,"quote_count":0},"attachments":{"media_keys":["3_525579209071423488"]},"conversation_id":"525579210132570112","possibly_sensitive":false,"created_at":"2014-10-24T09:27:03.000Z","referenced_tweets":{},"id":"525579210132570112","text":"What works and what doesn't in drug interventions #bestPractice Pls RT :-) : http://t.co/Hf2IptgjaE http://t.co/zKAzwaAkcd"},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/tqG6cycTb8","expanded_url":"http://www.youtube.com/watch?v=Ku4KsTQh7pM&feature=youtu.be","display_url":"youtube.com/watch?v=Ku4KsT…"}],"mentions":{},"annotations":{},"hashtags":[{"start":59,"end":72,"tag":"bestPractice"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"525312474971930626","possibly_sensitive":false,"created_at":"2014-10-23T15:47:08.000Z","referenced_tweets":{},"id":"525312474971930626","text":"Watch our video about best practices in drug interventions #bestPractice: http://t.co/tqG6cycTb8"},{"entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/Hf2IptgjaE","expanded_url":"http://www.emcdda.europa.eu/best-practice","display_url":"emcdda.europa.eu/best-practice"},{"start":99,"end":121,"url":"http://t.co/nEouzd7zSG","expanded_url":"http://eepurl.com/5rLmf","display_url":"eepurl.com/5rLmf"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"525275633845563392","possibly_sensitive":false,"created_at":"2014-10-23T13:20:44.000Z","referenced_tweets":{},"id":"525275633845563392","text":"Keep up to date on best practice in drug interventions http://t.co/Hf2IptgjaE with our newsletter: http://t.co/nEouzd7zSG"},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/9tbuSuBprt","expanded_url":"http://bit.ly/10qzDbw","display_url":"bit.ly/10qzDbw"}],"mentions":[{"start":3,"end":17,"username":"FundacionEDEX","id":"575265121"},{"start":132,"end":139,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"525228032819470336","possibly_sensitive":false,"created_at":"2014-10-23T10:11:35.000Z","referenced_tweets":[{"type":"retweeted","id":"525221970578010112"}],"id":"525228032819470336","text":"RT @FundacionEDEX: Portal europeo de buenas prácticas en materia de intervenciones en drogodependencias: http://t.co/9tbuSuBprt vía @EMCDDA"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/Hf2IptgjaE","expanded_url":"http://www.emcdda.europa.eu/best-practice","display_url":"emcdda.europa.eu/best-practice"},{"start":116,"end":138,"url":"http://t.co/rBR3vDjwdG","expanded_url":"https://twitter.com/EMCDDA/status/525218210422206464/photo/1","display_url":"pic.twitter.com/rBR3vDjwdG"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_525218209520427008"]},"conversation_id":"525218210422206464","possibly_sensitive":false,"created_at":"2014-10-23T09:32:34.000Z","referenced_tweets":{},"id":"525218210422206464","text":"What works in drug Interventions? Just launched the new version of our Best practice portal: http://t.co/Hf2IptgjaE http://t.co/rBR3vDjwdG"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/4cFxG8nHus","expanded_url":"http://bit.ly/1v84hBj","display_url":"bit.ly/1v84hBj"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":31,"end":41,"username":"JunckerEU","id":"169426475"}],"annotations":[{"start":88,"end":94,"probability":0.6412,"type":"Product","normalized_text":"Twitter"}],"hashtags":[{"start":119,"end":126,"tag":"EP2014"},{"start":127,"end":134,"tag":"EC2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"524884562804224000","possibly_sensitive":false,"created_at":"2014-10-22T11:26:46.000Z","referenced_tweets":[{"type":"retweeted","id":"524846051866726400"}],"id":"524884562804224000","text":"RT @Europarl_EN: The debate on @JunckerEU Commission is on! Follow what's being said on Twitter http://t.co/4cFxG8nHus #EP2014 #EC2014 http…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"BinghamInfo","id":"1914426696"},{"start":124,"end":131,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":111,"end":120,"tag":"silkroad"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"524833424910327809","possibly_sensitive":false,"created_at":"2014-10-22T08:03:34.000Z","referenced_tweets":[{"type":"retweeted","id":"524814289753100288"}],"id":"524833424910327809","text":"RT @BinghamInfo: Presenting on Obtaining NPS and illicit drugs from the Web. The user's perspective\" including #silkroad at @EMCDDA  next w…"},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/OaBpMJ9RoB","expanded_url":"http://wp.me/p2tOzX-a6","display_url":"wp.me/p2tOzX-a6"}],"mentions":[{"start":3,"end":16,"username":"EileenOrmsby","id":"595508725"},{"start":118,"end":125,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":30,"end":36,"probability":0.6818,"type":"Person","normalized_text":"DoctorX"},{"start":129,"end":134,"probability":0.9292,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"524657236308934656","possibly_sensitive":false,"created_at":"2014-10-21T20:23:27.000Z","referenced_tweets":[{"type":"retweeted","id":"524527404199329792"}],"id":"524657236308934656","text":"RT @EileenOrmsby: What Me and DoctorX did Next http://t.co/OaBpMJ9RoB - talking bout Silk Road and drug policy at the @EMCDDA in Lisbon nex…"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/wCSYv54nWk","expanded_url":"https://twitter.com/EMCDDA/status/524482448500211712/photo/1","display_url":"pic.twitter.com/wCSYv54nWk"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_524482447711674368"]},"conversation_id":"524482448500211712","possibly_sensitive":false,"created_at":"2014-10-21T08:48:54.000Z","referenced_tweets":{},"id":"524482448500211712","text":"What works and what doesn't work? New version of our Best practice portal coming Thursday 23rd October: http://t.co/wCSYv54nWk"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"EURightsAgency","id":"217422465"},{"start":109,"end":117,"username":"EU_OSHA","id":"23600999"},{"start":118,"end":125,"username":"EMCDDA","id":"50638521"},{"start":126,"end":134,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":30,"end":36,"probability":0.9396,"type":"Place","normalized_text":"Austria"},{"start":55,"end":60,"probability":0.4352,"type":"Place","normalized_text":"Europa"}],"hashtags":[{"start":40,"end":44,"tag":"OE1"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"524171941775937536","possibly_sensitive":false,"created_at":"2014-10-20T12:15:04.000Z","referenced_tweets":[{"type":"retweeted","id":"524148370253025281"}],"id":"524171941775937536","text":"RT @EURightsAgency: Listen to Austria's #OE1 programme Europa-Journal discussing the value of EU agencies w/ @EU_OSHA @EMCDDA @EFSA_EU http…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"EURightsAgency","id":"217422465"},{"start":97,"end":109,"username":"oe1journale","id":"20066934"}],"annotations":{},"hashtags":[{"start":35,"end":46,"tag":"EUagencies"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"524171903783940097","possibly_sensitive":false,"created_at":"2014-10-20T12:14:55.000Z","referenced_tweets":[{"type":"retweeted","id":"522746408802451457"}],"id":"524171903783940097","text":"RT @EURightsAgency: Today Heads of #EUagencies take part in debate on value of Agencies at AT TV @oe1journale. Debate tmrw 18:20 CET. http:…"},{"entities":{"urls":[{"start":18,"end":40,"url":"http://t.co/nwtpXlXeIy","expanded_url":"http://fra.europa.eu/en/news/2014/eu-agencies-underpinning-work-european-union","display_url":"fra.europa.eu/en/news/2014/e…"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":[{"start":83,"end":96,"probability":0.3312,"type":"Organization","normalized_text":"European Union"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"524116209839509504","possibly_sensitive":false,"created_at":"2014-10-20T08:33:36.000Z","referenced_tweets":[{"type":"retweeted","id":"523111307839406080"}],"id":"524116209839509504","text":"RT @KM_Robertson: http://t.co/nwtpXlXeIy EU Agencies: underpinning the work of the European Union"},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/HbXNtb3nZg","expanded_url":"http://www.emcdda.europa.eu/expert-meetings/2014/drd-drid","display_url":"emcdda.europa.eu/expert-meeting…"},{"start":109,"end":131,"url":"http://t.co/GIlAfL7bxM","expanded_url":"https://twitter.com/EMCDDA/status/523018389712035840/photo/1","display_url":"pic.twitter.com/GIlAfL7bxM"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_523018386222370816"]},"conversation_id":"523018389712035840","possibly_sensitive":false,"created_at":"2014-10-17T07:51:15.000Z","referenced_tweets":{},"id":"523018389712035840","text":"Programme for day 3 of our annual expert meeting on drug-related harms and responses: http://t.co/HbXNtb3nZg http://t.co/GIlAfL7bxM"},{"entities":{"urls":{},"mentions":[{"start":87,"end":95,"username":"ECDC_EU","id":"204752573"},{"start":100,"end":107,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":41,"end":46,"probability":0.9981,"type":"Place","normalized_text":"Latvia"},{"start":59,"end":61,"probability":0.5802,"type":"Other","normalized_text":"HIV"}],"hashtags":[{"start":108,"end":115,"tag":"emcdda"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"522691737161322496","possibly_sensitive":false,"created_at":"2014-10-16T10:13:15.000Z","referenced_tweets":[{"type":"retweeted","id":"522690720810147840"}],"id":"522691737161322496","text":"RT @kirstenlh23: Action plan underway in Latvia to improve HIV situation with partners @ECDC_EU and @EMCDDA #emcdda"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/XeFg7hM60f","expanded_url":"https://twitter.com/kirstenlh23/status/522668013846552576/photo/1","display_url":"pic.twitter.com/XeFg7hM60f"}],"mentions":[{"start":38,"end":45,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_522668000034295811"]},"conversation_id":"522672670320910336","possibly_sensitive":false,"created_at":"2014-10-16T08:57:30.000Z","referenced_tweets":[{"type":"retweeted","id":"522668013846552576"}],"id":"522672670320910336","text":"RT @kirstenlh23: Last day here for me @EMCDDA - busy day ahead on drug related infectious diseases http://t.co/XeFg7hM60f"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"arjmcauley","id":"299936744"},{"start":58,"end":65,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":81,"end":86,"probability":0.9926,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"522664072190652416","possibly_sensitive":false,"created_at":"2014-10-16T08:23:20.000Z","referenced_tweets":[{"type":"retweeted","id":"522661154200764417"}],"id":"522664072190652416","text":"RT @arjmcauley: Heading home after a great couple of days @EMCDDA DRD meeting in Lisbon. Learned a lot and met some great people. Until nex…"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/HbXNtb3nZg","expanded_url":"http://www.emcdda.europa.eu/expert-meetings/2014/drd-drid","display_url":"emcdda.europa.eu/expert-meeting…"},{"start":108,"end":130,"url":"http://t.co/c7k0UgT4nD","expanded_url":"https://twitter.com/EMCDDA/status/522659578857930752/photo/1","display_url":"pic.twitter.com/c7k0UgT4nD"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_522659577628594176"]},"conversation_id":"522299934209769472","possibly_sensitive":false,"created_at":"2014-10-16T08:05:28.000Z","referenced_tweets":[{"type":"replied_to","id":"522299934209769472"}],"id":"522659578857930752","text":"Day 2 of our annual expert's meeting on drug-related deaths and infectious diseases: http://t.co/HbXNtb3nZg http://t.co/c7k0UgT4nD","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/h5QOIWREOR","expanded_url":"http://ow.ly/CMP9m","display_url":"ow.ly/CMP9m"}],"mentions":[{"start":4,"end":18,"username":"EUAuditorsECA","id":"803430727844888576"},{"start":66,"end":73,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":29,"end":35,"tag":"audit"},{"start":47,"end":58,"tag":"EUagencies"},{"start":60,"end":64,"tag":"EBA"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"522361313541259264","possibly_sensitive":false,"created_at":"2014-10-15T12:54:13.000Z","referenced_tweets":[{"type":"replied_to","id":"522361313541259264"}],"id":"522369857455923201","text":"MT: @EUAuditorsECA: More new #audit reports on #EUagencies: #EBA, @EMCDDA http://t.co/h5QOIWREOR","in_reply_to_user_id":"424093888"},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/HbXNtb3nZg","expanded_url":"http://www.emcdda.europa.eu/expert-meetings/2014/drd-drid","display_url":"emcdda.europa.eu/expert-meeting…"},{"start":109,"end":131,"url":"http://t.co/qsoesuWNd2","expanded_url":"https://twitter.com/EMCDDA/status/522299934209769472/photo/1","display_url":"pic.twitter.com/qsoesuWNd2"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_522299933043347456"]},"conversation_id":"522299934209769472","possibly_sensitive":false,"created_at":"2014-10-15T08:16:22.000Z","referenced_tweets":{},"id":"522299934209769472","text":"Busy day 1 of annual expert's meeting on drug-related deaths and infectious diseases: http://t.co/HbXNtb3nZg http://t.co/qsoesuWNd2"},{"entities":{"urls":{},"mentions":[{"start":129,"end":136,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"522296073696849920","possibly_sensitive":false,"created_at":"2014-10-15T08:01:02.000Z","referenced_tweets":[{"type":"retweeted","id":"522115910518444033"}],"id":"522296073696849920","text":"RT @kirstenlh23: Well after a missing baggage drama and being close to a full on melt down, finally had a really good day at the @EMCDDA #n…"},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/g0Nb9HQJZb","expanded_url":"http://www.emcdda.europa.eu/topics/pods/preventing-overdose-deaths","display_url":"emcdda.europa.eu/topics/pods/pr…"},{"start":112,"end":134,"url":"http://t.co/EpyWPWW3dS","expanded_url":"https://twitter.com/EMCDDA/status/522043025057677313/photo/1","display_url":"pic.twitter.com/EpyWPWW3dS"}],"mentions":{},"annotations":[{"start":80,"end":85,"probability":0.9918,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":14,"end":23,"tag":"naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_522043021211086849"]},"conversation_id":"522043025057677313","possibly_sensitive":false,"created_at":"2014-10-14T15:15:30.000Z","referenced_tweets":{},"id":"522043025057677313","text":"After today's #naloxone meeting, time to revisit 'Preventing overdose deaths in Europe': http://t.co/g0Nb9HQJZb http://t.co/EpyWPWW3dS"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"arjmcauley","id":"299936744"},{"start":103,"end":110,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":80,"end":96,"probability":0.9882,"type":"Person","normalized_text":"Isabelle Giraudon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"522008874350813184","possibly_sensitive":false,"created_at":"2014-10-14T12:59:48.000Z","referenced_tweets":[{"type":"retweeted","id":"522008762337734656"}],"id":"522008874350813184","text":"RT @arjmcauley: Excellent overview of European drug-induced mortality trends by Isabelle Giraudon from @EMCDDA - 6 countries represent 2/3 …"},{"entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"idhdp","id":"388761105"},{"start":108,"end":115,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":22,"end":31,"tag":"naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"521977989610090496","possibly_sensitive":false,"created_at":"2014-10-14T10:57:05.000Z","referenced_tweets":[{"type":"retweeted","id":"521977422942846977"}],"id":"521977989610090496","text":"RT @idhdp: 'Take home #naloxone to reduce fatalities: scaling up a participatory intervention across EU',an @EMCDDA event today! http://t.c…"},{"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/YG4UCpf5Hm","expanded_url":"http://www.emcdda.europa.eu/events/2014/meetings/naloxone","display_url":"emcdda.europa.eu/events/2014/me…"}],"mentions":[{"start":3,"end":14,"username":"arjmcauley","id":"299936744"},{"start":43,"end":50,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":51,"end":60,"tag":"naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"521970342768955392","possibly_sensitive":false,"created_at":"2014-10-14T10:26:42.000Z","referenced_tweets":[{"type":"retweeted","id":"521955846277066752"}],"id":"521970342768955392","text":"RT @arjmcauley: Strong line up for today's @EMCDDA #naloxone meeting http://t.co/YG4UCpf5Hm"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Hf2IptgjaE","expanded_url":"http://www.emcdda.europa.eu/best-practice","display_url":"emcdda.europa.eu/best-practice"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"521670961826111489","possibly_sensitive":false,"created_at":"2014-10-13T14:37:04.000Z","referenced_tweets":{},"id":"521670961826111489","text":"Save the date — October 23 we are launching a new and (we hope!) improved version of our best practice portal: http://t.co/Hf2IptgjaE"},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/fjlVz1BCkz","expanded_url":"http://www.emcdda.europa.eu/news/2014/fs11","display_url":"emcdda.europa.eu/news/2014/fs11"},{"start":99,"end":121,"url":"http://t.co/3FoLYuTMil","expanded_url":"https://twitter.com/EMCDDA/status/521602247235739648/photo/1","display_url":"pic.twitter.com/3FoLYuTMil"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_521602246099099648"]},"conversation_id":"521602247235739648","possibly_sensitive":false,"created_at":"2014-10-13T10:04:01.000Z","referenced_tweets":{},"id":"521602247235739648","text":"Drug-related harms and responses in focus at annual EMCDDA expert meetings: http://t.co/fjlVz1BCkz http://t.co/3FoLYuTMil"},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/5riKQrusAn","expanded_url":"https://e-recruitment.emcdda.europa.eu/e-recruitment/jobvacancies","display_url":"e-recruitment.emcdda.europa.eu/e-recruitment/…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"},{"start":29,"end":36,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"521591614477963264","possibly_sensitive":false,"created_at":"2014-10-13T09:21:46.000Z","referenced_tweets":[{"type":"retweeted","id":"521587402553720832"}],"id":"521591614477963264","text":"RT @mevansbrown: Job vacancy @EMCDDA Analyst on new psychoactive substances: https://t.co/5riKQrusAn"},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/MbRmdEQkfx","expanded_url":"http://www.emcdda.europa.eu/topics/pods/controlling-new-psychoactive-substances","display_url":"emcdda.europa.eu/topics/pods/co…"},{"start":98,"end":120,"url":"http://t.co/Fvj2t0QnhT","expanded_url":"https://twitter.com/EMCDDA/status/521573621199011840/photo/1","display_url":"pic.twitter.com/Fvj2t0QnhT"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_521573619882020864"]},"conversation_id":"521573621199011840","possibly_sensitive":false,"created_at":"2014-10-13T08:10:16.000Z","referenced_tweets":{},"id":"521573621199011840","text":"Legal approaches to controlling new psychoactive substances — updated May: http://t.co/MbRmdEQkfx http://t.co/Fvj2t0QnhT"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/hBRDN6uU6t","expanded_url":"http://www.emcdda.europa.eu/expert-meetings/2014/drd-drid","display_url":"emcdda.europa.eu/expert-meeting…"}],"mentions":[{"start":3,"end":14,"username":"arjmcauley","id":"299936744"},{"start":56,"end":63,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":23,"end":28,"probability":0.9551,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"521569305155371009","possibly_sensitive":false,"created_at":"2014-10-13T07:53:07.000Z","referenced_tweets":[{"type":"retweeted","id":"521568533822865409"}],"id":"521569305155371009","text":"RT @arjmcauley: Off to Lisbon to make my first visit to @EMCDDA for the DRD meeting. Programme looks fantastic http://t.co/hBRDN6uU6t"},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/cCVwtcNlNj","expanded_url":"http://www.panmacmillan.com.au/display_title.asp?ISBN=9781742614090&Author=Ormsby,%20Eileen","display_url":"panmacmillan.com.au/display_title.…"}],"mentions":[{"start":3,"end":16,"username":"EileenOrmsby","id":"595508725"},{"start":74,"end":90,"username":"PanMacmillanAus","id":"2561910949"}],"annotations":[{"start":27,"end":35,"probability":0.6145,"type":"Other","normalized_text":"Silk Road"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"520152472506347520","possibly_sensitive":false,"created_at":"2014-10-09T10:03:08.000Z","referenced_tweets":[{"type":"retweeted","id":"520125474890977280"}],"id":"520152472506347520","text":"RT @EileenOrmsby: My book \"Silk Road\" seems to be available to order from @PanMacmillanAus ... http://t.co/cCVwtcNlNj Please RT! :)"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/cWlIK8RE9N","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1002/dta.1735/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1002/dt…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"520125433489391617","possibly_sensitive":false,"created_at":"2014-10-09T08:15:41.000Z","referenced_tweets":[{"type":"retweeted","id":"519963984293015552"}],"id":"520125433489391617","text":"RT @toxicovigilance: Synthetic stimulant 1,3-dimethylbutylamine (DMBA) identified in multiple dietary supplements http://t.co/cWlIK8RE9N (f…"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/rLh0Qxnphf","expanded_url":"http://www.emcdda.europa.eu/publications/technical-reports/online-data-collection-gps","display_url":"emcdda.europa.eu/publications/t…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519763205204094977","possibly_sensitive":false,"created_at":"2014-10-08T08:16:19.000Z","referenced_tweets":{},"id":"519763205204094977","text":"New technical report published: 'Computer-assisted and online data collection in general population surveys' http://t.co/rLh0Qxnphf"},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/kQCy1FRVv4","expanded_url":"http://ec.europa.eu/justice/grants1/calls/just_2014_jdru_ag_drug_en.htm","display_url":"ec.europa.eu/justice/grants…"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519757521276264448","possibly_sensitive":false,"created_at":"2014-10-08T07:53:44.000Z","referenced_tweets":[{"type":"retweeted","id":"519527399609102338"}],"id":"519757521276264448","text":"RT @mvapmoreira: Open call for proposals - Drugs policy initiatives – Action grants 2014. Deadline 5.Nov http://t.co/kQCy1FRVv4"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"IATDMCT","id":"488649401"},{"start":44,"end":51,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519757004152119297","possibly_sensitive":false,"created_at":"2014-10-08T07:51:41.000Z","referenced_tweets":[{"type":"retweeted","id":"519559354358308866"}],"id":"519757004152119297","text":"RT @IATDMCT: Nice new interactive tool from @EMCDDA Synthetic drugs, precursors and pre-precursors: understanding the connections http://t.…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":107,"end":117,"tag":"medicines"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519475008876584960","possibly_sensitive":false,"created_at":"2014-10-07T13:11:08.000Z","referenced_tweets":[{"type":"retweeted","id":"519436247736254464"}],"id":"519475008876584960","text":"RT @EMA_News: A single website now provides information on suspected side effects of nationally authorised #medicines: http://t.co/GBJXXWOR…"},{"entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"nigelhawtin","id":"269395266"}],"annotations":{},"hashtags":[{"start":66,"end":80,"tag":"visualisation"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519065498773110784","possibly_sensitive":false,"created_at":"2014-10-06T13:48:29.000Z","referenced_tweets":[{"type":"replied_to","id":"519065498773110784"}],"id":"519122023046742016","text":"@nigelhawtin thank you for sharing your insights and knowledge on #visualisation with us. It was fascinating — a great workshop!","in_reply_to_user_id":"269395266"},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/kIPKhWtGO1","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1002/dta.1728/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1002/dt…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519072806437666817","possibly_sensitive":false,"created_at":"2014-10-06T10:32:55.000Z","referenced_tweets":[{"type":"retweeted","id":"519050365195780096"}],"id":"519072806437666817","text":"RT @mevansbrown: Anabolic steroids detected in bodybuilding dietary supplements – a significant risk to public health http://t.co/kIPKhWtGO1"},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/F2MIjpUIMF","expanded_url":"http://www.nhs.uk/Tools/Pages/NHSAtlasofrisk.aspx","display_url":"nhs.uk/Tools/Pages/NH…"},{"start":109,"end":131,"url":"http://t.co/syOPTEaxbZ","expanded_url":"https://twitter.com/NephJC/status/511173154505383936/photo/1","display_url":"pic.twitter.com/syOPTEaxbZ"}],"mentions":[{"start":44,"end":51,"username":"NephJC","id":"2449899066"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":6,"quote_count":0},"attachments":{"media_keys":["3_511173152143966208"]},"conversation_id":"511173154505383936","possibly_sensitive":false,"created_at":"2014-10-06T08:32:56.000Z","referenced_tweets":[{"type":"replied_to","id":"511173154505383936"}],"id":"519042609218859008","text":"Drug-related = non-transport accidents. RT “@NephJC: This Atlas of Risk is brilliant! http://t.co/F2MIjpUIMF http://t.co/syOPTEaxbZ”","in_reply_to_user_id":"2449899066"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/CfIV3YYTXv","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1111/add.12610/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1111/ad…"}],"mentions":{},"annotations":[{"start":75,"end":80,"probability":0.8436,"type":"Person","normalized_text":"Hughes"},{"start":87,"end":95,"probability":0.8414,"type":"Person","normalized_text":"Griffiths"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":2,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519037583654141952","possibly_sensitive":false,"created_at":"2014-10-06T08:12:57.000Z","referenced_tweets":{},"id":"519037583654141952","text":"Addiction: Regulatory approaches to new psychoactive substances in the EU (Hughes  and Griffiths, EMCDDA): http://t.co/CfIV3YYTXv"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"TIAFT_Tweets","id":"1858734884"}],"annotations":{},"hashtags":[{"start":18,"end":27,"tag":"European"},{"start":28,"end":38,"tag":"Workplace"},{"start":39,"end":44,"tag":"Drug"},{"start":45,"end":53,"tag":"Testing"},{"start":95,"end":102,"tag":"Lisbon"},{"start":103,"end":112,"tag":"Portugal"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"519033038047813632","possibly_sensitive":false,"created_at":"2014-10-06T07:54:54.000Z","referenced_tweets":[{"type":"retweeted","id":"518121841568014339"}],"id":"519033038047813632","text":"RT @TIAFT_Tweets: #European #Workplace #Drug #Testing Society will hold its 2015 conference\nin #Lisbon #Portugal on \n28-29 May 2015 \nhttp:/…"},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Eg2Isy64VU","expanded_url":"http://www.emcdda.europa.eu/topics/pods/synthetic-drug-production","display_url":"emcdda.europa.eu/topics/pods/sy…"},{"start":105,"end":127,"url":"http://t.co/jLPBlyD7jK","expanded_url":"https://twitter.com/EMCDDA/status/518010877329817600/photo/1","display_url":"pic.twitter.com/jLPBlyD7jK"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_518010877111717891"]},"conversation_id":"518010877329817600","possibly_sensitive":false,"created_at":"2014-10-03T12:13:11.000Z","referenced_tweets":{},"id":"518010877329817600","text":"Interactive tool shows connections between synthetic drugs, and (pre-)precursors: http://t.co/Eg2Isy64VU http://t.co/jLPBlyD7jK"},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/IdHPwNtEdB","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"},{"start":103,"end":125,"url":"http://t.co/uUDuDzh86y","expanded_url":"https://twitter.com/EMCDDA/status/517988421722447872/photo/1","display_url":"pic.twitter.com/uUDuDzh86y"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":4,"quote_count":0},"attachments":{"media_keys":["3_517988421504344064"]},"conversation_id":"517988421722447872","possibly_sensitive":false,"created_at":"2014-10-03T10:43:58.000Z","referenced_tweets":{},"id":"517988421722447872","text":"Prevalence of driving under the influence of different drugs and accident risk: http://t.co/IdHPwNtEdB http://t.co/uUDuDzh86y"},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/IdHPwNtEdB","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"},{"start":111,"end":133,"url":"http://t.co/m98uFbMX2P","expanded_url":"https://twitter.com/EMCDDA/status/517953604049977344/photo/1","display_url":"pic.twitter.com/m98uFbMX2P"}],"mentions":{},"annotations":[{"start":38,"end":43,"probability":0.9958,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":["3_517953603836071936"]},"conversation_id":"517953604049977344","possibly_sensitive":false,"created_at":"2014-10-03T08:25:36.000Z","referenced_tweets":{},"id":"517953604049977344","text":"Prevalence of different substances in Europe in the general driving population p. 27 of http://t.co/IdHPwNtEdB http://t.co/m98uFbMX2P"},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/IdHPwNtEdB","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"},{"start":115,"end":137,"url":"http://t.co/aPvEvoY6pQ","expanded_url":"https://twitter.com/EMCDDA/status/517713128663298048/photo/1","display_url":"pic.twitter.com/aPvEvoY6pQ"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["3_517713128310984704"]},"conversation_id":"517713128663298048","possibly_sensitive":false,"created_at":"2014-10-02T16:30:03.000Z","referenced_tweets":{},"id":"517713128663298048","text":"One of the cognitive tests described in ￼'Drug use, impaired driving and traffic accidents' http://t.co/IdHPwNtEdB http://t.co/aPvEvoY6pQ"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/IdHPwNtEdB","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"517710894214942722","possibly_sensitive":false,"created_at":"2014-10-02T16:21:10.000Z","referenced_tweets":{},"id":"517710894214942722","text":"In case you missed it during the summer, 'Drug use, impaired driving and traffic accidents': http://t.co/IdHPwNtEdB"},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/zWSrhx6mfG","expanded_url":"http://prezi.com/qegovx-qkves/tdi-expertmeeting-september-2014-nl-presentation/?utm_source=twitter&utm_medium=landing_share","display_url":"prezi.com/qegovx-qkves/t…"}],"mentions":[{"start":3,"end":16,"username":"StichtingIVZ","id":"1288218422"},{"start":89,"end":96,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"in","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"517657129894043648","possibly_sensitive":false,"created_at":"2014-10-02T12:47:32.000Z","referenced_tweets":[{"type":"retweeted","id":"517654135034753024"}],"id":"517657129894043648","text":"RT @StichtingIVZ: Presentation Netherlands (IVZ) at TDI/HRDU meeting Lisbon 23 september @emcdda  http://t.co/zWSrhx6mfG"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"LukaszBalwicki","id":"991536061"},{"start":20,"end":27,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":57,"end":98,"probability":0.3122,"type":"Other","normalized_text":"European Drug Prevention Quality Standards"},{"start":103,"end":108,"probability":0.9267,"type":"Place","normalized_text":"Warsaw"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"517657080887783424","possibly_sensitive":false,"created_at":"2014-10-02T12:47:20.000Z","referenced_tweets":[{"type":"retweeted","id":"517635534089625600"}],"id":"517657080887783424","text":"RT @LukaszBalwicki: @EMCDDA outastanding presentation on European Drug Prevention Quality Standards in Warsaw. Will start using http://t.co…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"1920yesilay","id":"299665643"},{"start":59,"end":66,"username":"EMCDDA","id":"50638521"},{"start":114,"end":124,"username":"mikaraman","id":"257884875"}],"annotations":{},"hashtags":{}},"lang":"tr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"517228154633854976","possibly_sensitive":false,"created_at":"2014-10-01T08:22:56.000Z","referenced_tweets":[{"type":"retweeted","id":"517200363813085184"}],"id":"517228154633854976","text":"RT @1920yesilay: Avrupa Uyuşturcu Bağmlılğı İzleme Merkezi @EMCDDA dan Paul Griffiths ile Yeşilay Genel Bşk.Prof. @mikaraman görüşmesi http…"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/mWAc58CHd5","expanded_url":"http://www.emcdda.europa.eu/news/2014/2nd-emdas","display_url":"emcdda.europa.eu/news/2014/2nd-…"}],"mentions":{},"annotations":[{"start":39,"end":82,"probability":0.2871,"type":"Other","normalized_text":"European Masters in Drug and Alcohol Studies"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"516520116964823040","possibly_sensitive":false,"created_at":"2014-09-29T09:29:27.000Z","referenced_tweets":{},"id":"516520116964823040","text":"Congratulations to the students of the European Masters in Drug and Alcohol Studies; graduation ceremony at EMCDDA: http://t.co/mWAc58CHd5"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/9rRwL6SyCo","expanded_url":"http://ec.europa.eu/research/researchersnight/index_en.htm","display_url":"ec.europa.eu/research/resea…"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"515556959035346945","possibly_sensitive":false,"created_at":"2014-09-26T17:42:12.000Z","referenced_tweets":[{"type":"retweeted","id":"515426767361024000"}],"id":"515556959035346945","text":"RT @KM_Robertson: 300 cities set for European Researchers' Night! Encouraging young people into research careers\nhttp://t.co/9rRwL6SyCo"},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/6CiUpWHj8t","expanded_url":"http://wp.me/py8lk-2zO","display_url":"wp.me/py8lk-2zO"}],"mentions":[{"start":3,"end":12,"username":"EU_Logos","id":"288130686"},{"start":46,"end":53,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":27,"end":32,"tag":"drug"},{"start":57,"end":62,"tag":"LIBE"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"515493166410395648","possibly_sensitive":false,"created_at":"2014-09-26T13:28:42.000Z","referenced_tweets":[{"type":"retweeted","id":"515492166693445632"}],"id":"515493166410395648","text":"RT @Eu_Logos: The European #drug report  2014 @EMCDDA at #LIBE http://t.co/6CiUpWHj8t"},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/fTBvLjSNqn","expanded_url":"http://buff.ly/1n7XGpJ","display_url":"buff.ly/1n7XGpJ"}],"mentions":[{"start":3,"end":15,"username":"DroguesInfo","id":"90431580"},{"start":92,"end":99,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"515490099690491904","possibly_sensitive":false,"created_at":"2014-09-26T13:16:31.000Z","referenced_tweets":[{"type":"retweeted","id":"515490026814459904"}],"id":"515490099690491904","text":"RT @DroguesInfo: L'Europe place sous contrôle MDPV, méthoxétamine, AH-7921 et 25I-NBOMe via @EMCDDA http://t.co/fTBvLjSNqn (en anglais)"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":[{"start":18,"end":24,"probability":0.9112,"type":"Person","normalized_text":"W. Götz"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"515457150756614144","possibly_sensitive":false,"created_at":"2014-09-26T11:05:36.000Z","referenced_tweets":[{"type":"retweeted","id":"515180037482754048"}],"id":"515457150756614144","text":"RT @KM_Robertson: W. Götz at LIBE: EMCDDA will deliver a 'timely, objective and balanced analysis of an ever more complex drug problem'"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/DG5pwJQL7o","expanded_url":"http://europa.eu/rapid/press-release_MEX-14-0925_en.htm?locale=en","display_url":"europa.eu/rapid/press-re…"}],"mentions":{},"annotations":[{"start":0,"end":11,"probability":0.4585,"type":"Organization","normalized_text":"EU Ministers"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"515131201792004096","possibly_sensitive":false,"created_at":"2014-09-25T13:30:23.000Z","referenced_tweets":{},"id":"515131201792004096","text":"EU Ministers adopt the European Commission's proposal on 4 substances linked to more than 100 deaths across EU: http://t.co/DG5pwJQL7o"},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/zaKZcNNlKu","expanded_url":"https://www.flickr.com/photos/emcdda/sets/72157647963913871/","display_url":"flickr.com/photos/emcdda/…"}],"mentions":[{"start":33,"end":45,"username":"EMSA_LISBON","id":"23603194"},{"start":50,"end":57,"username":"EMCDDA","id":"50638521"},{"start":61,"end":74,"username":"EP_President","id":"818837224003289088"},{"start":80,"end":93,"username":"EUparliament","id":"1299237188"},{"start":94,"end":107,"username":"MartinSchulz","id":"17675072"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"514737404440485889","possibly_sensitive":false,"created_at":"2014-09-24T11:25:35.000Z","referenced_tweets":{},"id":"514737404440485889","text":"Photos from yesterday's visit to @EMSA_LISBON and @EMCDDA of @EP_President from @EUparliament @MartinSchulz: https://t.co/zaKZcNNlKu"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Qr9h1xfUXS","expanded_url":"https://twitter.com/EMSA_LISBON/status/514471737736855552/photo/1","display_url":"pic.twitter.com/Qr9h1xfUXS"}],"mentions":[{"start":3,"end":15,"username":"EMSA_LISBON","id":"23603194"},{"start":17,"end":29,"username":"EMSA_LISBON","id":"23603194"},{"start":36,"end":43,"username":"EMCDDA","id":"50638521"},{"start":70,"end":83,"username":"EP_President","id":"818837224003289088"},{"start":89,"end":102,"username":"EUparliament","id":"1299237188"},{"start":103,"end":116,"username":"MartinSchulz","id":"17675072"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_514471736528490496"]},"conversation_id":"514686160464248832","possibly_sensitive":false,"created_at":"2014-09-24T08:01:57.000Z","referenced_tweets":[{"type":"retweeted","id":"514471737736855552"}],"id":"514686160464248832","text":"RT @EMSA_LISBON: @EMSA_Lisbon &amp; @EMCDDA had the honour to welcome @EP_President from @EUparliament @MartinSchulz http://t.co/Qr9h1xfUXS"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"PE_Portugal","id":"1097836022"},{"start":50,"end":63,"username":"MartinSchulz","id":"17675072"},{"start":89,"end":96,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":99,"end":104,"tag":"EMSA"},{"start":129,"end":134,"tag":"EMSA"}]},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"514449382977314816","possibly_sensitive":false,"created_at":"2014-09-23T16:21:05.000Z","referenced_tweets":[{"type":"retweeted","id":"514447861048954880"}],"id":"514449382977314816","text":"RT @PE_Portugal: Conferência de Imprensa conjunta @MartinSchulz e diretores das agências @EMCDDA e #EMSA na Sala de Conferências #EMSA http…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"EP_President","id":"818837224003289088"},{"start":43,"end":50,"username":"EMCDDA","id":"50638521"},{"start":71,"end":83,"username":"EMSA_LISBON","id":"23603194"}],"annotations":[{"start":96,"end":101,"probability":0.9932,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"514445395200851968","possibly_sensitive":false,"created_at":"2014-09-23T16:05:14.000Z","referenced_tweets":[{"type":"retweeted","id":"514445327022456833"}],"id":"514445395200851968","text":"RT @EP_President: Visiting Drug Monitoring @EMCDDA and Maritime Safety @EMSA_lisbon Agencies in Lisbon. Their added-value key for wellbeing…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"LocalPassEurope","id":"1857628910"},{"start":106,"end":113,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":42,"end":76,"probability":0.3465,"type":"Other","normalized_text":"International Local PASS Conference"}],"hashtags":[{"start":81,"end":87,"tag":"Breda"},{"start":91,"end":105,"tag":"JaneMounteney"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"514384846844866562","possibly_sensitive":false,"created_at":"2014-09-23T12:04:38.000Z","referenced_tweets":[{"type":"retweeted","id":"514384699167625216"}],"id":"514384846844866562","text":"RT @LocalPassEurope: Also speaking at our International Local PASS Conference in #Breda is #JaneMounteney @EMCDDA"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"EP_President","id":"818837224003289088"},{"start":77,"end":90,"username":"passoscoelho","id":"19689047"},{"start":92,"end":101,"username":"ajseguro","id":"177736182"},{"start":103,"end":117,"username":"STARTUPLISBOA","id":"491221839"}],"annotations":[{"start":62,"end":74,"probability":0.7784,"type":"Place","normalized_text":"António Costa"},{"start":122,"end":123,"probability":0.496,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":34,"end":41,"tag":"Lisbon"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"514327683040571392","possibly_sensitive":false,"created_at":"2014-09-23T08:17:30.000Z","referenced_tweets":[{"type":"retweeted","id":"514327602950311937"}],"id":"514327683040571392","text":"RT @EP_President: A packed day in #Lisbon today: meeting with António Costa, @passoscoelho, @ajseguro, @STARTUPLISBOA and EU agencies @EMCD…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"Europarl_PT","id":"40872043"},{"start":31,"end":44,"username":"EP_President","id":"818837224003289088"},{"start":72,"end":84,"username":"EMSA_LISBON","id":"23603194"},{"start":85,"end":92,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":17,"end":29,"probability":0.9571,"type":"Person","normalized_text":"Martin Schulz"},{"start":53,"end":67,"probability":0.9011,"type":"Place","normalized_text":"Lisboa Reuniões"}],"hashtags":{}},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"514325819796520960","possibly_sensitive":false,"created_at":"2014-09-23T08:10:05.000Z","referenced_tweets":[{"type":"retweeted","id":"514312348153438208"}],"id":"514325819796520960","text":"RT @Europarl_PT: Martin Schulz @EP_President hoje em Lisboa Reuniões c/ @EMSA_LISBON @EMCDDA PM Passos Coelho"},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/gm4qjuQ2uJ","expanded_url":"http://www.emcdda.europa.eu/news/2014/8","display_url":"emcdda.europa.eu/news/2014/8"}],"mentions":{},"annotations":[{"start":30,"end":42,"probability":0.8973,"type":"Person","normalized_text":"Martin Schulz"},{"start":53,"end":54,"probability":0.6857,"type":"Organization","normalized_text":"EU"},{"start":68,"end":73,"probability":0.9933,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":3,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"512950714214391808","possibly_sensitive":false,"created_at":"2014-09-19T13:05:55.000Z","referenced_tweets":{},"id":"512950714214391808","text":"European Parliament President Martin Schulz to visit EU agencies in Lisbon: http://t.co/gm4qjuQ2uJ"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/tRtfu2ydvv","expanded_url":"http://drugdriving.org.nz/","display_url":"drugdriving.org.nz"}],"mentions":[{"start":77,"end":84,"username":"nzdrug","id":"36256235"}],"annotations":[{"start":11,"end":24,"probability":0.3548,"type":"Place","normalized_text":"Wellington, NZ"}],"hashtags":[{"start":86,"end":98,"tag":"drugdriving"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"512795188255662080","possibly_sensitive":false,"created_at":"2014-09-19T08:33:14.000Z","referenced_tweets":[{"type":"replied_to","id":"512795188255662080"}],"id":"512882091496046592","text":"12-13 Nov, Wellington, NZ — 2nd International Symposium on Drugs and Driving @nzdrug: #drugdriving http://t.co/tRtfu2ydvv","in_reply_to_user_id":"36256235"},{"entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/eKguvtow5t","expanded_url":"http://drugdriving.org.nz","display_url":"drugdriving.org.nz"}],"mentions":[{"start":0,"end":7,"username":"nzdrug","id":"36256235"},{"start":8,"end":14,"username":"ONDCP","id":"1355187199457841153"},{"start":15,"end":26,"username":"CCSACanada","id":"242412733"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"512795188255662080","possibly_sensitive":false,"created_at":"2014-09-19T08:29:21.000Z","referenced_tweets":[{"type":"replied_to","id":"512795188255662080"}],"id":"512881115447971840","text":"@nzdrug @ondcp @ccsacanada the site looks great! http://t.co/eKguvtow5t","in_reply_to_user_id":"36256235"},{"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/4QqZPKsAoG","expanded_url":"http://www.emcdda.europa.eu/news/2014/fs9","display_url":"emcdda.europa.eu/news/2014/fs9"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"511919111115665408","possibly_sensitive":false,"created_at":"2014-09-16T16:46:41.000Z","referenced_tweets":{},"id":"511919111115665408","text":"European scientists to assess risks of new stimulant drug 4,4′-DMAR: http://t.co/4QqZPKsAoG"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/J5padhiqg0","expanded_url":"https://twitter.com/RIOorg/status/510382992834170881/photo/1","display_url":"pic.twitter.com/J5padhiqg0"}],"mentions":[{"start":3,"end":10,"username":"RIOorg","id":"2752846128"},{"start":68,"end":75,"username":"EMCDDA","id":"50638521"},{"start":76,"end":88,"username":"k_arctander","id":"103097873"}],"annotations":[{"start":33,"end":45,"probability":0.9825,"type":"Person","normalized_text":"Alessandra Bo"},{"start":49,"end":62,"probability":0.9722,"type":"Person","normalized_text":"Jane Mounteney"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_510382986274308096"]},"conversation_id":"511799774371401728","possibly_sensitive":false,"created_at":"2014-09-16T08:52:29.000Z","referenced_tweets":[{"type":"retweeted","id":"510382992834170881"}],"id":"511799774371401728","text":"RT @RIOorg: Thanks for the visit Alessandra Bo &amp; Jane Mounteney @emcdda @k_arctander Very informative. http://t.co/J5padhiqg0"},{"entities":{"urls":[{"start":35,"end":57,"url":"http://t.co/paTnLarwBI","expanded_url":"http://paper.li/drugism/1361483039","display_url":"paper.li/drugism/136148…"}],"mentions":[{"start":3,"end":11,"username":"Drugism","id":"28785456"},{"start":70,"end":77,"username":"EMCDDA","id":"50638521"},{"start":78,"end":93,"username":"VoteToLegalize","id":"63944648"},{"start":94,"end":103,"username":"MAPSnews","id":"4765034478"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"510342970806394880","possibly_sensitive":false,"created_at":"2014-09-12T08:23:40.000Z","referenced_tweets":[{"type":"retweeted","id":"509819513030721536"}],"id":"510342970806394880","text":"RT @Drugism: Drugism Daily is out! http://t.co/paTnLarwBI Stories via @EMCDDA @VoteToLegalize @MAPSnews"},{"entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/Za9IvJN854","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/87","display_url":"emcdda.europa.eu/publications/d…"}],"mentions":{},"annotations":[{"start":49,"end":54,"probability":0.3327,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"510064728618835968","possibly_sensitive":false,"created_at":"2014-09-11T13:58:02.000Z","referenced_tweets":{},"id":"510064728618835968","text":"Just published our quarterly newsletter, Drugnet Europe: http://t.co/Za9IvJN854"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"profsandyoliver","id":"172361526"},{"start":34,"end":41,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"509618701923270656","possibly_sensitive":false,"created_at":"2014-09-10T08:25:41.000Z","referenced_tweets":[{"type":"retweeted","id":"509601946039488512"}],"id":"509618701923270656","text":"RT @profsandyoliver: No surprise: @EMCDDA finds research focuses on methodology &gt; managing care &amp; individual patients. Sorry, £wall http://…"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/eAFM1A2NDi","expanded_url":"http://drogfokuszpont.hu/wp-content/uploads/standardok_rovid.pdf","display_url":"drogfokuszpont.hu/wp-content/upl…"}],"mentions":[{"start":3,"end":10,"username":"pbm_ab","id":"382602234"}],"annotations":{},"hashtags":[{"start":50,"end":56,"tag":"EDPQS"},{"start":57,"end":77,"tag":"preventionstandards"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"509365100684509185","possibly_sensitive":false,"created_at":"2014-09-09T15:37:58.000Z","referenced_tweets":[{"type":"retweeted","id":"509362763156967424"}],"id":"509365100684509185","text":"RT @pbm_ab: and here's another translation of our #EDPQS #preventionstandards Quick Guide - this time: Hungarian http://t.co/eAFM1A2NDi @EM…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"infodrogas","id":"110941593"},{"start":19,"end":26,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":55,"end":61,"probability":0.5735,"type":"Organization","normalized_text":"Europol"}],"hashtags":[{"start":79,"end":86,"tag":"opiode"}]},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506737881751490560","possibly_sensitive":false,"created_at":"2014-09-02T09:38:20.000Z","referenced_tweets":[{"type":"retweeted","id":"506737710380625922"}],"id":"506737881751490560","text":"RT @infodrogas: MT @EMCDDA  Informe (inglés) del OEDT/ Europol sobre MT-45, un #opiode sintético asociado a intoxicaciones y muertes http:/…"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/tprJlitUXl","expanded_url":"http://www.emcdda.europa.eu/publications/thematic-papers/druid","display_url":"emcdda.europa.eu/publications/t…"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":20,"end":35,"username":"TransformDrugs","id":"59458901"},{"start":40,"end":47,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506735429534904320","possibly_sensitive":false,"created_at":"2014-09-02T09:28:35.000Z","referenced_tweets":[{"type":"retweeted","id":"506733844482260993"}],"id":"506735429534904320","text":"RT @andrewbrown365: @TransformDrugs the @EMCDDA paper on DRUID project useful overview of European picture http://t.co/tprJlitUXl http://t.…"},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/Qa3gn2EGEM","expanded_url":"http://informahealthcare.com/doi/abs/10.3109/15563650.2014.943908?mobileUi=0","display_url":"informahealthcare.com/doi/abs/10.310…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":[{"start":92,"end":97,"probability":0.7735,"type":"Place","normalized_text":"Sweden"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506716863230144512","possibly_sensitive":false,"created_at":"2014-09-02T08:14:49.000Z","referenced_tweets":[{"type":"retweeted","id":"506687067649490945"}],"id":"506716863230144512","text":"RT @toxicovigilance: Case series of serious non-fatal intoxications associated with MT-45  (Sweden) http://t.co/Qa3gn2EGEM"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/dGv4z6LShm","expanded_url":"http://www.emcdda.europa.eu/publications/joint-reports/MT-45","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":3,"end":12,"username":"SedefovR","id":"955287361"},{"start":103,"end":114,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506460489455796224","possibly_sensitive":false,"created_at":"2014-09-02T08:14:15.000Z","referenced_tweets":[{"type":"replied_to","id":"506467924715261952"}],"id":"506716720611201024","text":"MT @SedefovR: As highlighted in our report new synthetic opioids like MT45 are causing serious concern @Europol_EU \nhttp://t.co/dGv4z6LShm","in_reply_to_user_id":"955287361"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/dGv4z6LShm","expanded_url":"http://www.emcdda.europa.eu/publications/joint-reports/MT-45","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":34,"end":45,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506460489455796224","possibly_sensitive":false,"created_at":"2014-09-01T15:16:04.000Z","referenced_tweets":{},"id":"506460489455796224","text":"Just published: joint report with @Europol_EU on a new psychoactive substance ‘MT-45’: http://t.co/dGv4z6LShm"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/jqgY7SwOWF","expanded_url":"http://informahealthcare.com/doi/abs/10.3109/09687637.2014.954988","display_url":"informahealthcare.com/doi/abs/10.310…"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":81,"end":88,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506397994951139328","possibly_sensitive":false,"created_at":"2014-09-01T11:07:45.000Z","referenced_tweets":[{"type":"retweeted","id":"506393018916933632"}],"id":"506397994951139328","text":"RT @andrewbrown365: What is needed in future drug treatment research? paper from @EMCDDA \nhttp://t.co/jqgY7SwOWF"},{"entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/jpFpm6STvf","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1111/add.12610/pdf","display_url":"onlinelibrary.wiley.com/doi/10.1111/ad…"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":110,"end":117,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":45,"end":47,"probability":0.5851,"type":"Organization","normalized_text":"NPS"},{"start":71,"end":84,"probability":0.9823,"type":"Person","normalized_text":"Brendan Hughes"},{"start":88,"end":101,"probability":0.9765,"type":"Person","normalized_text":"Paul Griffiths"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"506386111565160448","possibly_sensitive":false,"created_at":"2014-09-01T10:20:31.000Z","referenced_tweets":[{"type":"retweeted","id":"506381365370445825"}],"id":"506386111565160448","text":"RT @andrewbrown365: Regulatory approaches to NPS in the European Union\nBrendan Hughes &amp; Paul Griffiths of @EMCDDA \nhttp://t.co/jpFpm6STvf"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EU_Justice","id":"461919971"},{"start":17,"end":33,"username":"EurobarometerEU","id":"304876789"}],"annotations":{},"hashtags":[{"start":79,"end":90,"tag":"legalhighs"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"502408785512902656","possibly_sensitive":false,"created_at":"2014-08-21T10:56:03.000Z","referenced_tweets":[{"type":"retweeted","id":"502398915640295425"}],"id":"502408785512902656","text":"RT @EU_Justice: .@EurobarometerEU study shows young people less informed about #legalhighs. Time to inform about the lethal risks. http://t…"},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/3v5CnTy1Ti","expanded_url":"https://e-recruitment.emcdda.europa.eu/e-recruitment/jobvacancies","display_url":"e-recruitment.emcdda.europa.eu/e-recruitment/…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"499195006528552960","possibly_sensitive":false,"created_at":"2014-08-12T14:05:38.000Z","referenced_tweets":{},"id":"499195006528552960","text":"Reminder: deadline to apply for the analyst/writer on drug markets and drug related crime is on Thursday (14 Aug)  https://t.co/3v5CnTy1Ti"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"MalmstromEU","id":"460966881"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":185,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"497390580566351872","possibly_sensitive":false,"created_at":"2014-08-07T14:35:30.000Z","referenced_tweets":[{"type":"retweeted","id":"494755717803679744"}],"id":"497390580566351872","text":"RT @MalmstromEU: Happy and honoured to have been nominated as Commissioner for a second term /CM"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/aVHvfknxto","expanded_url":"http://www.emcdda.europa.eu/events/2015/addiction-conference","display_url":"emcdda.europa.eu/events/2015/ad…"}],"mentions":{},"annotations":[{"start":88,"end":93,"probability":0.597,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"497348907400433664","possibly_sensitive":false,"created_at":"2014-08-07T11:49:54.000Z","referenced_tweets":{},"id":"497348907400433664","text":"1st European conference on addictive behaviours and dependencies, 23–25 September 2015, Lisbon. Save the date! http://t.co/aVHvfknxto"},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/8Vc5aC7u3p","expanded_url":"http://www.emcdda.europa.eu/html.cfm/index10451EN.html","display_url":"emcdda.europa.eu/html.cfm/index…"}],"mentions":{},"annotations":[{"start":36,"end":73,"probability":0.7529,"type":"Other","normalized_text":"Drug Use Disorders Identification Test"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"497011068477407232","possibly_sensitive":false,"created_at":"2014-08-06T13:27:27.000Z","referenced_tweets":{},"id":"497011068477407232","text":"Just added Farsi translation of the Drug Use Disorders Identification Test - DUDIT: http://t.co/8Vc5aC7u3p"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"AniShakari","id":"2502499914"},{"start":130,"end":137,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":70,"end":75,"probability":0.993,"type":"Place","normalized_text":"Europe"},{"start":116,"end":117,"probability":0.8016,"type":"Place","normalized_text":"Tx"}],"hashtags":[{"start":29,"end":39,"tag":"Hepatitis"},{"start":61,"end":66,"tag":"PWID"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"496938212418650112","possibly_sensitive":false,"created_at":"2014-08-06T08:37:57.000Z","referenced_tweets":[{"type":"retweeted","id":"496702497063727104"}],"id":"496938212418650112","text":"RT @AniShakari: Good review: #Hepatitis C epidemiology among #PWID in Europe suggesting many undiagnosed inf-s&amp;poor Tx uptake @EMCDDA http:…"},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/cf24KKua6b","expanded_url":"https://www.europol.europa.eu/internships","display_url":"europol.europa.eu/internships"}],"mentions":[{"start":3,"end":14,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":[{"start":27,"end":38,"tag":"internship"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"495194739587969024","possibly_sensitive":false,"created_at":"2014-08-01T13:10:00.000Z","referenced_tweets":[{"type":"retweeted","id":"494775287671189504"}],"id":"495194739587969024","text":"RT @Europol_EU: We have 22 #internship positions available at Europol. Deadlines in August 2014. Check them out! https://t.co/cf24KKua6b"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/fZlbqZtfQ0","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":29,"end":32,"probability":0.5318,"type":"Place","normalized_text":"ECHA"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"495194732168245249","possibly_sensitive":false,"created_at":"2014-08-01T13:09:59.000Z","referenced_tweets":[{"type":"retweeted","id":"494819514689679361"}],"id":"495194732168245249","text":"RT @EU_ECHA: Want to work at ECHA? We need new Scientific Officers - apply by 1 September http://t.co/fZlbqZtfQ0"},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/2vQMrtVC6i","expanded_url":"http://www.emcdda.europa.eu/events/2014/meetings/naloxone","display_url":"emcdda.europa.eu/events/2014/me…"}],"mentions":{},"annotations":[{"start":26,"end":31,"probability":0.4631,"type":"Organization","normalized_text":"EMCDDA"},{"start":69,"end":74,"probability":0.7215,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"494805154848571392","possibly_sensitive":false,"created_at":"2014-07-31T11:21:56.000Z","referenced_tweets":{},"id":"494805154848571392","text":"Registration now open for EMCDDA event on naloxone, 14 October, 2014 Lisbon: http://t.co/2vQMrtVC6i"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/odt18rdenr","expanded_url":"https://twitter.com/PHE_uk/status/493686056475447296/photo/1","display_url":"pic.twitter.com/odt18rdenr"}],"mentions":{},"annotations":[{"start":105,"end":106,"probability":0.9663,"type":"Place","normalized_text":"UK"}],"hashtags":[{"start":29,"end":47,"tag":"WorldHepatitisDay"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":102,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_493686055758204928"]},"conversation_id":"493768542198968320","possibly_sensitive":false,"created_at":"2014-07-28T14:42:48.000Z","referenced_tweets":[{"type":"retweeted","id":"493686056475447296"}],"id":"493768542198968320","text":"RT @PHE_uk: To coincide with #WorldHepatitisDay we’re releasing the latest figures on hepatitis C in the UK http://t.co/odt18rdenr"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/uQ5QuW4a09","expanded_url":"http://bit.ly/1om9C5l","display_url":"bit.ly/1om9C5l"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":33,"end":38,"probability":0.9948,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":19,"end":29,"tag":"hepatitis"},{"start":116,"end":134,"tag":"WorldHepatitisDay"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"493761076849565696","possibly_sensitive":false,"created_at":"2014-07-28T14:13:09.000Z","referenced_tweets":[{"type":"retweeted","id":"492621495320207360"}],"id":"493761076849565696","text":"RT @ECDC_EU: Viral #hepatitis in Europe is undiagnosed and under-reported, shows new report  http://t.co/uQ5QuW4a09 #WorldHepatitisDay"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":36,"end":41,"probability":0.9871,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":13,"end":31,"tag":"WorldHepatitisDay"},{"start":43,"end":48,"tag":"hepA"},{"start":73,"end":78,"tag":"hepB"},{"start":110,"end":115,"tag":"hepC"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"493760938164903936","possibly_sensitive":false,"created_at":"2014-07-28T14:12:35.000Z","referenced_tweets":[{"type":"retweeted","id":"493742129936859136"}],"id":"493760938164903936","text":"RT @ECDC_EU: #WorldHepatitisDay: in Europe #hepA is re-emerging, chronic #hepB cases have doubled, &gt;30 000 #hepC cases in 2012 http://t.co/…"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/qIuku8dWPm","expanded_url":"http://www.emcdda.europa.eu/news/2014/hepatitis-day","display_url":"emcdda.europa.eu/news/2014/hepa…"}],"mentions":{},"annotations":[{"start":82,"end":87,"probability":0.9699,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":119,"end":134,"tag":"thinkhepatitis"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"493760555162030080","possibly_sensitive":false,"created_at":"2014-07-28T14:11:04.000Z","referenced_tweets":{},"id":"493760555162030080","text":"New EMCDDA review on hepatitis C virus infection among people who inject drugs in Europe study: http://t.co/qIuku8dWPm #thinkhepatitis"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"492233666907885568","possibly_sensitive":false,"created_at":"2014-07-24T09:03:46.000Z","referenced_tweets":[{"type":"retweeted","id":"491911603105693696"}],"id":"492233666907885568","text":"RT @andcunningham: NEWSFLASH: Young people don't think 'legal highs' are safe. 96% think regular use is med or high risk. See slide 20. htt…"},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/gtMMfqIVkC","expanded_url":"http://dlvr.it/6PfRvB","display_url":"dlvr.it/6PfRvB"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":101,"end":110,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":52,"end":58,"tag":"H2020"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"492232483208192000","possibly_sensitive":false,"created_at":"2014-07-24T08:59:03.000Z","referenced_tweets":[{"type":"retweeted","id":"491979087913959424"}],"id":"492232483208192000","text":"RT @mvapmoreira: Forthcoming call for proposals for #H2020 ERC Starting Grant http://t.co/gtMMfqIVkC @EU_H2020"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":91,"end":98,"username":"EMCDDA","id":"50638521"},{"start":105,"end":118,"username":"ukhomeoffice","id":"138037459"}],"annotations":[{"start":25,"end":26,"probability":0.7128,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"491976091780001792","possibly_sensitive":false,"created_at":"2014-07-23T16:00:15.000Z","referenced_tweets":[{"type":"retweeted","id":"491956302437171201"}],"id":"491976091780001792","text":"RT @andrewbrown365: \"The UK benefits considerably from the information we receive from the @EMCDDA\" says @ukhomeoffice Minister http://t.co…"},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/RkhLlVqPZQ","expanded_url":"http://www.nih.gov/news/health/jul2014/nida-17.htm","display_url":"nih.gov/news/health/ju…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":33,"end":34,"probability":0.6808,"type":"Place","normalized_text":"US"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"491904038733361152","possibly_sensitive":false,"created_at":"2014-07-23T11:13:56.000Z","referenced_tweets":[{"type":"retweeted","id":"490040531503034368"}],"id":"491904038733361152","text":"RT @mevansbrown: NIDA to setup a US national drug early warning system http://t.co/RkhLlVqPZQ"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/4sL7C8Rprs","expanded_url":"http://www.emcdda.europa.eu/publications/joint-reports/4-4-DMAR","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":74,"end":85,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":5,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"489760837121634304","possibly_sensitive":false,"created_at":"2014-07-17T13:17:37.000Z","referenced_tweets":{},"id":"489760837121634304","text":"Just published: our joint report on new psychoactive substance: 4,4′-DMAR @Europol_EU  http://t.co/4sL7C8Rprs"},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/fUC3MguVDg","expanded_url":"http://www.surveymonkey.com/s/YNT6676","display_url":"surveymonkey.com/s/YNT6676"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"483895836431364096","possibly_sensitive":false,"created_at":"2014-07-16T13:57:26.000Z","referenced_tweets":[{"type":"replied_to","id":"487143346809622529"}],"id":"489408469414731776","text":"What should we focus on over the next three years? Take our short survey if you haven't already done so: http://t.co/fUC3MguVDg","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/BeJfn7JmIF","expanded_url":"http://us7.campaign-archive1.com/?u=7661463396b2fc9d763392225&id=ff5687999b","display_url":"us7.campaign-archive1.com/?u=7661463396b…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"489378861675982848","possibly_sensitive":false,"created_at":"2014-07-16T11:59:47.000Z","referenced_tweets":{},"id":"489378861675982848","text":"Latest issue of our 'Just published' email update just went out. View or subscribe to it here: http://t.co/BeJfn7JmIF"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/YajAUmkmdt","expanded_url":"http://www.emcdda.europa.eu/news/2014/7","display_url":"emcdda.europa.eu/news/2014/7"}],"mentions":{},"annotations":[{"start":24,"end":28,"probability":0.52,"type":"Place","normalized_text":"Hague"},{"start":80,"end":87,"probability":0.3482,"type":"Person","normalized_text":"Eurojust"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"489045492714995713","possibly_sensitive":false,"created_at":"2014-07-15T13:55:06.000Z","referenced_tweets":{},"id":"489045492714995713","text":"Our Director was in the Hague today  to sign a memorandum of understanding with Eurojust: http://t.co/YajAUmkmdt"},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/gSPoFfdkZ7","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/residential-treatment","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":21,"end":26,"probability":0.8845,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":5,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"488709057612890112","possibly_sensitive":false,"created_at":"2014-07-14T15:38:13.000Z","referenced_tweets":{},"id":"488709057612890112","text":"Just published — our Europe-wide overview of the history and availability of residential drug treatment: http://t.co/gSPoFfdkZ7"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":[{"start":106,"end":118,"probability":0.8463,"type":"Person","normalized_text":"Meni Malliori"}],"hashtags":[{"start":16,"end":25,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"487722905560969217","possibly_sensitive":false,"created_at":"2014-07-11T22:19:36.000Z","referenced_tweets":[{"type":"retweeted","id":"487558515175997440"}],"id":"487722905560969217","text":"RT @EDSSLisbon: #EDSS2014 finishing today with debate on DRUG POLICIES AFTER THE ECONOMIC RECESSION  with Meni Malliori (University of Athe…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":105,"end":116,"username":"EDSSLisbon","id":"2213957400"},{"start":117,"end":124,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":76,"end":82,"probability":0.4835,"type":"Person","normalized_text":"Minerva"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"487722884794957824","possibly_sensitive":false,"created_at":"2014-07-11T22:19:31.000Z","referenced_tweets":[{"type":"retweeted","id":"487590779700150272"}],"id":"487722884794957824","text":"RT @mvapmoreira: Debate on drug policies after the economic recession, with Minerva- \nMelpomeni Malliori @EDSSLisbon @EMCDDA http://t.co/MU…"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/Vxvl8Ze0KZ","expanded_url":"http://www.emcdda.europa.eu/publications/implementation-reports/2013","display_url":"emcdda.europa.eu/publications/i…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"487547516662337536","possibly_sensitive":false,"created_at":"2014-07-11T10:42:40.000Z","referenced_tweets":{},"id":"487547516662337536","text":"Just published: EMCDDA-Europol 2013 Annual implementation report including new psychoactive substances in 2013: http://t.co/Vxvl8Ze0KZ"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/5jc2ToTTPg","expanded_url":"http://www.lesinrocks.com/2014/07/09/actualite/nouvelles-drogues-synthese-participez-lenquete-lofdt-11514193/#.U75D03HG5tQ.twitter","display_url":"lesinrocks.com/2014/07/09/act…"}],"mentions":[{"start":3,"end":8,"username":"OFDT","id":"121702523"},{"start":117,"end":128,"username":"lesinrocks","id":"16097522"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"487534753638526976","possibly_sensitive":false,"created_at":"2014-07-11T09:51:57.000Z","referenced_tweets":[{"type":"retweeted","id":"487139909291868161"}],"id":"487534753638526976","text":"RT @OFDT: Les Inrocks - Nouvelles drogues de synthèse : participez à l'enquête de l'OFDT: http://t.co/5jc2ToTTPg via @lesinrocks"},{"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/64Ae7I23LK","expanded_url":"https://twitter.com/EDSSLisbon/status/487253789133791232/photo/1","display_url":"pic.twitter.com/64Ae7I23LK"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"},{"start":55,"end":67,"username":"robertjwest","id":"260345372"},{"start":85,"end":97,"username":"SusanMichie","id":"161988348"}],"annotations":[{"start":75,"end":79,"probability":0.779,"type":"Person","normalized_text":"Susan"}],"hashtags":[{"start":16,"end":25,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_487253786575253504"]},"conversation_id":"487511715824013313","possibly_sensitive":false,"created_at":"2014-07-11T08:20:25.000Z","referenced_tweets":[{"type":"retweeted","id":"487253789133791232"}],"id":"487511715824013313","text":"RT @EDSSLisbon: #EDSS2014 students group exercise with @robertjwest West &amp; Susan @SusanMichie on Models of Addiction http://t.co/64Ae7I23LK"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/fUC3MguVDg","expanded_url":"http://www.surveymonkey.com/s/YNT6676","display_url":"surveymonkey.com/s/YNT6676"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"483895836431364096","possibly_sensitive":false,"created_at":"2014-07-10T07:56:39.000Z","referenced_tweets":[{"type":"replied_to","id":"483895836431364096"}],"id":"487143346809622529","text":"What do you think we should focus on over the next three years? Let us know by taking our short survey: http://t.co/fUC3MguVDg Please RT :)","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/rlhVSMBrze","expanded_url":"http://euspr.org/fifth-euspr-conference","display_url":"euspr.org/fifth-euspr-co…"}],"mentions":[{"start":3,"end":18,"username":"GregorBurkhart","id":"1119061916"},{"start":27,"end":33,"username":"euspr","id":"1008636883"}],"annotations":[{"start":107,"end":114,"probability":0.9582,"type":"Place","normalized_text":"Mallorca"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"486916427971313664","possibly_sensitive":false,"created_at":"2014-07-09T16:54:57.000Z","referenced_tweets":[{"type":"retweeted","id":"486526421528248320"}],"id":"486916427971313664","text":"RT @GregorBurkhart: Annual @EUSPR Conference registrations now open http://t.co/rlhVSMBrze and joint us in Mallorca 15-18 October"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"daniloballotta","id":"1260106290"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"486916394546909186","possibly_sensitive":false,"created_at":"2014-07-09T16:54:49.000Z","referenced_tweets":[{"type":"retweeted","id":"486164844551626754"}],"id":"486916394546909186","text":"RT @daniloballotta: Always nice to exchange views with scholars and professionals on drug policy in a learing environment. Here My pres  ht…"},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/LWYmq6VJYh","expanded_url":"https://e-recruitment.emcdda.europa.eu/e-recruitment/jobvacancies","display_url":"e-recruitment.emcdda.europa.eu/e-recruitment/…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"},{"start":29,"end":36,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"486915852953206784","possibly_sensitive":false,"created_at":"2014-07-09T16:52:40.000Z","referenced_tweets":[{"type":"retweeted","id":"485078203191799808"}],"id":"486915852953206784","text":"RT @mevansbrown: Job vacancy @EMCDDA analyst/writer on drug markets and drug related crime https://t.co/LWYmq6VJYh"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ojhXo3GnCp","expanded_url":"http://www.surveymonkey.com/s/YNT6676","display_url":"surveymonkey.com/s/YNT6676"}],"mentions":[{"start":3,"end":15,"username":"michelerhee","id":"31353538"},{"start":20,"end":27,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":47,"end":61,"probability":0.7527,"type":"Organization","normalized_text":"EU Drugs Agency"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"486915533770874881","possibly_sensitive":false,"created_at":"2014-07-09T16:51:24.000Z","referenced_tweets":[{"type":"retweeted","id":"486118716720291840"}],"id":"486915533770874881","text":"RT @michelerhee: MT @EMCDDA: What do you think EU Drugs Agency should focus on over next 3 years? Short survey: http://t.co/ojhXo3GnCp"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":16,"end":25,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"485062141268197377","possibly_sensitive":false,"created_at":"2014-07-04T14:06:41.000Z","referenced_tweets":[{"type":"retweeted","id":"485047597124812800"}],"id":"485062141268197377","text":"RT @EDSSLisbon: #EDSS2014 students during an interactive exercise on Best practices in drug-related fields at the EMCDDA http://t.co/u6JuAj…"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/uO4gFmsBpP","expanded_url":"http://europa.eu/!PY64pp","display_url":"europa.eu/!PY64pp"},{"start":116,"end":138,"url":"http://t.co/JkKuL48gKg","expanded_url":"https://twitter.com/EU_Commission/status/484640436267778048/photo/1","display_url":"pic.twitter.com/JkKuL48gKg"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":82,"end":92,"tag":"Science20"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":99,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_484640435160506369"]},"conversation_id":"484707905967779842","possibly_sensitive":false,"created_at":"2014-07-03T14:39:04.000Z","referenced_tweets":[{"type":"retweeted","id":"484640436267778048"}],"id":"484707905967779842","text":"RT @EU_Commission: Have your say on the future of science! Public consultation on #Science20 http://t.co/uO4gFmsBpP http://t.co/JkKuL48gKg"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/1EdpEPhCON","expanded_url":"http://www.emcdda.europa.eu/publications/joint-publications/2012-espad-impact-survey","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":[{"start":50,"end":61,"probability":0.6717,"type":"Person","normalized_text":"Björn Hibell"}],"hashtags":[{"start":29,"end":38,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"484655466568757249","possibly_sensitive":false,"created_at":"2014-07-03T11:10:42.000Z","referenced_tweets":[{"type":"retweeted","id":"484245190107213824"}],"id":"484655466568757249","text":"RT @EDSSLisbon: Today at the #EDSS2014 lecture of Björn Hibell - author of recently published ESPAD impact study: http://t.co/1EdpEPhCON"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":16,"end":25,"tag":"EDSS2014"}]},"lang":"pt","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"484655305218068480","possibly_sensitive":false,"created_at":"2014-07-03T11:10:03.000Z","referenced_tweets":[{"type":"retweeted","id":"484336197196865536"}],"id":"484655305218068480","text":"RT @EDSSLisbon: #EDSS2014 at the Commission for the Dissuasion of Drug Abuse. João Goulão presented Portugal's national drug policy. http:/…"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/fUC3MguVDg","expanded_url":"http://www.surveymonkey.com/s/YNT6676","display_url":"surveymonkey.com/s/YNT6676"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":28,"reply_count":3,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"483895836431364096","possibly_sensitive":false,"created_at":"2014-07-01T08:52:12.000Z","referenced_tweets":{},"id":"483895836431364096","text":"What do you think we should focus on over the next three years? Take our short survey and tell us: http://t.co/fUC3MguVDg"},{"entities":{"urls":{},"mentions":[{"start":0,"end":11,"username":"EDSSLisbon","id":"2213957400"}],"annotations":[{"start":42,"end":47,"probability":0.9879,"type":"Place","normalized_text":"Lisbon"}],"hashtags":[{"start":13,"end":18,"tag":"EDSS"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"483512504107421696","possibly_sensitive":false,"created_at":"2014-06-30T09:01:38.000Z","referenced_tweets":[{"type":"replied_to","id":"483512504107421696"}],"id":"483535823099686912","text":"@EDSSLisbon: #EDSS 2014 starting today in Lisbon! We welcome students from all over the world attending this two week course!","in_reply_to_user_id":"2213957400"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Ed8QIgDVws","expanded_url":"http://www.emcdda.europa.eu/countries/prevention-profiles","display_url":"emcdda.europa.eu/countries/prev…"}],"mentions":{},"annotations":[{"start":22,"end":27,"probability":0.9988,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482525284194074624","possibly_sensitive":false,"created_at":"2014-06-27T14:06:07.000Z","referenced_tweets":{},"id":"482525284194074624","text":"What are countries in Europe doing to prevent illicit drug use? Find out in our just updated Prevention profiles: http://t.co/Ed8QIgDVws"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/NcfAaJ8aGG","expanded_url":"http://www.emcdda.europa.eu/news/speeches","display_url":"emcdda.europa.eu/news/speeches"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482514491067080704","possibly_sensitive":false,"created_at":"2014-06-27T13:23:14.000Z","referenced_tweets":[{"type":"retweeted","id":"482168986088783873"}],"id":"482514491067080704","text":"RT @KM_Robertson: Just published! Speeches from our 26 June event. EMCDDA Director and Minister of Health\nhttp://t.co/NcfAaJ8aGG"},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/HF9ZZQcynj","expanded_url":"http://www.unodc.org/wdr","display_url":"unodc.org/wdr"},{"start":117,"end":139,"url":"http://t.co/q67CXGwH2Q","expanded_url":"https://twitter.com/WHO_Europe/status/482149958599340032/photo/1","display_url":"pic.twitter.com/q67CXGwH2Q"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":30,"end":44,"probability":0.5838,"type":"Place","normalized_text":"European Region"}],"hashtags":[{"start":16,"end":20,"tag":"HIV"},{"start":80,"end":93,"tag":"WorldDrugDay"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_482149957550764032"]},"conversation_id":"482151877178822656","possibly_sensitive":false,"created_at":"2014-06-26T13:22:20.000Z","referenced_tweets":[{"type":"retweeted","id":"482149958599340032"}],"id":"482151877178822656","text":"RT @WHO_Europe: #HIV rates in European Region high among those who inject drugs #WorldDrugDay http://t.co/HF9ZZQcynj http://t.co/q67CXGwH2Q"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":49,"end":54,"tag":"drug"},{"start":73,"end":85,"tag":"trafficking"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482147175020134400","possibly_sensitive":false,"created_at":"2014-06-26T13:03:39.000Z","referenced_tweets":[{"type":"retweeted","id":"482048242990206976"}],"id":"482147175020134400","text":"RT @eubookshop: 26/6 - International day against #drug abuse and illicit #trafficking. The latest trends in the EU (23 languages): http://t…"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/h45P7MBB4E","expanded_url":"http://europa.eu/rapid/press-release_MEMO-14-445_en.htm","display_url":"europa.eu/rapid/press-re…"}],"mentions":[{"start":3,"end":14,"username":"EU_Justice","id":"461919971"}],"annotations":{},"hashtags":[{"start":16,"end":30,"tag":"Eurobarometer"},{"start":31,"end":42,"tag":"legalhighs"},{"start":76,"end":89,"tag":"worlddrugday"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482126414674939905","possibly_sensitive":false,"created_at":"2014-06-26T11:41:09.000Z","referenced_tweets":[{"type":"retweeted","id":"482103953535299585"}],"id":"482126414674939905","text":"RT @EU_Justice: #Eurobarometer:#legalhighs on the rise among European youth #worlddrugday http://t.co/h45P7MBB4E"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/codEw6WoyV","expanded_url":"http://www.emcdda.europa.eu/news/2014/3","display_url":"emcdda.europa.eu/news/2014/3"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":135,"end":142,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":83,"end":88,"probability":0.992,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":29,"end":34,"tag":"Drug"},{"start":102,"end":111,"tag":"cannabis"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482086833409765377","possibly_sensitive":false,"created_at":"2014-06-26T09:03:52.000Z","referenced_tweets":[{"type":"retweeted","id":"482085869290287104"}],"id":"482086833409765377","text":"RT @Europarl_EN: Day against #Drug Abuse &amp; Illicit Trafficking: 80 %of seizures in Europe are for #cannabis http://t.co/codEw6WoyV @EMCDDA"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":57,"end":59,"probability":0.5996,"type":"Organization","normalized_text":"NPS"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482082232526733313","possibly_sensitive":false,"created_at":"2014-06-26T08:45:35.000Z","referenced_tweets":[{"type":"retweeted","id":"482068698170396672"}],"id":"482082232526733313","text":"RT @mevansbrown: Conclusions from the ECJ on classifying NPS used for recreational purposes as medicinal products… very interesting http://…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"brycepardo","id":"25888310"},{"start":45,"end":52,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":99,"end":106,"probability":0.8249,"type":"Place","normalized_text":"Americas"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"482082151312424960","possibly_sensitive":false,"created_at":"2014-06-26T08:45:16.000Z","referenced_tweets":[{"type":"retweeted","id":"482082009909829632"}],"id":"482082151312424960","text":"RT @brycepardo: Legal correspondents meeting @EMCDDA. Later today I'll present on drug laws in the Americas and cannabis regulations. http:…"},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/Ryt2QZ7BQ9","expanded_url":"https://twitter.com/UNODC/status/482056086779088896/photo/1","display_url":"pic.twitter.com/Ryt2QZ7BQ9"}],"mentions":[{"start":3,"end":9,"username":"UNODC","id":"17969699"}],"annotations":{},"hashtags":[{"start":20,"end":33,"tag":"WorldDrugDay"},{"start":80,"end":85,"tag":"drug"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_482056086640680960"]},"conversation_id":"482080623860142080","possibly_sensitive":false,"created_at":"2014-06-26T08:39:12.000Z","referenced_tweets":[{"type":"retweeted","id":"482056086779088896"}],"id":"482080623860142080","text":"RT @UNODC: Today is #WorldDrugDay. What’s happening in your community to tackle #drug use? http://t.co/Ryt2QZ7BQ9"},{"entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/OIDzTMTdCG","expanded_url":"http://bit.ly/1pABBw6","display_url":"bit.ly/1pABBw6"}],"mentions":[{"start":3,"end":19,"username":"AlainVerstraete","id":"450118672"},{"start":25,"end":32,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481922813029515266","possibly_sensitive":false,"created_at":"2014-06-25T22:12:07.000Z","referenced_tweets":[{"type":"retweeted","id":"481902806065246208"}],"id":"481922813029515266","text":"RT @AlainVerstraete: New @EMCDDA Insight: Drug use, impaired driving&amp;traffic accidents, that I co-authored, is out http://t.co/OIDzTMTdCG h…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"CCLTCanada","id":"851447014944632834"},{"start":19,"end":34,"username":"andrewbrown365","id":"105148303"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481802818035396610","possibly_sensitive":false,"created_at":"2014-06-25T14:15:17.000Z","referenced_tweets":[{"type":"retweeted","id":"481801187927543809"}],"id":"481802818035396610","text":"RT @CCLTcanada: MT @andrewbrown365: Au moins 1 substance psychoactive décelée chez 28% à 53% des conducteurs grav. blessés http://t.co/Cvbt…"},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/31lBdjwq5V","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"},{"start":107,"end":129,"url":"http://t.co/UvoR7rwLZq","expanded_url":"https://twitter.com/andrewbrown365/status/481799633023537152/photo/1","display_url":"pic.twitter.com/UvoR7rwLZq"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":76,"end":83,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_481799631731314691"]},"conversation_id":"481802733176254465","possibly_sensitive":false,"created_at":"2014-06-25T14:14:57.000Z","referenced_tweets":[{"type":"retweeted","id":"481799633023537152"}],"id":"481802733176254465","text":"RT @andrewbrown365: prevalence and injury risk of drug driving by substance @EMCDDA http://t.co/31lBdjwq5V http://t.co/UvoR7rwLZq"},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/IdHPwNLNrJ","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481748669746937856","possibly_sensitive":false,"created_at":"2014-06-25T10:40:07.000Z","referenced_tweets":{},"id":"481748669746937856","text":"Just published: Drug use, impaired driving and traffic accidents: http://t.co/IdHPwNLNrJ"},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/Vcjx97yoOD","expanded_url":"http://goo.gl/Xjkoxd","display_url":"goo.gl/Xjkoxd"}],"mentions":[{"start":3,"end":17,"username":"EUEnvironment","id":"22362552"}],"annotations":{},"hashtags":[{"start":19,"end":25,"tag":"Photo"},{"start":26,"end":38,"tag":"competition"},{"start":74,"end":86,"tag":"environment"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481731822054023168","possibly_sensitive":false,"created_at":"2014-06-25T09:33:11.000Z","referenced_tweets":[{"type":"retweeted","id":"481724096380948480"}],"id":"481731822054023168","text":"RT @EUEnvironment: #Photo #competition with cash prizes:\nTell us what the #environment means to you! http://t.co/Vcjx97yoOD http://t.co/koc…"},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/bCrZDzSDmK","expanded_url":"http://bit.ly/1nAQRXf","display_url":"bit.ly/1nAQRXf"}],"mentions":[{"start":3,"end":8,"username":"OECD","id":"25390350"}],"annotations":{},"hashtags":[{"start":32,"end":39,"tag":"health"},{"start":49,"end":54,"tag":"jobs"},{"start":77,"end":82,"tag":"OECD"},{"start":114,"end":125,"tag":"YourRegion"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481731545238347776","possibly_sensitive":false,"created_at":"2014-06-25T09:32:05.000Z","referenced_tweets":[{"type":"retweeted","id":"481500280408645635"}],"id":"481731545238347776","text":"RT @OECD: Compare your Index on #health, skills, #jobs, income, more, w/ 360 #OECD regions http://t.co/bCrZDzSDmK #YourRegion http://t.co/Y…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"brycepardo","id":"25888310"},{"start":68,"end":75,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":16,"end":35,"probability":0.2933,"type":"Organization","normalized_text":"Dulles international"},{"start":105,"end":112,"probability":0.8625,"type":"Place","normalized_text":"Americas"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481721082316357633","possibly_sensitive":false,"created_at":"2014-06-25T08:50:30.000Z","referenced_tweets":[{"type":"retweeted","id":"481503550162616320"}],"id":"481721082316357633","text":"RT @brycepardo: Dulles international? I was just here! On my way to @EMCDDA to brief on drug laws in the Americas and cannabis regulations."},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/LWudZfsxgT","expanded_url":"http://bit.ly/V8KcNu","display_url":"bit.ly/V8KcNu"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":28,"end":42,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":76,"end":87,"tag":"pharmacies"},{"start":112,"end":131,"tag":"falsifiedmedicines"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"481720804598898688","possibly_sensitive":false,"created_at":"2014-06-25T08:49:24.000Z","referenced_tweets":[{"type":"retweeted","id":"481720310748966912"}],"id":"481720804598898688","text":"RT @EMA_News: Yesterday the @EU_Commission launched a logo for legal online #pharmacies: http://t.co/LWudZfsxgT #falsifiedmedicines http://…"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/mt7ReN4Dfp","expanded_url":"http://bit.ly/1i7svlV","display_url":"bit.ly/1i7svlV"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{},"hashtags":[{"start":28,"end":41,"tag":"PrisonHealth"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"479932993847721984","possibly_sensitive":false,"created_at":"2014-06-20T10:25:17.000Z","referenced_tweets":[{"type":"retweeted","id":"471281170672791553"}],"id":"479932993847721984","text":"RT @WHO_Europe: New book on #PrisonHealth about how to facilitate better prison health practices http://t.co/mt7ReN4Dfp"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":58,"end":66,"username":"CDCMMWR","id":"111354912"}],"annotations":[{"start":117,"end":118,"probability":0.7962,"type":"Place","normalized_text":"RI"},{"start":121,"end":125,"probability":0.5066,"type":"Place","normalized_text":"Nov13"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"479931859317821441","possibly_sensitive":false,"created_at":"2014-06-20T10:20:46.000Z","referenced_tweets":[{"type":"retweeted","id":"479745768090529792"}],"id":"479931859317821441","text":"RT @andcunningham: 52/165 deaths mostly illicit fentanyl “@CDCMMWR: fentanyls linked to large %age drug od deaths in RI, Nov13-Mar14. http:…"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/yPn7lUvptW","expanded_url":"http://goo.gl/T8ObZG","display_url":"goo.gl/T8ObZG"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":67,"end":75,"username":"SPAN_eu","id":"1951220473"},{"start":89,"end":95,"username":"euspr","id":"1008636883"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"479931758826516480","possibly_sensitive":false,"created_at":"2014-06-20T10:20:22.000Z","referenced_tweets":[{"type":"retweeted","id":"479617441291833344"}],"id":"479931758826516480","text":"RT @mvapmoreira: Young prevention researchers: available bursaries @SPAN_eu for the 2014 @euspr conference http://t.co/yPn7lUvptW"},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/h1dFv8L4Gi","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/86","display_url":"emcdda.europa.eu/publications/d…"}],"mentions":{},"annotations":[{"start":8,"end":13,"probability":0.3893,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"479267152693059584","possibly_sensitive":false,"created_at":"2014-06-18T14:19:28.000Z","referenced_tweets":{},"id":"479267152693059584","text":"Drugnet Europe 86 out today: Latest news from the EMCDDA, including EDR 2014 highlights http://t.co/h1dFv8L4Gi"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/Lr2AS5FYvM","expanded_url":"http://www.emcdda.europa.eu/topics/pods/synthetic-cathinones-injection#panel2","display_url":"emcdda.europa.eu/topics/pods/sy…"}],"mentions":[{"start":3,"end":14,"username":"LarsAmbach","id":"1829605148"},{"start":58,"end":65,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":43,"end":54,"tag":"cathinones"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"479213215541649409","possibly_sensitive":false,"created_at":"2014-06-18T10:45:08.000Z","referenced_tweets":[{"type":"retweeted","id":"478878120658083840"}],"id":"479213215541649409","text":"RT @LarsAmbach: Interactive naming app for #cathinones by @EMCDDA as part of the European Drug Report 2014:  http://t.co/Lr2AS5FYvM"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EU_Justice","id":"461919971"},{"start":20,"end":34,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":64,"end":79,"tag":"syntheticdrugs"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"478486117818585089","possibly_sensitive":false,"created_at":"2014-06-16T10:35:55.000Z","referenced_tweets":[{"type":"retweeted","id":"478480899760459776"}],"id":"478486117818585089","text":"RT @EU_Justice: The @EU_Commission proposes to ban 4 new deadly #syntheticdrugs: 25I-NBOMe, AH-7921, Methoxetamine, MDPV http://t.co/TqRXEn…"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":125,"end":137,"tag":"recruitment"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"477474225322983425","possibly_sensitive":false,"created_at":"2014-06-13T15:35:01.000Z","referenced_tweets":[{"type":"retweeted","id":"476764234177871872"}],"id":"477474225322983425","text":"RT @EMA_News: We're recruiting a Scientific Officer to work in Risk Management and Signal Management: http://t.co/S31YhJik3b #recruitment"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"GregorBurkhart","id":"1119061916"}],"annotations":[{"start":79,"end":95,"probability":0.963,"type":"Place","normalized_text":"Palma de Mallorca"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"477474097015033856","possibly_sensitive":false,"created_at":"2014-06-13T15:34:30.000Z","referenced_tweets":[{"type":"retweeted","id":"477453870550237184"}],"id":"477474097015033856","text":"RT @GregorBurkhart: Call for Abstracts! Don't miss the 5th EUSPR conference in Palma de Mallorca, 16th to 18th of October 2014.\nhttp://t.co…"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/jnaUF2GLSh","expanded_url":"http://www.emcdda.europa.eu/publications/gra/2013-highlights","display_url":"emcdda.europa.eu/publications/g…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"477474008720764928","possibly_sensitive":false,"created_at":"2014-06-13T15:34:09.000Z","referenced_tweets":{},"id":"477474008720764928","text":"Also published today, 'A year in review: Highlights from the EMCDDA’s General Report of Activities 2013': http://t.co/jnaUF2GLSh"},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/wWPTU1uK7u","expanded_url":"http://www.emcdda.europa.eu/publications/gra/2013","display_url":"emcdda.europa.eu/publications/g…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"477473653765201920","possibly_sensitive":false,"created_at":"2014-06-13T15:32:44.000Z","referenced_tweets":{},"id":"477473653765201920","text":"Just published our General report of activities 2013: http://t.co/wWPTU1uK7u"},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/h7V2NxK0Ow","expanded_url":"http://www.emcdda.europa.eu/attachements.cfm/att_228964_EN_EMCDDA-Europol_Joint%20Report_4,4'-DMAR_with%20annexes.pdf.pdf","display_url":"emcdda.europa.eu/attachements.c…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"und","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"477123255061725185","possibly_sensitive":false,"created_at":"2014-06-12T16:20:23.000Z","referenced_tweets":[{"type":"retweeted","id":"477117383577198592"}],"id":"477123255061725185","text":"RT @toxicovigilance: EMCDDA–Europol Joint Report on 4,4′-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine) http://t.co/h7V2NxK0Ow"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/Bmq3LbOImY","expanded_url":"http://www.drugsummerschool.cies.iscte-iul.pt/np4/23/","display_url":"drugsummerschool.cies.iscte-iul.pt/np4/23/"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":46,"end":51,"tag":"EDSS"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"476650859863244800","possibly_sensitive":false,"created_at":"2014-06-11T09:03:15.000Z","referenced_tweets":[{"type":"retweeted","id":"476632272796663808"}],"id":"476650859863244800","text":"RT @EDSSLisbon: Last chance to apply for the \n#EDSS! Still a few places left. Register until 15 June: http://t.co/Bmq3LbOImY"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/lqrA7zgLF7","expanded_url":"http://www.emcdda.europa.eu/edr2014","display_url":"emcdda.europa.eu/edr2014"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":{},"hashtags":{}},"lang":"ro","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"474830066623709184","possibly_sensitive":false,"created_at":"2014-06-06T08:28:04.000Z","referenced_tweets":[{"type":"retweeted","id":"474570233844600832"}],"id":"474830066623709184","text":"RT @KM_Robertson: Read EMCDDA Director Wolfgang Götz's speech to the JHA Council in Luxembourg (press and promos) http://t.co/lqrA7zgLF7"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"474503190374023168","possibly_sensitive":false,"created_at":"2014-06-05T10:49:11.000Z","referenced_tweets":[{"type":"retweeted","id":"474447196772134912"}],"id":"474503190374023168","text":"RT @toxicovigilance: Intoxications associated with 5-(2-aminopropyl)indole (5-IT): A case series from the Swedish STRIDA project http://t.c…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"EuropaAbierta","id":"407998197"}],"annotations":[{"start":71,"end":84,"probability":0.9908,"type":"Person","normalized_text":"Laurent Laniel"},{"start":100,"end":133,"probability":0.5101,"type":"Organization","normalized_text":"Observatorio Europeo de las Drogas"}],"hashtags":[{"start":59,"end":66,"tag":"drogas"}]},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"474493755018731520","possibly_sensitive":false,"created_at":"2014-06-05T10:11:41.000Z","referenced_tweets":[{"type":"retweeted","id":"474478762600329216"}],"id":"474493755018731520","text":"RT @EuropaAbierta: Hoy analizamos el informe europeo sobre #drogas con Laurent Laniel, analista del Observatorio Europeo de las Drogas y To…"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/RafdG6yJVr","expanded_url":"http://books.google.pt/books?id=1mf5eEG0nRUC&printsec=frontcover&output=html_text","display_url":"books.google.pt/books?id=1mf5e…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":50,"end":61,"probability":0.6958,"type":"Person","normalized_text":"Gordon Alles"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"473739976073805824","possibly_sensitive":false,"created_at":"2014-06-03T08:16:26.000Z","referenced_tweets":[{"type":"retweeted","id":"473730206877118464"}],"id":"473739976073805824","text":"RT @mevansbrown: Today is the 85th anniversary of Gordon Alles first self-experiment with amphetamine http://t.co/RafdG6yJVr"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":104,"end":119,"username":"WEDINOSProject","id":"1513306045"},{"start":120,"end":126,"username":"Po_st","id":"386270039"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"473739956398358529","possibly_sensitive":false,"created_at":"2014-06-03T08:16:21.000Z","referenced_tweets":[{"type":"retweeted","id":"473508881453555712"}],"id":"473739956398358529","text":"RT @andcunningham: Note the proper use of the term 'legal highs' in this report. Credit where it's due. @WEDINOSProject @Po_st"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/ZgiENnTbdK","expanded_url":"http://www.drugsummerschool.cies.iscte-iul.pt/np4/23/","display_url":"drugsummerschool.cies.iscte-iul.pt/np4/23/"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":57,"end":62,"tag":"EDSS"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"473405674496729088","possibly_sensitive":false,"created_at":"2014-06-02T10:08:02.000Z","referenced_tweets":[{"type":"retweeted","id":"473387849081815041"}],"id":"473405674496729088","text":"RT @EDSSLisbon: Don't miss the deadline to apply for the #EDSS! Still a few places left. Register until 15 June: http://t.co/ZgiENnTbdK"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"AddictoParis","id":"628245898"},{"start":18,"end":25,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":97,"end":114,"tag":"Addictovigilance"},{"start":115,"end":126,"tag":"cathinones"}]},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"473380051099353088","possibly_sensitive":false,"created_at":"2014-06-02T08:26:13.000Z","referenced_tweets":[{"type":"retweeted","id":"472311116090335232"}],"id":"473380051099353088","text":"RT @AddictoParis: @EMCDDA très jolie roue des cathinones. Pour démystifier la chimie. Simplifier #Addictovigilance #cathinones http://t.co/…"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/8QGZDcZWf0","expanded_url":"http://www.youtube.com/watch?v=74Qf8V3_cWk","display_url":"youtube.com/watch?v=74Qf8V…"}],"mentions":[{"start":3,"end":18,"username":"TransformDrugs","id":"59458901"},{"start":26,"end":33,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":61,"end":66,"probability":0.9937,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":70,"end":79,"tag":"cannabis"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471754547124506625","possibly_sensitive":false,"created_at":"2014-05-28T20:47:03.000Z","referenced_tweets":[{"type":"retweeted","id":"471749493596368896"}],"id":"471754547124506625","text":"RT @TransformDrugs: 8-min @EMCDDA video: New developments in Europe's #cannabis market http://t.co/8QGZDcZWf0"},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/tyaqbGHtLj","expanded_url":"http://www.youtube.com/watch?feature=player_embedded&v=PUVsZJQh_HQ","display_url":"youtube.com/watch?feature=…"}],"mentions":[{"start":36,"end":43,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":17,"end":23,"probability":0.4719,"type":"Product","normalized_text":"YouTube"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471593527361929216","possibly_sensitive":false,"created_at":"2014-05-28T10:07:13.000Z","referenced_tweets":[{"type":"retweeted","id":"471583413510868992"}],"id":"471593527361929216","text":"RT @SMMGP: Handy YouTube summary by @EMCDDA experts of the Drugs Report 2014 http://t.co/tyaqbGHtLj"},{"entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"rosiecima","id":"273641183"},{"start":21,"end":34,"username":"plotlygraphs","id":"1392826357"},{"start":44,"end":51,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471593208246730752","possibly_sensitive":false,"created_at":"2014-05-28T10:05:57.000Z","referenced_tweets":[{"type":"retweeted","id":"471463548288126976"}],"id":"471593208246730752","text":"RT @rosiecima: quick @plotlygraphs with the @emcdda's (beautifully organized!) data: a breakdown of cannabis use by age and country https:/…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"CormacJOKeeffe","id":"598306677"},{"start":44,"end":51,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":61,"end":66,"probability":0.992,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471569651454185472","possibly_sensitive":false,"created_at":"2014-05-28T08:32:20.000Z","referenced_tweets":[{"type":"retweeted","id":"471361272664305664"}],"id":"471569651454185472","text":"RT @CormacJOKeeffe: Covering 2014 report of @EMCDDA today in Lisbon. Detailed coverage on drug deaths, new drugs and cannabis legalisation …"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/CkIri0lAfD","expanded_url":"http://www.emcdda.europa.eu/news/2014/3","display_url":"emcdda.europa.eu/news/2014/3"}],"mentions":[{"start":3,"end":15,"username":"MalmstromEU","id":"460966881"},{"start":100,"end":107,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":50,"end":55,"probability":0.9868,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471569079678291968","possibly_sensitive":false,"created_at":"2014-05-28T08:30:04.000Z","referenced_tweets":[{"type":"retweeted","id":"471323357959708672"}],"id":"471569079678291968","text":"RT @MalmstromEU: A critically important window on Europe’s evolving drugs problem - new report from @EMCDDA http://t.co/CkIri0lAfD"},{"entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"joehennon","id":"19530334"},{"start":11,"end":26,"username":"Weedliketotalk","id":"1956215515"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471233922186371072","possibly_sensitive":false,"created_at":"2014-05-27T15:03:14.000Z","referenced_tweets":[{"type":"replied_to","id":"471272650686615552"}],"id":"471305635481808896","text":"@joehennon @weedliketotalk …of cannabis (overdoses), though there could be deaths indirectly related to its use, such as traffic accidents.'","in_reply_to_user_id":"19530334"},{"entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"joehennon","id":"19530334"},{"start":11,"end":26,"username":"Weedliketotalk","id":"1956215515"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471233922186371072","possibly_sensitive":false,"created_at":"2014-05-27T15:02:18.000Z","referenced_tweets":[{"type":"replied_to","id":"471294341101924353"}],"id":"471305400453976064","text":"@joehennon @weedliketotalk here follows the answer from our experts: 'We are not aware of deaths directly produced by intoxication…","in_reply_to_user_id":"50638521"},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/5PdBSsfbRC","expanded_url":"http://www.emcdda.europa.eu/publications/searchresults?action=list&type=PUBLICATIONS&SERIES_PUB=w12","display_url":"emcdda.europa.eu/publications/s…"}],"mentions":[{"start":3,"end":17,"username":"anagallegos77","id":"2450862334"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471295007060946944","possibly_sensitive":false,"created_at":"2014-05-27T14:21:00.000Z","referenced_tweets":[{"type":"retweeted","id":"471222997500850176"}],"id":"471295007060946944","text":"RT @anagallegos77: EMCDDA Risk Assessments on MDPV, methoxetamine, 25I-NBOMe and AH-7921\nhttp://t.co/5PdBSsfbRC"},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/lqrA7zgLF7","expanded_url":"http://www.emcdda.europa.eu/edr2014","display_url":"emcdda.europa.eu/edr2014"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471294934453325824","possibly_sensitive":false,"created_at":"2014-05-27T14:20:43.000Z","referenced_tweets":[{"type":"retweeted","id":"471252718162808832"}],"id":"471294934453325824","text":"RT @KM_Robertson: The speeches from this morning's press conference are now available here http://t.co/lqrA7zgLF7"},{"entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"joehennon","id":"19530334"},{"start":11,"end":26,"username":"Weedliketotalk","id":"1956215515"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471233922186371072","possibly_sensitive":false,"created_at":"2014-05-27T14:18:21.000Z","referenced_tweets":[{"type":"replied_to","id":"471272650686615552"}],"id":"471294341101924353","text":"@joehennon @weedliketotalk — have forwarded your question to the relevant experts. Will be back with a reply (hopefully!) shortly.","in_reply_to_user_id":"19530334"},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/ZNTy9tOeqM","expanded_url":"http://youtu.be/PUVsZJQh_HQ","display_url":"youtu.be/PUVsZJQh_HQ"}],"mentions":[{"start":3,"end":14,"username":"fundsalcom","id":"242696498"},{"start":105,"end":112,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":47,"end":76,"probability":0.425,"type":"Other","normalized_text":"Informe Europeo de Drogas 2014"}],"hashtags":{}},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471264856721883136","possibly_sensitive":false,"created_at":"2014-05-27T12:21:12.000Z","referenced_tweets":[{"type":"retweeted","id":"471258824478064640"}],"id":"471264856721883136","text":"RT @fundsalcom: Todas las cuestiones clave del Informe Europeo de Drogas 2014 http://t.co/ZNTy9tOeqM via @EMCDDA"},{"entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/l7ujZHzvCa","expanded_url":"http://buff.ly/TPEu2G","display_url":"buff.ly/TPEu2G"}],"mentions":[{"start":3,"end":15,"username":"DroguesInfo","id":"90431580"},{"start":82,"end":87,"username":"OFDT","id":"121702523"},{"start":91,"end":98,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471245516077281281","possibly_sensitive":false,"created_at":"2014-05-27T11:04:21.000Z","referenced_tweets":[{"type":"retweeted","id":"471245416215117824"}],"id":"471245516077281281","text":"RT @DroguesInfo: Rapport européen sur les drogues 2014 http://t.co/l7ujZHzvCa via @OFDT et @EMCDDA"},{"entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"alantravis40","id":"15752099"}],"annotations":[{"start":18,"end":19,"probability":0.6186,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471244501357723648","possibly_sensitive":false,"created_at":"2014-05-27T11:00:19.000Z","referenced_tweets":[{"type":"retweeted","id":"471243683908431872"}],"id":"471244501357723648","text":"RT @alantravis40: EU drug experts warn over legal high 'chem-sex' parties saying indicator of increasingly complex issue http://t.co/UtzStb…"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/64vNCBdd3B","expanded_url":"http://www.emcdda.europa.eu/edr2014","display_url":"emcdda.europa.eu/edr2014"}],"mentions":{},"annotations":[{"start":25,"end":49,"probability":0.2992,"type":"Other","normalized_text":"European Drug Report 2014"}],"hashtags":[{"start":131,"end":139,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471243503037849600","possibly_sensitive":false,"created_at":"2014-05-27T10:56:21.000Z","referenced_tweets":{},"id":"471243503037849600","text":"That's all today for the European Drug Report 2014 package — thanks for following and for all the retweets: http://t.co/64vNCBdd3B #edr2014"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/QhQMK8uLSM","expanded_url":"http://www.youtube.com/watch?feature=player_embedded&v=PUVsZJQh_HQ","display_url":"youtube.com/watch?feature=…"}],"mentions":{},"annotations":[{"start":85,"end":104,"probability":0.427,"type":"Other","normalized_text":"European Drug Report"}],"hashtags":[{"start":129,"end":137,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":6,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471242634804334593","possibly_sensitive":false,"created_at":"2014-05-27T10:52:54.000Z","referenced_tweets":{},"id":"471242634804334593","text":"Watch this video where our experts highlight the key issues presented in this year's European Drug Report http://t.co/QhQMK8uLSM #edr2014"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/TPbKXfkuh1","expanded_url":"http://www.emcdda.europa.eu/countries","display_url":"emcdda.europa.eu/countries"}],"mentions":{},"annotations":{},"hashtags":[{"start":108,"end":116,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471241452383502336","possibly_sensitive":false,"created_at":"2014-05-27T10:48:12.000Z","referenced_tweets":{},"id":"471241452383502336","text":"We updated also today many of our country products which provide national overviews: http://t.co/TPbKXfkuh1 #edr2014"},{"entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/8N0CjSPTSB","expanded_url":"http://www.emcdda.europa.eu/topics/pods/treatment-for-cocaine-dependence","display_url":"emcdda.europa.eu/topics/pods/tr…"}],"mentions":{},"annotations":{},"hashtags":[{"start":96,"end":104,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471239831147016192","possibly_sensitive":false,"created_at":"2014-05-27T10:41:45.000Z","referenced_tweets":{},"id":"471239831147016192","text":"Here we review the current evidence for treatment of cocaine dependence: http://t.co/8N0CjSPTSB #edr2014"},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/cLyU89gAkz","expanded_url":"http://www.emcdda.europa.eu/topics/pods/internet-based-drug-treatment","display_url":"emcdda.europa.eu/topics/pods/in…"}],"mentions":{},"annotations":{},"hashtags":[{"start":118,"end":126,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471239168308576256","possibly_sensitive":false,"created_at":"2014-05-27T10:39:07.000Z","referenced_tweets":{},"id":"471239168308576256","text":"Here we chart developments in Internet-based drug treatment and explore some of the benefits : http://t.co/cLyU89gAkz #edr2014"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/SngZb7mxXY","expanded_url":"http://www.emcdda.europa.eu/topics/pods/synthetic-cathinones-injection","display_url":"emcdda.europa.eu/topics/pods/sy…"}],"mentions":{},"annotations":[{"start":98,"end":103,"probability":0.9961,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":129,"end":137,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471238343687426050","possibly_sensitive":false,"created_at":"2014-05-27T10:35:50.000Z","referenced_tweets":{},"id":"471238343687426050","text":"In this 'POD' we explore new localised and national outbreaks of synthetic cathinone injection in Europe: http://t.co/SngZb7mxXY #edr2014"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/BZxFU1Y8OG","expanded_url":"http://www.emcdda.europa.eu/topics/pods/waste-water-analysis","display_url":"emcdda.europa.eu/topics/pods/wa…"}],"mentions":[{"start":3,"end":11,"username":"jbquint","id":"2470565192"},{"start":79,"end":86,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Amazing"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471236863001624576","possibly_sensitive":false,"created_at":"2014-05-27T10:29:57.000Z","referenced_tweets":[{"type":"retweeted","id":"471236769695154176"}],"id":"471236863001624576","text":"RT @jbquint: #Amazing work with the interactive maps on wastewater analysis by @EMCDDA Check them out! http://t.co/BZxFU1Y8OG http://t.co/8…"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/Z0GH5ljUEp","expanded_url":"http://m.youtube.com/watch?feature=youtu.be&v=PUVsZJQh_HQ","display_url":"m.youtube.com/watch?feature=…"}],"mentions":[{"start":3,"end":14,"username":"AniShakari","id":"2502499914"},{"start":102,"end":109,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":67,"end":72,"probability":0.9921,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":53,"end":63,"tag":"drugusers"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471235803696619520","possibly_sensitive":false,"created_at":"2014-05-27T10:25:45.000Z","referenced_tweets":[{"type":"retweeted","id":"471235608703021056"}],"id":"471235803696619520","text":"RT @AniShakari: There are 1.3 million problem opioid #drugusers in Europe. Majority use heroine. Says @EMCDDA http://t.co/Z0GH5ljUEp"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/gqqe7m6Ccq","expanded_url":"http://www.emcdda.europa.eu/topics/pods/responses-for-methamphetamine-users","display_url":"emcdda.europa.eu/topics/pods/re…"}],"mentions":{},"annotations":{},"hashtags":[{"start":127,"end":135,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471235348790796288","possibly_sensitive":false,"created_at":"2014-05-27T10:23:56.000Z","referenced_tweets":{},"id":"471235348790796288","text":"Here we examine the challenges for provision of health and social responses related to methamphetamine: http://t.co/gqqe7m6Ccq #edr2014"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/jltKa2SK0c","expanded_url":"https://twitter.com/WHO_Europe/status/471234272582725632/photo/1","display_url":"pic.twitter.com/jltKa2SK0c"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":32,"end":39,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":16,"end":30,"probability":0.9013,"type":"Person","normalized_text":"Linda Montanari"}],"hashtags":[{"start":96,"end":109,"tag":"PrisonHealth"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_471234271273684992"]},"conversation_id":"471234902600728576","possibly_sensitive":false,"created_at":"2014-05-27T10:22:10.000Z","referenced_tweets":[{"type":"retweeted","id":"471234272582725632"}],"id":"471234902600728576","text":"RT @WHO_Europe: Linda Montanari @emcdda : drug use in prisons mirrors drug use in the community #PrisonHealth http://t.co/jltKa2SK0c"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/BZxFU1Y8OG","expanded_url":"http://www.emcdda.europa.eu/topics/pods/waste-water-analysis","display_url":"emcdda.europa.eu/topics/pods/wa…"}],"mentions":[{"start":3,"end":11,"username":"jbquint","id":"2470565192"},{"start":42,"end":49,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471234794475765760","possibly_sensitive":false,"created_at":"2014-05-27T10:21:44.000Z","referenced_tweets":[{"type":"retweeted","id":"471233397797695488"}],"id":"471234794475765760","text":"RT @jbquint: Glad to having participated \"@EMCDDA: European project to date on wastewater analysis and drugs http://t.co/BZxFU1Y8OG #edr201…"},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/J2olKvSCmv","expanded_url":"http://www.emcdda.europa.eu/topics/pods/cannabis-markets-developments","display_url":"emcdda.europa.eu/topics/pods/ca…"}],"mentions":{},"annotations":[{"start":0,"end":5,"probability":0.9844,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":117,"end":125,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471233922186371072","possibly_sensitive":false,"created_at":"2014-05-27T10:18:16.000Z","referenced_tweets":{},"id":"471233922186371072","text":"Europe is one of largest consumer markets for cannabis — learn about the latest developments: http://t.co/J2olKvSCmv #edr2014"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/n9YaUGc7hZ","expanded_url":"http://www.emcdda.europa.eu/topics/pods/waste-water-analysis","display_url":"emcdda.europa.eu/topics/pods/wa…"}],"mentions":{},"annotations":{},"hashtags":[{"start":120,"end":128,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471232732631404544","possibly_sensitive":false,"created_at":"2014-05-27T10:13:33.000Z","referenced_tweets":{},"id":"471232732631404544","text":"The findings of the largest multi-city European project to date on wastewater analysis and drugs http://t.co/n9YaUGc7hZ #edr2014"},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/FQBXmtNoSS","expanded_url":"http://www.emcdda.europa.eu/data","display_url":"emcdda.europa.eu/data"}],"mentions":{},"annotations":{},"hashtags":[{"start":124,"end":132,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471232031507369984","possibly_sensitive":false,"created_at":"2014-05-27T10:10:46.000Z","referenced_tweets":{},"id":"471232031507369984","text":"Data and statistics — now easier than ever to explore the data we use to analyse the drug situation: http://t.co/FQBXmtNoSS #edr2014"},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/LC44LGjK9z","expanded_url":"https://www.youtube.com/watch?v=PUVsZJQh_HQ","display_url":"youtube.com/watch?v=PUVsZJ…"}],"mentions":[{"start":3,"end":18,"username":"TransformDrugs","id":"59458901"},{"start":81,"end":88,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471229911160881152","possibly_sensitive":false,"created_at":"2014-05-27T10:02:20.000Z","referenced_tweets":[{"type":"retweeted","id":"471229477700517888"}],"id":"471229911160881152","text":"RT @TransformDrugs: Here's a 9-min video introducing the key themes from today's @EMCDDA report https://t.co/LC44LGjK9z"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/clNJ1svvJi","expanded_url":"http://www.emcdda.europa.eu/publications/edr/trends-developments/2014","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":{},"hashtags":[{"start":130,"end":138,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471229851287166976","possibly_sensitive":false,"created_at":"2014-05-27T10:02:06.000Z","referenced_tweets":{},"id":"471229851287166976","text":"Trends and Developments report (PDF): overview of the long-term trends and developments at European level, http://t.co/clNJ1svvJi #edr2014"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":127,"end":135,"tag":"edr2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471229344908853248","possibly_sensitive":false,"created_at":"2014-05-27T10:00:05.000Z","referenced_tweets":{},"id":"471229344908853248","text":"European Drug Report is a package of interlinked elements. Will tweet each of them in turn: then we'll be quiet for a while :) #edr2014"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/64vNCBdd3B","expanded_url":"http://www.emcdda.europa.eu/edr2014","display_url":"emcdda.europa.eu/edr2014"}],"mentions":{},"annotations":[{"start":60,"end":65,"probability":0.9986,"type":"Place","normalized_text":"Europe"},{"start":72,"end":96,"probability":0.2858,"type":"Other","normalized_text":"European Drug Report 2014"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":48,"reply_count":1,"like_count":7,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"471225216166035457","possibly_sensitive":false,"created_at":"2014-05-27T09:43:41.000Z","referenced_tweets":{},"id":"471225216166035457","text":"Just published our yearly overview of the drug situation in Europe, the European Drug Report 2014: http://t.co/64vNCBdd3B"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/NGaJw0qz2b","expanded_url":"http://www.emcdda.europa.eu/news/2014/2","display_url":"emcdda.europa.eu/news/2014/2"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":[{"start":34,"end":58,"probability":0.2873,"type":"Other","normalized_text":"European Drug Report 2014"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"469109210207494144","possibly_sensitive":false,"created_at":"2014-05-21T13:35:26.000Z","referenced_tweets":[{"type":"retweeted","id":"468713758597328896"}],"id":"469109210207494144","text":"RT @KM_Robertson: One week to go! European Drug Report 2014 (27 May). Details in 23 languages here http://t.co/NGaJw0qz2b"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/z6lnADsaEQ","expanded_url":"http://feedly.com/k/1ouU7IS","display_url":"feedly.com/k/1ouU7IS"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":95,"end":102,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"467220924669112320","possibly_sensitive":false,"created_at":"2014-05-16T08:32:03.000Z","referenced_tweets":[{"type":"retweeted","id":"467057554385031168"}],"id":"467220924669112320","text":"RT @andrewbrown365: International experts to examine latest findings in the field of new drugs @EMCDDA  http://t.co/z6lnADsaEQ"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":35,"tag":"3NPSconference"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"467214174733762561","possibly_sensitive":false,"created_at":"2014-05-16T08:05:14.000Z","referenced_tweets":[{"type":"retweeted","id":"467212057402966016"}],"id":"467214174733762561","text":"RT @3NPSConference: #3NPSconference the 2nd day of the conference is about to start"},{"entities":{"urls":{},"mentions":[{"start":101,"end":115,"username":"anagallegos77","id":"2450862334"},{"start":116,"end":123,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":124,"end":139,"tag":"3NPSconference"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"467214087056019456","possibly_sensitive":false,"created_at":"2014-05-16T08:04:53.000Z","referenced_tweets":[{"type":"retweeted","id":"467213991056789505"}],"id":"467214087056019456","text":"RT @3NPSConference: New psychoactive substances and the EU Early Warning System: chemistry matters - @anagallegos77 @EMCDDA #3NPSconference"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":[{"start":16,"end":28,"probability":0.9857,"type":"Person","normalized_text":"Frank Francis"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"466981678356119553","possibly_sensitive":false,"created_at":"2014-05-15T16:41:22.000Z","referenced_tweets":[{"type":"retweeted","id":"466961690547208192"}],"id":"466981678356119553","text":"RT @EDSSLisbon: Frank Francis from the Maritime Analysis and Operations Centre – Narcotics will give lecture on Drug Enforcement Activity a…"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/urhJ1igIEb","expanded_url":"http://jat.oxfordjournals.org/content/early/2014/05/14/jat.bku031.extract","display_url":"jat.oxfordjournals.org/content/early/…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":[{"start":76,"end":77,"probability":0.9915,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"466981631728050176","possibly_sensitive":false,"created_at":"2014-05-15T16:41:11.000Z","referenced_tweets":[{"type":"retweeted","id":"466951000193249280"}],"id":"466981631728050176","text":"RT @toxicovigilance: More information on the 4,4′-DMAR associated deaths in UK in this paper just published: http://t.co/urhJ1igIEb"},{"entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/AXDec6ofaZ","expanded_url":"http://eepurl.com/UDfNL","display_url":"eepurl.com/UDfNL"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":99,"end":108,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"466981609263366144","possibly_sensitive":false,"created_at":"2014-05-15T16:41:06.000Z","referenced_tweets":[{"type":"retweeted","id":"466938511753748480"}],"id":"466981609263366144","text":"RT @EDSSLisbon: Third issue of EDSS Update now available: http://t.co/AXDec6ofaZ.  Get all news on #EDSS2014 and subscribe to Update http:/…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"},{"start":27,"end":43,"username":"toxicovigilance","id":"2291691778"},{"start":130,"end":137,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":84,"end":85,"probability":0.4941,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"465840642527338496","possibly_sensitive":false,"created_at":"2014-05-12T13:07:18.000Z","referenced_tweets":[{"type":"retweeted","id":"465835545399402497"}],"id":"465840642527338496","text":"RT @toxicovigilance: Today @toxicovigilance becomes an official twitter feed of the EU drugs agency. Be sure to also follow us at @EMCDDA"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/YYay4Ir63Q","expanded_url":"http://www.emcdda.europa.eu/activities/expert-meetings/2014/ki-event","display_url":"emcdda.europa.eu/activities/exp…"}],"mentions":{},"annotations":[{"start":67,"end":72,"probability":0.8934,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"464421865742925824","possibly_sensitive":false,"created_at":"2014-05-08T15:09:35.000Z","referenced_tweets":{},"id":"464421865742925824","text":"Treatment Demand and High Risk Drug Use indicators expert meeting, Lisbon, Sept 2014 — call for abstracts: http://t.co/YYay4Ir63Q"},{"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/Y5twzUAO36","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/policy-profile-austria","display_url":"emcdda.europa.eu/publications/e…"},{"start":98,"end":120,"url":"http://t.co/ZALG3MoARt","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/policy-profile-poland","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":53,"end":59,"probability":0.9715,"type":"Place","normalized_text":"Austria"},{"start":90,"end":95,"probability":0.9741,"type":"Place","normalized_text":"Poland"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"464402194679476225","possibly_sensitive":false,"created_at":"2014-05-08T13:51:26.000Z","referenced_tweets":{},"id":"464402194679476225","text":"We've just published two new Drug Policy Profiles on Austria (http://t.co/Y5twzUAO36) and Poland (http://t.co/ZALG3MoARt)"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/HF85QS3OxY","expanded_url":"http://ow.ly/wBQRT","display_url":"ow.ly/wBQRT"}],"mentions":[{"start":3,"end":15,"username":"EuropeanHRN","id":"2292912787"},{"start":110,"end":117,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":70,"end":75,"probability":0.9915,"type":"Place","normalized_text":"Lisbon"}],"hashtags":[{"start":118,"end":130,"tag":"EuroHRN2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"464320716784291841","possibly_sensitive":false,"created_at":"2014-05-08T08:27:40.000Z","referenced_tweets":[{"type":"retweeted","id":"464314878271180800"}],"id":"464320716784291841","text":"RT @EuropeanHRN: Here's the link for the SCTE–EMCDDA summer school in Lisbon this July http://t.co/HF85QS3OxY @EMCDDA #EuroHRN2014"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/JGTxgseX1L","expanded_url":"https://twitter.com/kirstenlh23/status/464312130318393344/photo/1","display_url":"pic.twitter.com/JGTxgseX1L"}],"mentions":[{"start":32,"end":39,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":64,"end":73,"tag":"naloxone"},{"start":77,"end":86,"tag":"Scotland"},{"start":90,"end":102,"tag":"EuroHRN2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_464312118058438657"]},"conversation_id":"464320648635228161","possibly_sensitive":false,"created_at":"2014-05-08T08:27:23.000Z","referenced_tweets":[{"type":"retweeted","id":"464312130318393344"}],"id":"464320648635228161","text":"RT @kirstenlh23: Dagmar Hedrich @EMCDDA - note the reference to #naloxone in #Scotland :) #EuroHRN2014 http://t.co/JGTxgseX1L"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/CIni5Xdcb5","expanded_url":"https://twitter.com/HCLUDrugReform/status/464310096731049984/photo/1","display_url":"pic.twitter.com/CIni5Xdcb5"}],"mentions":[{"start":20,"end":27,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":61,"end":65,"tag":"OST"},{"start":100,"end":112,"tag":"EuroHRN2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_464310090342748160"]},"conversation_id":"464320619522572288","possibly_sensitive":false,"created_at":"2014-05-08T08:27:17.000Z","referenced_tweets":[{"type":"retweeted","id":"464310096731049984"}],"id":"464320619522572288","text":"RT @HCLUDrugReform: @EMCDDA' Dagmar Heidrich: \"the number of #OST clients is decreasing in Europe\"  #EuroHRN2014 http://t.co/CIni5Xdcb5"},{"entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/wZWKAbkklB","expanded_url":"http://ow.ly/w444b","display_url":"ow.ly/w444b"}],"mentions":[{"start":27,"end":39,"username":"EuropeanHRN","id":"2292912787"}],"annotations":{},"hashtags":[{"start":82,"end":96,"tag":"HarmReduction"},{"start":97,"end":109,"tag":"EuroHRN2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"464308140692217856","possibly_sensitive":false,"created_at":"2014-05-08T07:37:41.000Z","referenced_tweets":[{"type":"retweeted","id":"464298871041327105"}],"id":"464308140692217856","text":"RT @FMG_Exchange: Day 2 of @EuropeanHRN is about to start! http://t.co/wZWKAbkklB #HarmReduction #EuroHRN2014"},{"entities":{"urls":{},"mentions":[{"start":60,"end":67,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":40,"end":53,"probability":0.9818,"type":"Person","normalized_text":"Dagmar Hedrich"},{"start":102,"end":107,"probability":0.9972,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":84,"end":98,"tag":"HarmReduction"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"464308064284573696","possibly_sensitive":false,"created_at":"2014-05-08T07:37:23.000Z","referenced_tweets":[{"type":"retweeted","id":"464307924782043136"}],"id":"464308064284573696","text":"RT @kirstenlh23: First speaker today is Dagmar Hedrich from @EMCDDA - New trends in #HarmReduction in Europe:progress made-challenges ahead…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"463960958810198016","possibly_sensitive":false,"created_at":"2014-05-07T08:38:07.000Z","referenced_tweets":[{"type":"retweeted","id":"463824562317049857"}],"id":"463960958810198016","text":"RT @toxicovigilance: 2 deaths associated with MT-45. Autopsies confirmed acute intoxication from MT-45 and ethanol (NY-US) (August 2013) ht…"},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/EmzH8YlWns","expanded_url":"http://link.springer.com/article/10.1007/s00063-014-0360-5","display_url":"link.springer.com/article/10.100…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"461403550418231296","possibly_sensitive":false,"created_at":"2014-04-30T07:15:53.000Z","referenced_tweets":[{"type":"retweeted","id":"461087726864199680"}],"id":"461403550418231296","text":"RT @toxicovigilance: Near fatal intoxication with 25C-NBOMe (AC collected sample) (DE) http://t.co/EmzH8YlWns"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/syTW4gAlCg","expanded_url":"http://www.sciencedirect.com/science/article/pii/S0735675714003131","display_url":"sciencedirect.com/science/articl…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"460688673332535296","possibly_sensitive":false,"created_at":"2014-04-28T07:55:13.000Z","referenced_tweets":[{"type":"retweeted","id":"460394175310340096"}],"id":"460688673332535296","text":"RT @toxicovigilance: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication (US), patient believed she was taking LSD http://t.co/syTW4gAlCg"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/NGaJw0qz2b","expanded_url":"http://www.emcdda.europa.eu/news/2014/2","display_url":"emcdda.europa.eu/news/2014/2"}],"mentions":[{"start":3,"end":16,"username":"KM_Robertson","id":"507480360"}],"annotations":[{"start":31,"end":55,"probability":0.283,"type":"Other","normalized_text":"European Drug Report 2014"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"460688089120526336","possibly_sensitive":false,"created_at":"2014-04-28T07:52:54.000Z","referenced_tweets":[{"type":"retweeted","id":"459347948254818305"}],"id":"460688089120526336","text":"RT @KM_Robertson: Coming soon: European Drug Report 2014 (27 May). See news release today in 23 languages http://t.co/NGaJw0qz2b"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/2zSXyPpchC","expanded_url":"http://www.europarl.europa.eu/news/en/news-room/content/20140411IPR43486/html/Drugs-MEPs-back-rules-to-take-harmful-%E2%80%9Clegal-highs%E2%80%9D-off-the-market-faster","display_url":"europarl.europa.eu/news/en/news-r…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":17,"end":35,"probability":0.5013,"type":"Organization","normalized_text":"European Parliament"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"457069449636757504","possibly_sensitive":false,"created_at":"2014-04-22T10:42:30.000Z","referenced_tweets":[{"type":"replied_to","id":"457087305099255808"}],"id":"458556445861351426","text":"MT @mevansbrown: European Parliament's vote on first reading of the draft legislation on new psychoactive substances http://t.co/2zSXyPpchC","in_reply_to_user_id":"1976092548"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"GregorBurkhart","id":"1119061916"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"458555476012449792","possibly_sensitive":false,"created_at":"2014-04-22T10:38:39.000Z","referenced_tweets":[{"type":"retweeted","id":"456854581205422080"}],"id":"458555476012449792","text":"RT @GregorBurkhart: NICE just updated: Community-based interventions to reduce substance misuse among vulnerable young people http://t.co/B…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"458555200484417536","possibly_sensitive":false,"created_at":"2014-04-22T10:37:34.000Z","referenced_tweets":[{"type":"retweeted","id":"455772574421880832"}],"id":"458555200484417536","text":"RT @mevansbrown: Tufte's excellent 'Data analysis for politics and policy' is now available as a PDF. Essential reading… a steal at $2 http…"},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/D90Uw9aBla","expanded_url":"http://bit.ly/1qDrBBF","display_url":"bit.ly/1qDrBBF"}],"mentions":[{"start":3,"end":19,"username":"Eurosurveillanc","id":"455839750"}],"annotations":[{"start":53,"end":55,"probability":0.6915,"type":"Other","normalized_text":"HIV"},{"start":72,"end":74,"probability":0.6956,"type":"Place","normalized_text":"Eng"},{"start":78,"end":82,"probability":0.6086,"type":"Place","normalized_text":"Wales"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"458554417047171072","possibly_sensitive":false,"created_at":"2014-04-22T10:34:27.000Z","referenced_tweets":[{"type":"retweeted","id":"455347473830002688"}],"id":"458554417047171072","text":"RT @Eurosurveillanc: Controlling the transmission of HIV through IDU in Eng &amp; Wales, 1990-2011 : http://t.co/D90Uw9aBla http://t.co/iKkgGiy…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"CQDTox","id":"266003759"},{"start":33,"end":40,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"454232990680616960","possibly_sensitive":false,"created_at":"2014-04-10T12:22:38.000Z","referenced_tweets":[{"type":"retweeted","id":"454197680886284289"}],"id":"454232990680616960","text":"RT @CQDTox: Nouveau rapport de l'@EMCDDA sur les méfaits certaines substances en lien avec les niveaux de consommation | http://t.co/RG0JSr…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"arjmcauley","id":"299936744"},{"start":32,"end":39,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"453898924202688512","possibly_sensitive":false,"created_at":"2014-04-09T14:15:11.000Z","referenced_tweets":[{"type":"retweeted","id":"453883459396976640"}],"id":"453898924202688512","text":"RT @arjmcauley: Interesting new @EMCDDA publication highlights signifcance of polydrug use in impacting levels of drug-related harm: http:/…"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/kLlkXX1gsU","expanded_url":"http://www.emcdda.europa.eu/publications/joint-report/methoxetamine","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"}],"annotations":[{"start":91,"end":96,"probability":0.991,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"453435623253491713","possibly_sensitive":false,"created_at":"2014-04-08T07:34:11.000Z","referenced_tweets":[{"type":"retweeted","id":"453416893026955264"}],"id":"453435623253491713","text":"RT @andcunningham: Contrary to this piece, there are several deaths associated with MXE in Europe see http://t.co/kLlkXX1gsU  http://t.co/N…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"GregorBurkhart","id":"1119061916"},{"start":75,"end":83,"username":"SPAN_eu","id":"1951220473"}],"annotations":[{"start":67,"end":73,"probability":0.4892,"type":"Product","normalized_text":"Twitter"}],"hashtags":[{"start":84,"end":95,"tag":"prevention"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"453083777498349568","possibly_sensitive":false,"created_at":"2014-04-07T08:16:05.000Z","referenced_tweets":[{"type":"retweeted","id":"452466051046199299"}],"id":"453083777498349568","text":"RT @GregorBurkhart: The Science for Prevention Academic Network on Twitter @SPAN_eu #prevention"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"bengoldacre","id":"6705042"},{"start":116,"end":131,"username":"KristinaMFiore","id":"20635115"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"452039676510363648","possibly_sensitive":false,"created_at":"2014-04-04T11:07:12.000Z","referenced_tweets":[{"type":"retweeted","id":"451835757226110977"}],"id":"452039676510363648","text":"RT @bengoldacre: Naloxone (heroin antidote) in pen form. Great news, one in the home of every heroin user please RT @KristinaMFiore:  http:…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"452019589845893120","possibly_sensitive":false,"created_at":"2014-04-04T09:47:23.000Z","referenced_tweets":[{"type":"retweeted","id":"451778205972967424"}],"id":"452019589845893120","text":"RT @mevansbrown: Has anybody else got data on this type of switch (temporary or otherwise) from amphetamine and opioids to new drugs?"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":90,"end":101,"tag":"mosquitoes"},{"start":102,"end":108,"tag":"ticks"},{"start":109,"end":117,"tag":"sandfly"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"452008769946681344","possibly_sensitive":false,"created_at":"2014-04-04T09:04:23.000Z","referenced_tweets":[{"type":"retweeted","id":"451999728642060288"}],"id":"452008769946681344","text":"RT @ECDC_EU: Vector-borne diseases are global public health threats; See ECDC vector maps #mosquitoes #ticks #sandfly http://t.co/yYBoW1U6y…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"452007597747761152","possibly_sensitive":false,"created_at":"2014-04-04T08:59:43.000Z","referenced_tweets":[{"type":"retweeted","id":"451771202533851137"}],"id":"452007597747761152","text":"RT @US_FDA: In 2010 opioid analgesics, e.g. oxycodone, hydrocodone, &amp; methadone, were involved in about 3 out of 4 pharmaceutical overdose …"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/u2uVwAgHfc","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1002/dta.1625/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1002/dt…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":[{"start":66,"end":72,"probability":0.9949,"type":"Place","normalized_text":"Hungary"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"452007471788609537","possibly_sensitive":false,"created_at":"2014-04-04T08:59:13.000Z","referenced_tweets":[{"type":"retweeted","id":"451773377221779456"}],"id":"452007471788609537","text":"RT @toxicovigilance: Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones http://t.co/u2uVwAgHfc"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/qbZBQ4VpD8","expanded_url":"http://www.emcdda.europa.eu/edr2013","display_url":"emcdda.europa.eu/edr2013"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"451307848455430144","possibly_sensitive":false,"created_at":"2014-04-02T10:39:10.000Z","referenced_tweets":{},"id":"451307848455430144","text":"Save the date: 27 May we're launching the 2014 European Drug Report (you can access the current report here: http://t.co/qbZBQ4VpD8)"},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/acaQ5dZhP2","expanded_url":"http://bulletin.sciencebusiness.net/news/76504/EU-to-offer-%E2%82%AC20M-in-R-and-D-prizes","display_url":"bulletin.sciencebusiness.net/news/76504/EU-…"}],"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"450978567636398080","possibly_sensitive":false,"created_at":"2014-04-01T12:50:43.000Z","referenced_tweets":[{"type":"retweeted","id":"449564615287275520"}],"id":"450978567636398080","text":"RT @EU_ScienceChief: EU to offer €20M in R&amp;D prizes see http://t.co/acaQ5dZhP2 - also see Saltire Prize @SaltirePrize £10M prize for marine…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"}],"annotations":[{"start":120,"end":138,"probability":0.5575,"type":"Organization","normalized_text":"Scientific Committe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"450933187838238720","possibly_sensitive":false,"created_at":"2014-04-01T09:50:24.000Z","referenced_tweets":[{"type":"retweeted","id":"450333488047468544"}],"id":"450933187838238720","text":"RT @andcunningham: EU-level risk assessments on methoxetamine, AH-7921, 25I-NBOMe and MDPV being conducted this week by Scientific Committe…"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/1gGkFt6NgY","expanded_url":"http://www.sciencedirect.com/science/article/pii/S095539591400070X","display_url":"sciencedirect.com/science/articl…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"450933110184882176","possibly_sensitive":false,"created_at":"2014-04-01T09:50:06.000Z","referenced_tweets":[{"type":"retweeted","id":"450615208097378304"}],"id":"450933110184882176","text":"RT @mevansbrown: Drug policy and global regulatory capitalism: the case of new psychoactive substances (NPS)\n http://t.co/1gGkFt6NgY"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":{},"hashtags":{}},"lang":"ro","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"449672944810475521","possibly_sensitive":false,"created_at":"2014-03-28T22:22:39.000Z","referenced_tweets":[{"type":"retweeted","id":"449539055005741056"}],"id":"449672944810475521","text":"RT @toxicovigilance: 15 new drugs (not all new to EU) detected in Japan, inc 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP http://t…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"},{"start":106,"end":121,"username":"HamiltonMorris","id":"364369195"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"449489481742434304","possibly_sensitive":false,"created_at":"2014-03-28T10:13:38.000Z","referenced_tweets":[{"type":"retweeted","id":"449301955069112320"}],"id":"449489481742434304","text":"RT @toxicovigilance: From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs @HamiltonMorris  http://t.co/prUi…"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/sTYQZglCBO","expanded_url":"http://goo.gl/hiO8o0","display_url":"goo.gl/hiO8o0"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"449249944441196544","possibly_sensitive":false,"created_at":"2014-03-27T18:21:48.000Z","referenced_tweets":[{"type":"retweeted","id":"448424001879441408"}],"id":"449249944441196544","text":"RT @mvapmoreira: CfT on alternatives to coercive sanctions as response to drug law offences and drug-related crime http://t.co/sTYQZglCBO D…"},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/kVISHP3duG","expanded_url":"https://t.co/","display_url":"t.co"}],"mentions":[{"start":45,"end":52,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":26,"end":32,"tag":"CEPOL"},{"start":33,"end":41,"tag":"webinar"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"449145967749906432","possibly_sensitive":false,"created_at":"2014-03-27T11:33:56.000Z","referenced_tweets":[{"type":"replied_to","id":"449145967749906432"}],"id":"449147302205476864","text":"“@elearningCEPOL: Outcome #CEPOL #webinar on @EMCDDA: Extensive best practice portal about drugs at http://t.co/kVISHP3duG”","in_reply_to_user_id":"125381738"},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/lo2vCseJTQ","expanded_url":"http://www.emcdda.europa.eu/topics-a-z","display_url":"emcdda.europa.eu/topics-a-z"}],"mentions":[{"start":45,"end":52,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":26,"end":32,"tag":"CEPOL"},{"start":33,"end":41,"tag":"webinar"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"449145661427294208","possibly_sensitive":false,"created_at":"2014-03-27T11:33:38.000Z","referenced_tweets":[{"type":"replied_to","id":"449145661427294208"}],"id":"449147225927847936","text":"“@elearningCEPOL: Outcome #CEPOL #webinar on @EMCDDA: Variety topics on drugs elaborated at http://t.co/lo2vCseJTQ”","in_reply_to_user_id":"125381738"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/Ea8l2ExVUB","expanded_url":"http://www.drugsummerschool.cies.iscte-iul.pt/np4/home","display_url":"drugsummerschool.cies.iscte-iul.pt/np4/home"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":54,"end":63,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"448759630253277184","possibly_sensitive":false,"created_at":"2014-03-26T09:53:28.000Z","referenced_tweets":[{"type":"retweeted","id":"448481875901054976"}],"id":"448759630253277184","text":"RT @EDSSLisbon: Already 15 students registered to the #EDSS2014! Have a look at our programme and APPLY NOW: http://t.co/Ea8l2ExVUB"},{"entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ERATrier","id":"222470247"},{"start":90,"end":104,"username":"EUHomeAffairs","id":"420461348"},{"start":124,"end":131,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":77,"end":88,"probability":0.736,"type":"Person","normalized_text":"Anabela Gago"},{"start":109,"end":122,"probability":0.9926,"type":"Person","normalized_text":"Brendan Hughes"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"448759387977691136","possibly_sensitive":false,"created_at":"2014-03-26T09:52:30.000Z","referenced_tweets":[{"type":"retweeted","id":"448381714298335232"}],"id":"448759387977691136","text":"RT @ERATrier: Enhancing Cross-border Law Enf Coop to Reduce Drug Supply with Anabela Gago @EUHomeAffairs and Brendan Hughes @EMCDDA http://…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"woodesteban","id":"298554585"},{"start":25,"end":32,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":55,"end":60,"tag":"drug"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"446589895839318017","possibly_sensitive":false,"created_at":"2014-03-20T10:11:43.000Z","referenced_tweets":[{"type":"retweeted","id":"446410289299197952"}],"id":"446589895839318017","text":"RT @woodesteban: Reading @EMCDDA paper about \"Regional #drug strategies across the world\": important principle explicitly mentioned is shar…"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/lEQvg4g1mb","expanded_url":"http://goo.gl/vINjS0","display_url":"goo.gl/vINjS0"}],"mentions":[{"start":3,"end":10,"username":"CQDTox","id":"266003759"},{"start":33,"end":40,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":87,"end":95,"tag":"drogues"}]},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"446589731296776192","possibly_sensitive":false,"created_at":"2014-03-20T10:11:03.000Z","referenced_tweets":[{"type":"retweeted","id":"446587246574305280"}],"id":"446589731296776192","text":"RT @CQDTox: Nouveau livret de l' @EMCDDA sur les stratégies régionales portant sur les #drogues à travers le monde | http://t.co/lEQvg4g1mb"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"446577312440782848","possibly_sensitive":false,"created_at":"2014-03-20T09:21:42.000Z","referenced_tweets":[{"type":"retweeted","id":"446337900800929792"}],"id":"446577312440782848","text":"RT @mevansbrown: If you want to keep in the loop on serious adverse events associated with new drugs you should follow my other feed @toxic…"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/rwPNClXplR","expanded_url":"http://bit.ly/1hA2ax9","display_url":"bit.ly/1hA2ax9"}],"mentions":[{"start":3,"end":17,"username":"FundacionEDEX","id":"575265121"},{"start":30,"end":37,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"446248020670435328","possibly_sensitive":false,"created_at":"2014-03-19T11:33:13.000Z","referenced_tweets":[{"type":"retweeted","id":"446211338336231424"}],"id":"446248020670435328","text":"RT @FundacionEDEX: Informe de @EMCDDA que analiza comparativamente las estrategias sobre drogas de 148 países: http://t.co/rwPNClXplR"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/kkuz3hT2y9","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/regional-drug-strategies","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":28,"reply_count":4,"like_count":10,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"445955146850529280","possibly_sensitive":false,"created_at":"2014-03-18T16:09:27.000Z","referenced_tweets":{},"id":"445955146850529280","text":"Just published: a comparison of drug strategies by six intergovernmental organisations engaging 148 countries: http://t.co/kkuz3hT2y9"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/UXX91SfBhi","expanded_url":"https://twitter.com/pbm_ab/status/445585681046188034/photo/1","display_url":"pic.twitter.com/UXX91SfBhi"}],"mentions":[{"start":3,"end":10,"username":"pbm_ab","id":"382602234"},{"start":12,"end":19,"username":"EMCDDA","id":"50638521"},{"start":61,"end":67,"username":"UNODC","id":"17969699"}],"annotations":{},"hashtags":[{"start":29,"end":49,"tag":"preventionstandards"},{"start":50,"end":56,"tag":"EDPQS"},{"start":106,"end":114,"tag":"CND2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_445585681050382336"]},"conversation_id":"445835763310395392","possibly_sensitive":false,"created_at":"2014-03-18T08:15:03.000Z","referenced_tweets":[{"type":"retweeted","id":"445585681046188034"}],"id":"445835763310395392","text":"RT @pbm_ab: @EMCDDA european #preventionstandards #EDPQS and @unodc international standards advertised at #CND2014 http://t.co/UXX91SfBhi"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":77,"end":86,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"444486356342169600","possibly_sensitive":false,"created_at":"2014-03-14T14:53:00.000Z","referenced_tweets":[{"type":"retweeted","id":"444398533773647872"}],"id":"444486356342169600","text":"RT @EDSSLisbon: Last chance to apply for scholarships and early bird fee for #EDSS2014! Don't miss the deadline - 15 March: http://t.co/eyj…"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/utHG8R6bT7","expanded_url":"http://www.emcdda.europa.eu/activities/key-indicators","display_url":"emcdda.europa.eu/activities/key…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"444454093118263296","possibly_sensitive":false,"created_at":"2014-03-14T12:44:48.000Z","referenced_tweets":{},"id":"444454093118263296","text":"Learn all about the key indicators we use to monitor the drug situation in our newly revamped web section: http://t.co/utHG8R6bT7"},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/4QVfcKkR37","expanded_url":"http://www.unodc.org/hlr","display_url":"unodc.org/hlr"}],"mentions":[{"start":3,"end":9,"username":"UNODC","id":"17969699"}],"annotations":[{"start":71,"end":76,"probability":0.9326,"type":"Place","normalized_text":"Vienna"}],"hashtags":[{"start":64,"end":67,"tag":"UN"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"444040504192548864","possibly_sensitive":false,"created_at":"2014-03-13T09:21:20.000Z","referenced_tweets":[{"type":"retweeted","id":"444018870492614656"}],"id":"444040504192548864","text":"RT @UNODC: The Commission on Narcotic Drugs starts today at the #UN in Vienna. Find out more: http://t.co/4QVfcKkR37 &amp; http://t.co/DUACCH15…"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/C2xLxe4s7b","expanded_url":"https://twitter.com/EMCDDA/status/444024962467524608/photo/1","display_url":"pic.twitter.com/C2xLxe4s7b"}],"mentions":{},"annotations":[{"start":61,"end":67,"probability":0.4185,"type":"Place","normalized_text":"Rotunda"}],"hashtags":[{"start":15,"end":23,"tag":"CND2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_444024962224226304"]},"conversation_id":"444024962467524608","possibly_sensitive":false,"created_at":"2014-03-13T08:19:35.000Z","referenced_tweets":{},"id":"444024962467524608","text":"We are back at #CND2014! Come to our exhibition stand in the Rotunda and pick up a copy of our latest publications. http://t.co/C2xLxe4s7b"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/2bEdziYMH3","expanded_url":"http://www.emcdda.europa.eu/publications/subscribe","display_url":"emcdda.europa.eu/publications/s…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"443037007544348672","possibly_sensitive":false,"created_at":"2014-03-10T14:53:48.000Z","referenced_tweets":{},"id":"443037007544348672","text":"Occasional email updates about the most recent EMCDDA publications and products — sign up here: http://t.co/2bEdziYMH3"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/8vP83c0unA","expanded_url":"http://www.drugsummerschool.cies.iscte-iul.pt/np4/home","display_url":"drugsummerschool.cies.iscte-iul.pt/np4/home"}],"mentions":{},"annotations":[{"start":84,"end":111,"probability":0.6557,"type":"Other","normalized_text":"European Drugs Summer School"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"442992102776250369","possibly_sensitive":false,"created_at":"2014-03-10T11:55:22.000Z","referenced_tweets":{},"id":"442992102776250369","text":"Reminder: deadline is 15 March for scholarships and early bird fees for this year's European Drugs Summer School: http://t.co/8vP83c0unA"},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/AH5YghYLbE","expanded_url":"http://youtu.be/BjCSe0L-en8","display_url":"youtu.be/BjCSe0L-en8"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":68,"end":77,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"441969840228941824","possibly_sensitive":false,"created_at":"2014-03-07T16:13:15.000Z","referenced_tweets":[{"type":"retweeted","id":"441611491574571008"}],"id":"441969840228941824","text":"RT @EDSSLisbon: Find out what former students have to say about the #EDSS2014 and watch our video: http://t.co/AH5YghYLbE"},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/Ukpn5U2M7q","expanded_url":"http://bit.ly/1fFeM38","display_url":"bit.ly/1fFeM38","status":403,"unwound_url":"http://bit.ly/1fFeM38"}],"mentions":[{"start":3,"end":6,"username":"UN","id":"14159148"},{"start":43,"end":53,"username":"reliefweb","id":"19993545"}],"annotations":{},"hashtags":[{"start":17,"end":27,"tag":"WomensDay"},{"start":54,"end":67,"tag":"humanitarian"},{"start":113,"end":121,"tag":"IWD2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":146,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"441957309838012417","possibly_sensitive":false,"created_at":"2014-03-07T15:23:28.000Z","referenced_tweets":[{"type":"retweeted","id":"441830964965416960"}],"id":"441957309838012417","text":"RT @UN: Ahead of #WomensDay, check out new @reliefweb #humanitarian topic page on gender http://t.co/Ukpn5U2M7q  #IWD2014 http://t.co/FjLXB…"},{"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/czQ2rRP2Jf","expanded_url":"http://bit.ly/MTsfxr","display_url":"bit.ly/MTsfxr"}],"mentions":[{"start":3,"end":14,"username":"europol_eu","id":"4178310981"},{"start":94,"end":101,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":36,"end":42,"tag":"drugs"},{"start":51,"end":54,"tag":"EU"},{"start":85,"end":93,"tag":"Europol"},{"start":102,"end":109,"tag":"police"},{"start":110,"end":116,"tag":"crime"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"441895522769858560","possibly_sensitive":false,"created_at":"2014-03-07T11:17:57.000Z","referenced_tweets":[{"type":"retweeted","id":"441895465110745088"}],"id":"441895522769858560","text":"RT @Europol_EU: Dangerous synthetic #drugs hit the #EU market http://t.co/czQ2rRP2Jf #Europol @EMCDDA #police #crime"},{"entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/Q3giLH7vN2","expanded_url":"http://eepurl.com/OgKZv","display_url":"eepurl.com/OgKZv"}],"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":98,"end":107,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"440782854226984960","possibly_sensitive":false,"created_at":"2014-03-04T09:36:36.000Z","referenced_tweets":[{"type":"retweeted","id":"440492169351020544"}],"id":"440782854226984960","text":"RT @EDSSLisbon: Second issue of EDSS Update now available: http://t.co/Q3giLH7vN2\nGet all news on #EDSS2014 and subscribe to Update http://…"},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/P4LbPyZ348","expanded_url":"http://m.charityjob.co.uk/Jobs/316605/director-of-programmes","display_url":"m.charityjob.co.uk/Jobs/316605/di…"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":52,"end":65,"username":"Mentortweets","id":"245369354"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"438800175507984385","possibly_sensitive":false,"created_at":"2014-02-26T22:18:09.000Z","referenced_tweets":[{"type":"retweeted","id":"438743601569624064"}],"id":"438800175507984385","text":"RT @andrewbrown365: Job: Director of Programmes for @Mentortweets http://t.co/P4LbPyZ348 &lt; its a great job, sad to be leaving but its time"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/9Xa8EZlQVF","expanded_url":"http://www.novelpsychoactivesubstances.org","display_url":"novelpsychoactivesubstances.org"}],"mentions":{},"annotations":[{"start":108,"end":112,"probability":0.6518,"type":"Place","normalized_text":"Italy"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"438619281237217280","possibly_sensitive":false,"created_at":"2014-02-26T10:19:20.000Z","referenced_tweets":{},"id":"438619281237217280","text":"Register now for the 3rd International Conference on Novel Psychoactive Substances, 15-16th May 2014, Rome. Italy: http://t.co/9Xa8EZlQVF"},{"entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"Goosdeel","id":"22905084"},{"start":14,"end":21,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":131,"end":137,"probability":0.9197,"type":"Place","normalized_text":"Georgia"}],"hashtags":[{"start":22,"end":28,"tag":"drugs"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"438604907516813312","possibly_sensitive":false,"created_at":"2014-02-26T09:22:13.000Z","referenced_tweets":[{"type":"retweeted","id":"438603224330027008"}],"id":"438604907516813312","text":"RT @Goosdeel: @emcdda #drugs Presenting the European Model of National Drug Observatory to the Council for Combating Drug Abuse of Georgia,…"},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/JfwBg6ulKA","expanded_url":"http://owl.li/tVzBp","display_url":"owl.li/tVzBp"}],"mentions":{},"annotations":[{"start":34,"end":44,"probability":0.5184,"type":"Organization","normalized_text":"EU Bookshop"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"437915424651763712","possibly_sensitive":false,"created_at":"2014-02-24T11:42:27.000Z","referenced_tweets":[{"type":"retweeted","id":"437912258698825728"}],"id":"437915424651763712","text":"RT @eubookshop: Just Published on EU Bookshop! http://t.co/JfwBg6ulKA"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":50,"end":59,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"437908788180688896","possibly_sensitive":false,"created_at":"2014-02-24T11:16:05.000Z","referenced_tweets":[{"type":"retweeted","id":"437888428672180224"}],"id":"437908788180688896","text":"RT @EDSSLisbon: Subscribe now to receive our next #EDSS2014 update with latest news about the European drugs summer school http://t.co/36ha…"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/e3mvtVxK1Q","expanded_url":"http://www.emcdda.europa.eu/news/events#May2014","display_url":"emcdda.europa.eu/news/events#Ma…"}],"mentions":[{"start":0,"end":10,"username":"Chiron_AS","id":"2313910440"}],"annotations":[{"start":92,"end":111,"probability":0.5149,"type":"Other","normalized_text":"European Drug Report"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"437204479918997504","possibly_sensitive":false,"created_at":"2014-02-24T08:33:49.000Z","referenced_tweets":[{"type":"replied_to","id":"437204479918997504"}],"id":"437867950964748289","text":"@chiron_as — sorry, they're not available yet. They'll be released on May 27 along with the European Drug Report: http://t.co/e3mvtVxK1Q","in_reply_to_user_id":"2313910440"},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/hTIfZ1mzYE","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/public-expenditure-drug-law-offenders-in-prison","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":81,"end":86,"probability":0.9952,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":2,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"436864872929058816","possibly_sensitive":false,"created_at":"2014-02-21T14:07:56.000Z","referenced_tweets":{},"id":"436864872929058816","text":"Just published: Estimating public expenditure on drug-law offenders in prison in Europe: http://t.co/hTIfZ1mzYE"},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/Lv2IspSD7p","expanded_url":"http://www.ijdp.org/current","display_url":"ijdp.org/current"}],"mentions":[{"start":3,"end":16,"username":"ijdrugpolicy","id":"1058766716"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"436551673830703104","possibly_sensitive":false,"created_at":"2014-02-20T17:23:24.000Z","referenced_tweets":[{"type":"retweeted","id":"436472364357140480"}],"id":"436551673830703104","text":"RT @ijdrugpolicy: Issue 1 2014 all papers free access http://t.co/Lv2IspSD7p (and we mean free, not paid-for-by-author 'open' access!)"},{"entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/4VtrpyN8T3","expanded_url":"http://www.emcdda.europa.eu/topics/pods/preventing-overdose-deaths","display_url":"emcdda.europa.eu/topics/pods/pr…"}],"mentions":[{"start":3,"end":14,"username":"SCMRfrance","id":"3425957181"},{"start":82,"end":89,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":27,"end":36,"tag":"Overdose"},{"start":47,"end":54,"tag":"Europe"},{"start":90,"end":104,"tag":"HarmReduction"},{"start":105,"end":109,"tag":"OST"},{"start":110,"end":119,"tag":"Naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"436103782842507264","possibly_sensitive":false,"created_at":"2014-02-19T11:43:38.000Z","referenced_tweets":[{"type":"retweeted","id":"436103409087705088"}],"id":"436103782842507264","text":"RT @SCMRfrance: Preventing #Overdose deaths in #Europe http://t.co/4VtrpyN8T3 via @EMCDDA #HarmReduction #OST #Naloxone #DrugConsumptionRoo…"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Bc1XX2of0N","expanded_url":"http://bbc.in/1iQiJpW","display_url":"bbc.in/1iQiJpW"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.867,"type":"Organization","normalized_text":"BBC"},{"start":92,"end":108,"probability":0.7848,"type":"Person","normalized_text":"Isabelle Giraudon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"436073774157688832","possibly_sensitive":false,"created_at":"2014-02-19T09:44:24.000Z","referenced_tweets":{},"id":"436073774157688832","text":"BBC audio: More or Less: Rising Drug Overdose Deaths, including interview with the EMCDDA's Isabelle Giraudon: http://t.co/Bc1XX2of0N"},{"entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"idhdp","id":"388761105"},{"start":66,"end":73,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"436068388528742400","possibly_sensitive":false,"created_at":"2014-02-19T09:23:00.000Z","referenced_tweets":[{"type":"retweeted","id":"436068126778597376"}],"id":"436068388528742400","text":"RT @idhdp: What is addiction? Clear video re defn of addicn &amp; @EMCDDA publication  + why should be seen as health issue not CJ http://t.co/…"},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/tmzVOABKSv","expanded_url":"http://bit.ly/N7aQlV","display_url":"bit.ly/N7aQlV"}],"mentions":[{"start":3,"end":15,"username":"trimegalabs","id":"96102857"},{"start":76,"end":83,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":34,"end":48,"tag":"familytherapy"},{"start":53,"end":64,"tag":"adolescent"},{"start":65,"end":75,"tag":"drugusers"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"435741475130048512","possibly_sensitive":false,"created_at":"2014-02-18T11:43:58.000Z","referenced_tweets":[{"type":"retweeted","id":"435737660640858113"}],"id":"435741475130048512","text":"RT @trimegalabs: Multidimensional #familytherapy for #adolescent #drugusers @EMCDDA http://t.co/tmzVOABKSv 'promising results but needs fam…"},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Om5FChKjCf","expanded_url":"http://www.emcdda.europa.eu/publications/insights/models-addiction","display_url":"emcdda.europa.eu/publications/i…"}],"mentions":[{"start":0,"end":12,"username":"robertjwest","id":"260345372"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"435692163469672448","possibly_sensitive":false,"created_at":"2014-02-18T08:28:01.000Z","referenced_tweets":{},"id":"435692163469672448","text":"@robertjwest is the author of our very popular 'Models of addiction' publication: http://t.co/Om5FChKjCf","in_reply_to_user_id":"260345372"},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/1csAOrRIEK","expanded_url":"http://www.youtube.com/watch?v=HxxLNBWaFXY&feature=youtu.be","display_url":"youtube.com/watch?v=HxxLNB…"}],"mentions":[{"start":40,"end":52,"username":"robertjwest","id":"260345372"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"435690429070467072","possibly_sensitive":false,"created_at":"2014-02-18T08:21:07.000Z","referenced_tweets":{},"id":"435690429070467072","text":"What is addiction? Watch our video with @robertjwest: http://t.co/1csAOrRIEK"},{"entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/F9Ipj5kx2u","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/85","display_url":"emcdda.europa.eu/publications/d…"}],"mentions":{},"annotations":[{"start":50,"end":63,"probability":0.2034,"type":"Other","normalized_text":"Drugnet Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"435394697054658560","possibly_sensitive":false,"created_at":"2014-02-17T12:45:59.000Z","referenced_tweets":{},"id":"435394697054658560","text":"Just out — the latest edition of our newsletter, 'Drugnet Europe': http://t.co/F9Ipj5kx2u"},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/xJJpcoB5B6","expanded_url":"http://www.emcdda.europa.eu/publications/work-programmes/2014","display_url":"emcdda.europa.eu/publications/w…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"433969738918932480","possibly_sensitive":false,"created_at":"2014-02-13T14:23:43.000Z","referenced_tweets":{},"id":"433969738918932480","text":"Just published: find out what we have planned for this year in our 2014 work programme: http://t.co/xJJpcoB5B6"},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/HCgnNZ4OB1","expanded_url":"https://www.europol.europa.eu/vacancies","display_url":"europol.europa.eu/vacancies"}],"mentions":[{"start":3,"end":14,"username":"europol_eu","id":"4178310981"}],"annotations":[{"start":16,"end":22,"probability":0.5011,"type":"Organization","normalized_text":"Europol"},{"start":71,"end":94,"probability":0.7103,"type":"Organization","normalized_text":"EU Institutional Affairs"}],"hashtags":[{"start":103,"end":106,"tag":"EU"},{"start":107,"end":115,"tag":"Europol"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"432833775459119104","possibly_sensitive":false,"created_at":"2014-02-10T11:09:48.000Z","referenced_tweets":[{"type":"retweeted","id":"431786475261149184"}],"id":"432833775459119104","text":"RT @Europol_EU: Europol is hiring! Specialist (2 posts) – External and EU Institutional Affairs (AD7)  #EU #Europol  https://t.co/HCgnNZ4OB1"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/1NvkPXW9QR","expanded_url":"https://twitter.com/History_Pics/status/431427202966880257/photo/1","display_url":"pic.twitter.com/1NvkPXW9QR"}],"mentions":[{"start":3,"end":10,"username":"Erowid","id":"284162348"},{"start":15,"end":28,"username":"History_Pics","id":"1086485478"}],"annotations":[{"start":30,"end":43,"probability":0.5505,"type":"Person","normalized_text":"Lloyd Brothers"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"432833701127663616","possibly_sensitive":false,"created_at":"2014-02-10T11:09:30.000Z","referenced_tweets":[{"type":"retweeted","id":"431835658928533504"}],"id":"432833701127663616","text":"RT @Erowid: RT @History_Pics: Lloyd Brothers Specific Medicine: Cannabis in 74% alcohol, c. 1910 http://t.co/1NvkPXW9QR"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/TfnHBiEk7W","expanded_url":"http://www.flickr.com/photos/emcdda/sets/72157640770698673/","display_url":"flickr.com/photos/emcdda/…"}],"mentions":[{"start":85,"end":96,"username":"EUinIsrael","id":"2302683607"},{"start":97,"end":107,"username":"IsraelMFA","id":"85796380"}],"annotations":[{"start":21,"end":23,"probability":0.6357,"type":"Organization","normalized_text":"MoU"},{"start":48,"end":58,"probability":0.4232,"type":"Organization","normalized_text":"Israel Anti"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"432832492312465408","possibly_sensitive":false,"created_at":"2014-02-10T11:04:42.000Z","referenced_tweets":{},"id":"432832492312465408","text":"Some photos from the MoU signing event with the Israel Anti-Drug Authority last week @EUinIsrael @IsraelMFA: http://t.co/TfnHBiEk7W"},{"entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"CQDTox","id":"266003759"},{"start":46,"end":53,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431744919024447488","possibly_sensitive":false,"created_at":"2014-02-07T11:03:04.000Z","referenced_tweets":[{"type":"retweeted","id":"431744790011863040"}],"id":"431744919024447488","text":"RT @CQDTox: Nouvelle revue systématique de l' @EMCDDA: Thérapie familiale multidimensionnelle pour les ados toxicomanes | http://t.co/RAdxL…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"VaughanBirbeck","id":"2149003652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431738201901129728","possibly_sensitive":false,"created_at":"2014-02-07T10:36:23.000Z","referenced_tweets":[{"type":"retweeted","id":"431734535680950272"}],"id":"431738201901129728","text":"RT @VaughanBirbeck: EMCDDA library bulletins sent out today with details of recent publications. Please contact me to be added to the maili…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"profhrs","id":"189969652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431737710462898176","possibly_sensitive":false,"created_at":"2014-02-07T10:34:26.000Z","referenced_tweets":[{"type":"retweeted","id":"431725237768835072"}],"id":"431737710462898176","text":"RT @profhrs: The quick guide to the European drug prevention quality standards is now available in French and Slovenian http://t.co/rTqrdWp…"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/7VYBm5GYsU","expanded_url":"http://dartington.org.uk/standards-standards-everywhere/","display_url":"dartington.org.uk/standards-stan…"}],"mentions":[{"start":4,"end":19,"username":"andrewbrown365","id":"105148303"},{"start":71,"end":83,"username":"nick_axford","id":"257513718"},{"start":87,"end":101,"username":"socialresunit","id":"4524321915"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431727131518062592","possibly_sensitive":false,"created_at":"2014-02-07T10:34:20.000Z","referenced_tweets":[{"type":"replied_to","id":"431727131518062592"}],"id":"431737685963984896","text":"MT “@andrewbrown365: Nice overview of why standards are important from @nick_axford of @socialresunit http://t.co/7VYBm5GYsU”","in_reply_to_user_id":"105148303"},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/DwL6rjTBr1","expanded_url":"http://bit.ly/N7aQlV","display_url":"bit.ly/N7aQlV"}],"mentions":[{"start":3,"end":12,"username":"jcmelero","id":"54475633"},{"start":27,"end":34,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"es","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431705466125950976","possibly_sensitive":false,"created_at":"2014-02-07T08:26:18.000Z","referenced_tweets":[{"type":"retweeted","id":"431705208695959554"}],"id":"431705466125950976","text":"RT @jcmelero: Revisión del @EMCDDA sobre el abordaje familiar del abuso adolescente de drogas: http://t.co/DwL6rjTBr1"},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/ACwfJvk7sO","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/multidimensional-family-therapy-review","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431359625586569216","possibly_sensitive":false,"created_at":"2014-02-06T09:32:03.000Z","referenced_tweets":{},"id":"431359625586569216","text":"Just published: Multidimensional family therapy for adolescent drug users: a systematic review: http://t.co/ACwfJvk7sO"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/3JdJCJMFSb","expanded_url":"http://www.emcdda.europa.eu/news/2014/mdft","display_url":"emcdda.europa.eu/news/2014/mdft"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431359437719474176","possibly_sensitive":false,"created_at":"2014-02-06T09:31:18.000Z","referenced_tweets":{},"id":"431359437719474176","text":"Family can play vital role in addressing substance use disorders among adolescents:  http://t.co/3JdJCJMFSb"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/96rXxBs85A","expanded_url":"http://www.emcdda.europa.eu/activities/expert-meetings/2013/prevention","display_url":"emcdda.europa.eu/activities/exp…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431082558206799872","possibly_sensitive":false,"created_at":"2014-02-05T15:11:05.000Z","referenced_tweets":{},"id":"431082558206799872","text":"Presentations from our meeting 'Prevention systems: how to transform evidence into practice', Oct 2013: http://t.co/96rXxBs85A"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/k0jj7dcXgV","expanded_url":"http://www.emcdda.europa.eu/best-practice/prevention/partygoers","display_url":"emcdda.europa.eu/best-practice/…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431024141798752256","possibly_sensitive":false,"created_at":"2014-02-05T11:18:58.000Z","referenced_tweets":{},"id":"431024141798752256","text":"Our review of the evidence for prevention interventions for partygoers. Find out what works and what doesn't: http://t.co/k0jj7dcXgV"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"431019218528899072","possibly_sensitive":false,"created_at":"2014-02-05T10:59:24.000Z","referenced_tweets":[{"type":"retweeted","id":"430796194236100609"}],"id":"431019218528899072","text":"RT @andcunningham: A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids http://t.co/TDSa4…"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/95lYGR55Um","expanded_url":"http://www.mentoruk.org.uk/projects/youth-insight/","display_url":"mentoruk.org.uk/projects/youth…"}],"mentions":[{"start":3,"end":18,"username":"andrewbrown365","id":"105148303"},{"start":28,"end":40,"username":"MentorYouth","id":"93618366"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430737669145239553","possibly_sensitive":false,"created_at":"2014-02-04T16:20:37.000Z","referenced_tweets":[{"type":"retweeted","id":"430736769320226816"}],"id":"430737669145239553","text":"RT @andrewbrown365: Pls RT \"@MentorYouth: looking for 14-17 yrs Londoners to apply for Youth Insight! http://t.co/95lYGR55Um Closing date 1…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"MalmstromEU","id":"460966881"}],"annotations":{},"hashtags":[{"start":112,"end":118,"tag":"euacr"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430719120628547584","possibly_sensitive":false,"created_at":"2014-02-04T15:06:55.000Z","referenced_tweets":[{"type":"retweeted","id":"430718363556253696"}],"id":"430719120628547584","text":"RT @MalmstromEU: \"Corruption undermines citizens' confidence in democratic institutions &amp; rule of law.\" 1st #euacr report is out http://t.c…"},{"entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/lejjmBNVhZ","expanded_url":"http://www.tobaccoprofiles.info/","display_url":"tobaccoprofiles.info"}],"mentions":[{"start":3,"end":13,"username":"DrugScope","id":"978975991451340806"}],"annotations":[{"start":50,"end":56,"probability":0.8207,"type":"Place","normalized_text":"England"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430710262468182016","possibly_sensitive":false,"created_at":"2014-02-04T14:31:43.000Z","referenced_tweets":[{"type":"retweeted","id":"430706483844878336"}],"id":"430710262468182016","text":"RT @DrugScope: Local Tobacco Control Profiles for England, PHE, http://t.co/lejjmBNVhZ"},{"entities":{"urls":{},"mentions":[{"start":0,"end":13,"username":"Doubting_Ben","id":"328189773"}],"annotations":[{"start":19,"end":21,"probability":0.8968,"type":"Person","normalized_text":"Ben"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430706813919444992","possibly_sensitive":false,"created_at":"2014-02-04T14:22:53.000Z","referenced_tweets":[{"type":"replied_to","id":"430706813919444992"}],"id":"430708041634562048","text":"@doubting_ben Sure Ben, we'll be in touch with you shortly via email.","in_reply_to_user_id":"328189773"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EUinIsrael","id":"2302683607"},{"start":114,"end":121,"username":"EMCDDA","id":"50638521"},{"start":122,"end":132,"username":"IsraelMFA","id":"85796380"}],"annotations":{},"hashtags":[{"start":65,"end":72,"tag":"Israel"},{"start":97,"end":100,"tag":"EU"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430668539423637504","possibly_sensitive":false,"created_at":"2014-02-04T11:45:55.000Z","referenced_tweets":[{"type":"retweeted","id":"430667982285848576"}],"id":"430668539423637504","text":"RT @EUinIsrael: Memorandum of Understanding signed today between #Israel Anti-Drug Authority and #EU drugs agency @EMCDDA @IsraelMFA http:/…"},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/rbWty7oo9u","expanded_url":"http://www.drugsummerschool.cies.iscte-iul.pt/np4/docentes/103.html","display_url":"drugsummerschool.cies.iscte-iul.pt/np4/docentes/1…"}],"mentions":[{"start":4,"end":15,"username":"EDSSLisbon","id":"2213957400"},{"start":54,"end":66,"username":"SusanMichie","id":"161988348"}],"annotations":[{"start":68,"end":92,"probability":0.6844,"type":"Organization","normalized_text":"University College London"}],"hashtags":[{"start":33,"end":42,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430663778422648832","possibly_sensitive":false,"created_at":"2014-02-04T11:45:39.000Z","referenced_tweets":[{"type":"replied_to","id":"430663778422648832"}],"id":"430668471773716480","text":"RT: @EDSSLisbon: Keynote speaker #EDSS2014 confirmed: @SusanMichie, University College London http://t.co/rbWty7oo9u”","in_reply_to_user_id":"2213957400"},{"entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/cdxxW6XWEJ","expanded_url":"http://sco.lt/5kDUkj","display_url":"sco.lt/5kDUkj"}],"mentions":[{"start":3,"end":11,"username":"ReGenUC","id":"172599724"},{"start":82,"end":89,"username":"EMCDDA","id":"50638521"},{"start":101,"end":111,"username":"DrugScope","id":"978975991451340806"}],"annotations":[{"start":50,"end":55,"probability":0.992,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":23,"end":39,"tag":"methamphetamine"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430488783981907968","possibly_sensitive":false,"created_at":"2014-02-03T23:51:38.000Z","referenced_tweets":[{"type":"retweeted","id":"430481730492174336"}],"id":"430488783981907968","text":"RT @ReGenUC: Exploring #methamphetamine trends in Europe | http://t.co/cdxxW6XWEJ @EMCDDA report via @DrugScope"},{"entities":{"urls":{},"mentions":[{"start":3,"end":8,"username":"OFDT","id":"121702523"}],"annotations":{},"hashtags":{}},"lang":"fr","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430375090795331584","possibly_sensitive":false,"created_at":"2014-02-03T16:19:52.000Z","referenced_tweets":[{"type":"retweeted","id":"428622297310580736"}],"id":"430375090795331584","text":"RT @OFDT: Standards qualité européens prévention des usages de drogues : guide en français (23 p.). 8 étapes, liste de contrôle http://t.co…"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/o2eP8xwzyD","expanded_url":"http://www.emcdda.europa.eu/publications/risk-assessment/4-MA","display_url":"emcdda.europa.eu/publications/r…"}],"mentions":{},"annotations":[{"start":46,"end":51,"probability":0.9922,"type":"Place","normalized_text":"Europe"},{"start":95,"end":100,"probability":0.9771,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430366355641335808","possibly_sensitive":false,"created_at":"2014-02-03T15:45:09.000Z","referenced_tweets":{},"id":"430366355641335808","text":"Designer drug 4-Methylamphetamine appeared in Europe in 2009, sold as amphetamine. Learn about Europe’s response: http://t.co/o2eP8xwzyD"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/OIzc0zWSIu","expanded_url":"http://www.emcdda.europa.eu/publications/risk-assessment/5-IT","display_url":"emcdda.europa.eu/publications/r…"}],"mentions":{},"annotations":[{"start":97,"end":102,"probability":0.9742,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430366052275748864","possibly_sensitive":false,"created_at":"2014-02-03T15:43:57.000Z","referenced_tweets":{},"id":"430366052275748864","text":"‘Research chemical’ 5-IT was linked to 24 deaths over a 5 month period in 2012. Learn more about Europe’s response: http://t.co/OIzc0zWSIu"},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/02bfBG2BCy","expanded_url":"http://www.emcdda.europa.eu/activities/action-on-new-drugs","display_url":"emcdda.europa.eu/activities/act…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"430365912638980096","possibly_sensitive":false,"created_at":"2014-02-03T15:43:24.000Z","referenced_tweets":{},"id":"430365912638980096","text":"Just published: the reports on the 5-IT and 4-methylamphetamine risk assessments: http://t.co/02bfBG2BCy"},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/N14YPllkl0","expanded_url":"http://www.emcdda.europa.eu/attachements.cfm/att_222738_EN_TDAU14001ENN.pdf","display_url":"emcdda.europa.eu/attachements.c…"}],"mentions":[{"start":3,"end":16,"username":"davidastuart","id":"510722928"},{"start":94,"end":101,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":86,"end":91,"probability":0.9969,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"429745098902237185","possibly_sensitive":false,"created_at":"2014-02-01T22:36:30.000Z","referenced_tweets":[{"type":"retweeted","id":"429557442981003264"}],"id":"429745098902237185","text":"RT @davidastuart: Report from the Meth Trendspotter summit; Methamphetamine trends in Europe. @EMCDDA http://t.co/N14YPllkl0"},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/aKSHDlQOuh","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/exploring-methamphetamine-trends-in-Europe","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"},{"start":62,"end":75,"username":"davidastuart","id":"510722928"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"429267856610840576","possibly_sensitive":false,"created_at":"2014-01-31T15:00:07.000Z","referenced_tweets":[{"type":"retweeted","id":"429260756073213952"}],"id":"429267856610840576","text":"RT @andcunningham: EMCDDA trendspotter Meth report, featuring @davidastuart is out now. http://t.co/aKSHDlQOuh"},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/9pPofRk6YA","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/exploring-methamphetamine-trends-in-Europe","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":36,"end":41,"probability":0.997,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"429252824430825472","possibly_sensitive":false,"created_at":"2014-01-31T14:00:23.000Z","referenced_tweets":{},"id":"429252824430825472","text":"Exploring methamphetamine trends in Europe — chemistry, history, trends, production, trafficking, harms : http://t.co/9pPofRk6YA"},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/rSbTD5DMCK","expanded_url":"http://www.emcdda.europa.eu/news/2014/sicad-rarha-conference","display_url":"emcdda.europa.eu/news/2014/sica…"}],"mentions":{},"annotations":{},"hashtags":[{"start":94,"end":102,"tag":"alcohol"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"429180781723123712","possibly_sensitive":false,"created_at":"2014-01-31T09:14:06.000Z","referenced_tweets":{},"id":"429180781723123712","text":"Kicking off today, the Joint Action on Reducing Alcohol Related Harm project funded by the EU #alcohol: http://t.co/rSbTD5DMCK"},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/rzubOX65E7","expanded_url":"https://www.federalregister.gov/articles/2014/01/30/2014-01778/controlled-substances-2014-proposed-aggregate-production-quota-for-three-temporarily-controlled?utm_campaign=subscription+mailing+list&utm_medium=email&utm_source=federalregister.gov","display_url":"federalregister.gov/articles/2014/…"}],"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":17,"end":19,"probability":0.3825,"type":"Organization","normalized_text":"DEA"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428857478697484288","possibly_sensitive":false,"created_at":"2014-01-30T11:49:25.000Z","referenced_tweets":[{"type":"retweeted","id":"428825593967570946"}],"id":"428857478697484288","text":"RT @mevansbrown: DEA proposes aggregate production quotas for 25B-NBOMe, 25C-NBOMe, 25I-NBOMe. Spoiler: 15g each https://t.co/rzubOX65E7"},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/aZVvcdsLga","expanded_url":"http://www.novelpsychoactivesubstances.org/","display_url":"novelpsychoactivesubstances.org"}],"mentions":[{"start":3,"end":17,"username":"andcunningham","id":"430083320"}],"annotations":[{"start":19,"end":24,"probability":0.5857,"type":"Organization","normalized_text":"EU NPS"},{"start":40,"end":43,"probability":0.8361,"type":"Place","normalized_text":"Rome"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428477453628375040","possibly_sensitive":false,"created_at":"2014-01-29T10:39:20.000Z","referenced_tweets":[{"type":"retweeted","id":"428255873329532928"}],"id":"428477453628375040","text":"RT @andcunningham: EU NPS conference in Rome this year. Bellissimo! http://t.co/aZVvcdsLga"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/9Xi2JRXQYO","expanded_url":"http://www.emcdda.europa.eu/publications/joint-report/methoxetamine","display_url":"emcdda.europa.eu/publications/j…","status":200,"unwound_url":"https://www.emcdda.europa.eu/publications/joint-report/methoxetamine"}],"mentions":[{"start":7,"end":18,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":21,"reply_count":1,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428471665157505024","possibly_sensitive":false,"created_at":"2014-01-29T10:16:20.000Z","referenced_tweets":{},"id":"428471665157505024","text":"EMCDDA-@Europol_EU report on ketamine-like new drug methoxetamine. Associated with 110 intoxications and 20 deaths: http://t.co/9Xi2JRXQYO"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/t1arpMKtQs","expanded_url":"http://www.emcdda.europa.eu/publications/joint-report/MDPV","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":7,"end":18,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428470627721564160","possibly_sensitive":false,"created_at":"2014-01-29T10:12:12.000Z","referenced_tweets":{},"id":"428470627721564160","text":"EMCDDA-@Europol_EU report on synthetic cathinone MDPV. Detected in up to 107 non-fatal intoxications and 99 deaths: http://t.co/t1arpMKtQs"},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/VqYdrTm6uf","expanded_url":"http://www.emcdda.europa.eu/publications/joint-report/AH-7921","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":7,"end":18,"username":"europol_eu","id":"4178310981"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428469767390117888","possibly_sensitive":false,"created_at":"2014-01-29T10:08:47.000Z","referenced_tweets":{},"id":"428469767390117888","text":"EMCDDA-@Europol_EU report on synthetic opioid AH-7921 — associated with 6 intoxications and 15 deaths in 3 countries: http://t.co/VqYdrTm6uf"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/PFRCOz0vl7","expanded_url":"http://www.emcdda.europa.eu/publications/joint-report/25I-NBOMe","display_url":"emcdda.europa.eu/publications/j…"}],"mentions":[{"start":7,"end":18,"username":"europol_eu","id":"4178310981"}],"annotations":[{"start":107,"end":112,"probability":0.9955,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428468887144132609","possibly_sensitive":false,"created_at":"2014-01-29T10:05:17.000Z","referenced_tweets":{},"id":"428468887144132609","text":"EMCDDA-@Europol_EU report on hallucinogen 25I-NBOMe — reports of severe toxicity and linked to 3 deaths in Europe: http://t.co/PFRCOz0vl7"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ZT5uJHNGaZ","expanded_url":"http://www.emcdda.europa.eu/news/2014/1","display_url":"emcdda.europa.eu/news/2014/1"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"428467799317827584","possibly_sensitive":false,"created_at":"2014-01-29T10:00:58.000Z","referenced_tweets":{},"id":"428467799317827584","text":"4 new drugs (25I-NBOMe, AH-7921, MDPV methoxetamine) go under the microscope in wake of rising health concerns: http://t.co/ZT5uJHNGaZ"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/V4TN7GeE7b","expanded_url":"http://www.emcdda.europa.eu/about/procurement","display_url":"emcdda.europa.eu/about/procurem…"}],"mentions":[{"start":12,"end":24,"username":"EMSA_LISBON","id":"23603194"}],"annotations":[{"start":54,"end":69,"probability":0.8029,"type":"Place","normalized_text":"Lisbon, Portugal"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426721235889057792","possibly_sensitive":false,"created_at":"2014-01-24T14:20:45.000Z","referenced_tweets":{},"id":"426721235889057792","text":"Tender with @EMSA_LISBON: medical services for staff (Lisbon, Portugal). Please forward to interested parties! http://t.co/V4TN7GeE7b"},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/CfK2RHg9AK","expanded_url":"http://www.emcdda.europa.eu/publications/budget-2014","display_url":"emcdda.europa.eu/publications/b…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426695149943812096","possibly_sensitive":false,"created_at":"2014-01-24T12:37:06.000Z","referenced_tweets":{},"id":"426695149943812096","text":"The EMCDDA's draft budget for 2014 is now available online: http://t.co/CfK2RHg9AK"},{"entities":{"urls":{},"mentions":[{"start":0,"end":8,"username":"profhrs","id":"189969652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426664886786334721","possibly_sensitive":false,"created_at":"2014-01-24T11:42:25.000Z","referenced_tweets":[{"type":"replied_to","id":"426680119092977664"}],"id":"426681389451583489","text":"@profhrs @clubdrugs_cri indeed, and thanks for clearing things up! I will disconnect from our network first in future to check.","in_reply_to_user_id":"189969652"},{"entities":{"urls":{},"mentions":[{"start":0,"end":8,"username":"profhrs","id":"189969652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426664886786334721","possibly_sensitive":false,"created_at":"2014-01-24T11:36:03.000Z","referenced_tweets":[{"type":"replied_to","id":"426678402133680129"}],"id":"426679788640927744","text":"@profhrs  yes you're right. Sorry for the confusion @clubdrugs_cri","in_reply_to_user_id":"189969652"},{"entities":{"urls":{},"mentions":[{"start":0,"end":8,"username":"profhrs","id":"189969652"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426664886786334721","possibly_sensitive":false,"created_at":"2014-01-24T11:29:28.000Z","referenced_tweets":[{"type":"replied_to","id":"426675648984137728"}],"id":"426678131416920065","text":"@profhrs @clubdrugs_cri seem to be able to access full article here… You don't see a little 'F' in a circle to the left of each article?","in_reply_to_user_id":"189969652"},{"entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"IDPCnet","id":"423396432"}],"annotations":[{"start":85,"end":86,"probability":0.9724,"type":"Place","normalized_text":"UK"}],"hashtags":[{"start":13,"end":22,"tag":"Naloxone"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426671256185110528","possibly_sensitive":false,"created_at":"2014-01-24T11:02:09.000Z","referenced_tweets":[{"type":"retweeted","id":"426670155570368512"}],"id":"426671256185110528","text":"RT @IDPCnet: #Naloxone is a safe drug for reversing the effects of opioid overdoses. UK’s advisory council on the misuse of drugs http://t.…"},{"entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426670043988897792","possibly_sensitive":false,"created_at":"2014-01-24T11:01:00.000Z","referenced_tweets":[{"type":"replied_to","id":"426670043988897792"}],"id":"426670965851181056","text":"@clubdrugs_cri yes, it's open access and the full text is available (see links beneath each article). Hope that helps.","in_reply_to_user_id":"1275623462"},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/7Cnwvd8hCO","expanded_url":"http://informahealthcare.com/toc/dep/21/1","display_url":"informahealthcare.com/toc/dep/21/1"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426664886786334721","possibly_sensitive":false,"created_at":"2014-01-24T10:36:50.000Z","referenced_tweets":{},"id":"426664886786334721","text":"Drugs: Education, Prevention, and Policy Vol. 21, No 1, 2014 is now available online: http://t.co/7Cnwvd8hCO"},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/WTt2p1bO1q","expanded_url":"http://ow.ly/sTCH0","display_url":"ow.ly/sTCH0"}],"mentions":[{"start":3,"end":18,"username":"cochranecollab","id":"20429156"}],"annotations":{},"hashtags":[{"start":48,"end":57,"tag":"podcasts"},{"start":70,"end":79,"tag":"Cochrane"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426664418836217856","possibly_sensitive":false,"created_at":"2014-01-24T10:34:59.000Z","referenced_tweets":[{"type":"retweeted","id":"426659507318820864"}],"id":"426664418836217856","text":"RT @cochranecollab: Get caught up on the latest #podcasts of selected #Cochrane Reviews: http://t.co/WTt2p1bO1q"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"PompidouGroup","id":"1169002783"}],"annotations":[{"start":23,"end":36,"probability":0.5314,"type":"Organization","normalized_text":"Pompidou Group"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"426663883974389760","possibly_sensitive":false,"created_at":"2014-01-24T10:32:51.000Z","referenced_tweets":[{"type":"retweeted","id":"426662746763960320"}],"id":"426663883974389760","text":"RT @PompidouGroup: The Pompidou Group provides a multidisciplinary forum for policy-makers, professionals and researchers to discuss drug p…"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/fZWJA8moBy","expanded_url":"http://www.drugsummerschool.cies.iscte-iul.pt/np4/23/","display_url":"drugsummerschool.cies.iscte-iul.pt/np4/23/"}],"mentions":[{"start":33,"end":44,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":[{"start":65,"end":74,"tag":"EDSS2014"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"425575912034140160","possibly_sensitive":false,"created_at":"2014-01-21T13:50:45.000Z","referenced_tweets":[{"type":"replied_to","id":"425575912034140160"}],"id":"425626524558315520","text":"European drugs summer school: RT @EDSSLisbon: Early-bird fee for #EDSS2014 available! Register by 15 March 2014: http://t.co/fZWJA8moBy","in_reply_to_user_id":"2213957400"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/cdpyIYGnlv","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1111/add.12306/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1111/ad…"}],"mentions":[{"start":79,"end":91,"username":"mevansbrown","id":"1976092548"},{"start":92,"end":101,"username":"SedefovR","id":"955287361"},{"start":102,"end":116,"username":"AddictionJrnl","id":"56739214"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"423448300188999680","possibly_sensitive":false,"created_at":"2014-01-15T13:35:16.000Z","referenced_tweets":{},"id":"423448300188999680","text":"The (mis)use of psychoactive medicines: getting the balance right in complex…' @mevansbrown @SedefovR @AddictionJrnl http://t.co/cdpyIYGnlv"},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/gdzdKmh1ql","expanded_url":"http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids#panel2","display_url":"emcdda.europa.eu/topics/pods/sy…"}],"mentions":[{"start":3,"end":14,"username":"LarsAmbach","id":"1829605148"},{"start":76,"end":83,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":48,"end":58,"tag":"Synthetic"},{"start":59,"end":72,"tag":"Cannabinoids"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"423421488478584832","possibly_sensitive":false,"created_at":"2014-01-15T11:48:44.000Z","referenced_tweets":[{"type":"retweeted","id":"423188586658164737"}],"id":"423421488478584832","text":"RT @LarsAmbach: Cool interactive naming app for #Synthetic #Cannabinoids by @EMCDDA: http://t.co/gdzdKmh1ql … Build a structure, get a name."},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/E7u2fIkQTw","expanded_url":"http://eepurl.com/L7Au1","display_url":"eepurl.com/L7Au1"}],"mentions":[{"start":73,"end":84,"username":"EDSSLisbon","id":"2213957400"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"423394705309569024","possibly_sensitive":false,"created_at":"2014-01-15T10:02:18.000Z","referenced_tweets":{},"id":"423394705309569024","text":"Keep up with all the latest on the European drugs summer school — follow @EDSSLisbon or sign up for the newsletter: http://t.co/E7u2fIkQTw"},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/6BUzV3mgUP","expanded_url":"http://www.youtube.com/watch?v=BjCSe0L-en8&feature=youtu.be","display_url":"youtube.com/watch?v=BjCSe0…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"423392273003315200","possibly_sensitive":false,"created_at":"2014-01-15T09:52:38.000Z","referenced_tweets":{},"id":"423392273003315200","text":"Learn a bit more about and watch some testimonials about the European drugs summer school in this short video: http://t.co/6BUzV3mgUP"},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/dZSh46ECkA","expanded_url":"http://www.emcdda.europa.eu/news/2014/fs1","display_url":"emcdda.europa.eu/news/2014/fs1"}],"mentions":{},"annotations":[{"start":65,"end":70,"probability":0.9921,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"423391976742850560","possibly_sensitive":false,"created_at":"2014-01-15T09:51:28.000Z","referenced_tweets":{},"id":"423391976742850560","text":"Registration is now open for the European drugs summer school in Lisbon. Scholarships, and discounts available: http://t.co/dZSh46ECkA"},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/otZtO7cuUF","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"}],"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":49,"end":51,"probability":0.3433,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"422660987687550976","possibly_sensitive":false,"created_at":"2014-01-13T09:26:46.000Z","referenced_tweets":[{"type":"retweeted","id":"422660360550612992"}],"id":"422660987687550976","text":"RT @EMA_News: Interested in a traineeship at the EMA? Application details for 2014 now available: http://t.co/otZtO7cuUF"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/UTVjlsuIb3","expanded_url":"http://goo.gl/Er4CPV","display_url":"goo.gl/Er4CPV"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"421559848703377408","possibly_sensitive":false,"created_at":"2014-01-10T08:31:14.000Z","referenced_tweets":[{"type":"retweeted","id":"421268513378930688"}],"id":"421559848703377408","text":"RT @mvapmoreira: Maintenance agonist treatments for opiate-dependent pregnant women, a Cochrane review http://t.co/UTVjlsuIb3"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":17,"end":19,"probability":0.8811,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"421559753681424384","possibly_sensitive":false,"created_at":"2014-01-10T08:30:52.000Z","referenced_tweets":[{"type":"retweeted","id":"421429753380605952"}],"id":"421559753681424384","text":"RT @mevansbrown: FDA seeking comments on 26 substances (mostly NPS) that will be subject to critical review at 36th ECDD https://t.co/E4YKQ…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":36,"end":55,"probability":0.4922,"type":"Organization","normalized_text":"Kings College London"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"420853489594826752","possibly_sensitive":false,"created_at":"2014-01-08T09:44:25.000Z","referenced_tweets":[{"type":"retweeted","id":"420610939864358912"}],"id":"420853489594826752","text":"RT @mevansbrown: Researcher post at Kings College London looking at prescribed and over-the-counter codeine use, misuse and dependence http…"},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/JITeFd81DF","expanded_url":"http://goo.gl/xkjEQD","display_url":"goo.gl/xkjEQD"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":107,"end":116,"username":"NIDAnews","id":"102234123"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"420853477192237056","possibly_sensitive":false,"created_at":"2014-01-08T09:44:22.000Z","referenced_tweets":[{"type":"retweeted","id":"420173357468745728"}],"id":"420853477192237056","text":"RT @mvapmoreira: Open applications for NIDA's fellowships for postdoctoral training http://t.co/JITeFd81DF @NIDAnews"},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/0XmEYrpDHe","expanded_url":"http://goo.gl/7lcWtO","display_url":"goo.gl/7lcWtO"}],"mentions":[{"start":3,"end":11,"username":"HRInews","id":"253043017"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"420467661672579072","possibly_sensitive":false,"created_at":"2014-01-07T08:11:17.000Z","referenced_tweets":[{"type":"retweeted","id":"420184127350915073"}],"id":"420467661672579072","text":"RT @HRInews: New report calls for the reduction of drug-induced deaths &amp; improvement of harm reduction in prisons http://t.co/0XmEYrpDHe  @…"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/bO7SiVIwDk","expanded_url":"http://www.emcdda.europa.eu/news/2013/fs13","display_url":"emcdda.europa.eu/news/2013/fs13"}],"mentions":{},"annotations":[{"start":36,"end":55,"probability":0.6694,"type":"Organization","normalized_text":"Scientific Committee"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"414047753421860864","possibly_sensitive":false,"created_at":"2013-12-20T15:00:51.000Z","referenced_tweets":{},"id":"414047753421860864","text":"Delighted to announce today our new Scientific Committee for 2014-2016. Warm thanks also to the outgoing members: http://t.co/bO7SiVIwDk"},{"entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/ndWiV4dlXl","expanded_url":"http://www.emcdda.europa.eu/vacancies/2014/traineeships","display_url":"emcdda.europa.eu/vacancies/2014…"}],"mentions":{},"annotations":[{"start":46,"end":51,"probability":0.8574,"type":"Place","normalized_text":"Lisbon"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"413693912503427072","possibly_sensitive":false,"created_at":"2013-12-19T15:34:49.000Z","referenced_tweets":{},"id":"413693912503427072","text":"Apply for a paid traineeship with us in 2014 (Lisbon). Areas: new drugs, markets, data management, &amp; interventions: http://t.co/ndWiV4dlXl"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"TimGluckman","id":"302152701"},{"start":32,"end":39,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":43,"end":44,"probability":0.8851,"type":"Place","normalized_text":"UK"}],"hashtags":[{"start":17,"end":21,"tag":"PHE"},{"start":81,"end":91,"tag":"injecting"},{"start":94,"end":102,"tag":"smoking"},{"start":103,"end":111,"tag":"opiates"},{"start":112,"end":118,"tag":"crack"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"413291152738381824","possibly_sensitive":false,"created_at":"2013-12-18T12:54:24.000Z","referenced_tweets":[{"type":"retweeted","id":"413279620645928960"}],"id":"413291152738381824","text":"RT @TimGluckman: #PHE report to @EMCDDA on UK drug position:significnt switch f/ #injecting t #smoking #opiates/#crack Tables 4.1&amp;4.2 http:…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"TimGluckman","id":"302152701"},{"start":32,"end":39,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":136,"end":137,"probability":0.7822,"type":"Place","normalized_text":"UK"}],"hashtags":[{"start":112,"end":121,"tag":"overview"},{"start":128,"end":135,"tag":"entire"}]},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"413291130386939904","possibly_sensitive":false,"created_at":"2013-12-18T12:54:18.000Z","referenced_tweets":[{"type":"retweeted","id":"413290810528890880"}],"id":"413291130386939904","text":"RT @TimGluckman: Shows value of @EMCDDA again: stats f/ so many sources r collected in 1 report; vg place t get #overview and 4 #entire UK …"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/MSOp7KboLF","expanded_url":"http://goo.gl/ltXKv5","display_url":"goo.gl/ltXKv5"}],"mentions":[{"start":1,"end":13,"username":"mvapmoreira","id":"2206996310"}],"annotations":[{"start":44,"end":46,"probability":0.5234,"type":"Organization","normalized_text":"NPS"}],"hashtags":[{"start":31,"end":40,"tag":"research"},{"start":54,"end":60,"tag":"H2020"}]},"lang":"en","author_id":"50638521","source":"Twitter for Mac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"412910893903532032","possibly_sensitive":false,"created_at":"2013-12-18T08:37:17.000Z","referenced_tweets":[{"type":"replied_to","id":"412910893903532032"}],"id":"413226447592226816","text":"“@mvapmoreira: Opportunity for #research on NPS under #H2020 call on New approaches to improve human safety testing http://t.co/MSOp7KboLF”","in_reply_to_user_id":"2206996310"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"}],"annotations":{},"hashtags":[{"start":39,"end":44,"tag":"ISEC"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"412523815449952256","possibly_sensitive":false,"created_at":"2013-12-16T10:05:16.000Z","referenced_tweets":[{"type":"retweeted","id":"412519515558129664"}],"id":"412523815449952256","text":"RT @mvapmoreira: Just published - 2013 #ISEC call for proposals on illicit drug trafficking and new psychoactive substances http://t.co/6Li…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":91,"end":103,"probability":0.2098,"type":"Place","normalized_text":"Baumann et al"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"412506497592356864","possibly_sensitive":false,"created_at":"2013-12-16T08:56:27.000Z","referenced_tweets":[{"type":"retweeted","id":"411826906326368257"}],"id":"412506497592356864","text":"RT @mevansbrown: Excellent preclinical study that reports on pharmacology/MoA of MDPV from Baumann et al., published in 2013… http://t.co/H…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mevansbrown","id":"1976092548"}],"annotations":[{"start":64,"end":66,"probability":0.6172,"type":"Organization","normalized_text":"NPS"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"412506353559953408","possibly_sensitive":false,"created_at":"2013-12-16T08:55:53.000Z","referenced_tweets":[{"type":"retweeted","id":"411812072750870528"}],"id":"412506353559953408","text":"RT @mevansbrown: There are 30 national early warning systems on NPS that are part of the pan-European Early Warning System: http://t.co/IOv…"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"BinghamInfo","id":"1914426696"},{"start":20,"end":32,"username":"mevansbrown","id":"1976092548"},{"start":55,"end":62,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":71,"end":73,"probability":0.4948,"type":"Organization","normalized_text":"NPS"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"412506191928238081","possibly_sensitive":false,"created_at":"2013-12-16T08:55:14.000Z","referenced_tweets":[{"type":"retweeted","id":"411816030554816512"}],"id":"412506191928238081","text":"RT @BinghamInfo: RT @mevansbrown: Learn more about the @EMCDDA work on NPS, including the pan-European Early Warning System http://t.co/nBT…"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/2NTYvTg25V","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/drug-squads","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":105,"end":110,"probability":0.9928,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"411143547966865408","possibly_sensitive":false,"created_at":"2013-12-12T14:40:35.000Z","referenced_tweets":{},"id":"411143547966865408","text":"Drug squads are units specialised in drug law enforcement. This study looks at how they are organised in Europe: http://t.co/2NTYvTg25V"},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/D7No85zzZe","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/co-morbidity","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":49,"end":54,"probability":0.9893,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"411143046311317504","possibly_sensitive":false,"created_at":"2013-12-12T14:38:35.000Z","referenced_tweets":{},"id":"411143046311317504","text":"'Co-morbid substance use and mental disorders in Europe: a review of the data': http://t.co/D7No85zzZe"},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/2W2uk9jcjS","expanded_url":"http://www.emcdda.europa.eu/news/2013/fs12","display_url":"emcdda.europa.eu/news/2013/fs12"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"411142694061088768","possibly_sensitive":false,"created_at":"2013-12-12T14:37:11.000Z","referenced_tweets":{},"id":"411142694061088768","text":"New publications series just launched aimed at policymakers and specialists with. Learn all the details here: http://t.co/2W2uk9jcjS"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/oZIHVAzWIi","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/sr-internal-security","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"411140544631287808","possibly_sensitive":false,"created_at":"2013-12-12T14:28:39.000Z","referenced_tweets":{},"id":"411140544631287808","text":"Also published today: 'Drug supply reduction and internal security policies in the European Union: an overview': http://t.co/oZIHVAzWIi"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/d3UTrL8t9M","expanded_url":"http://www.emcdda.europa.eu/publications/emcdda-papers/advocacy","display_url":"emcdda.europa.eu/publications/e…"}],"mentions":{},"annotations":[{"start":105,"end":110,"probability":0.9953,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"411140124085202944","possibly_sensitive":false,"created_at":"2013-12-12T14:26:58.000Z","referenced_tweets":{},"id":"411140124085202944","text":"Just published: a study exploring the civil society organisations that engage in drug policy advocacy in Europe: http://t.co/d3UTrL8t9M"},{"entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/ouXGSZyQgr","expanded_url":"http://inef.ie/?p=6496","display_url":"inef.ie/?p=6496"}],"mentions":[{"start":3,"end":8,"username":"INEF","id":"24549260"},{"start":26,"end":33,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"410777730524127232","possibly_sensitive":false,"created_at":"2013-12-11T14:26:57.000Z","referenced_tweets":[{"type":"retweeted","id":"410763646386864130"}],"id":"410777730524127232","text":"RT @INEF: Presentation to @EMCDDA on Silk Road Market Place  http://t.co/ouXGSZyQgr"},{"entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/x2sGFiSeKV","expanded_url":"http://www.emcdda.europa.eu/activities/research","display_url":"emcdda.europa.eu/activities/res…"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":44,"end":51,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":25,"end":37,"tag":"Horizon2020"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"410777423412604928","possibly_sensitive":false,"created_at":"2013-12-11T14:25:44.000Z","referenced_tweets":[{"type":"retweeted","id":"410775106147741696"}],"id":"410777423412604928","text":"RT @mvapmoreira: Link to #Horizon2020 calls @EMCDDA http://t.co/x2sGFiSeKV"},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/x2sGFiSeKV","expanded_url":"http://www.emcdda.europa.eu/activities/research","display_url":"emcdda.europa.eu/activities/res…"}],"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":94,"end":101,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":23,"end":35,"tag":"Horizon2020"},{"start":36,"end":42,"tag":"h2020"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"410706994358910976","possibly_sensitive":false,"created_at":"2013-12-11T09:45:52.000Z","referenced_tweets":[{"type":"retweeted","id":"410701596578689024"}],"id":"410706994358910976","text":"RT @mvapmoreira: First #Horizon2020 #h2020 calls to be launched today. We'll publish the link @EMCDDA here http://t.co/x2sGFiSeKV"},{"entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"mvapmoreira","id":"2206996310"},{"start":104,"end":111,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"408916834017353728","possibly_sensitive":false,"created_at":"2013-12-06T11:12:25.000Z","referenced_tweets":[{"type":"retweeted","id":"408916477639553024"}],"id":"408916834017353728","text":"RT @mvapmoreira: Our Management Board has just appointed a new Scientific Committee (2014-2016) for the @EMCDDA"},{"entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"eurogender","id":"146793059"},{"start":103,"end":110,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":86,"end":98,"probability":0.9338,"type":"Person","normalized_text":"Wolfgang Götz"}],"hashtags":[{"start":17,"end":21,"tag":"VAW"},{"start":111,"end":123,"tag":"WhiteRibbon"}]},"lang":"en","author_id":"50638521","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"408900551511121920","possibly_sensitive":false,"created_at":"2013-12-06T10:07:43.000Z","referenced_tweets":[{"type":"retweeted","id":"408625975945986048"}],"id":"408900551511121920","text":"RT @eurogender: \"#VAW should not be tolerated and efforts must be made to prevent it\" Wolfgang Götz of @EMCDDA #WhiteRibbon http://t.co/QyU…"},{"entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/uAx7mVqP2C","expanded_url":"http://www.nature.com/news/policy-twenty-tips-for-interpreting-scientific-claims-1.14183?WT.ec_id=NATURE-20131121","display_url":"nature.com/news/policy-tw…"}],"mentions":[{"start":3,"end":14,"username":"kenanmalik","id":"18696855"}],"annotations":{},"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"408853108421566464","possibly_sensitive":false,"created_at":"2013-12-06T06:59:11.000Z","referenced_tweets":[{"type":"retweeted","id":"403838864022052864"}],"id":"408853108421566464","text":"RT @kenanmalik: Twenty tips for interpreting scientific claims: http://t.co/uAx7mVqP2C"},{"entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":92,"end":97,"probability":0.7644,"type":"Person","normalized_text":"Nelson"}],"hashtags":{}},"lang":"en","author_id":"50638521","source":"Twitter for iPhone","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}},"conversation_id":"408850104490418176","possibly_sensitive":false,"created_at":"2013-12-06T06:47:15.000Z","referenced_tweets":[{"type":"retweeted","id":"408738046679330816"}],"id":"408850104490418176","text":"RT @EU_Commission: Joint message by Presidents @BarrosoEU and @EUHvR on the passing away of Nelson #Mandela http://t.co/htnQ5a47nC"}]
